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CHAPTER 1 
CHOLELITHIASIS AND VARIATIONS IN PRACTICE -
AN INTRODUCTION 

GALLSTONE DISEASE 
Gallstone disease (cholelith iasis) is one of the most common gastroenterologica l disorders, 
associated with significant morbidity and expenses. 1 Gal lstones are crystalline deposits 
and result from a misbalance in physical-chemical composition of bile. Approximately 
37-86% of cholelithiasis patients have gallstones mainly consisting of cholesterol. Other 
types include pigment (2-27%) or mixed (4-16%) stanes (a combination of cholesterol 
and pigmented stones).2- 3 The types of gallstone vary by their cause. Risk factors for 
cholesterol stone formation include female gender, pregnancy, high dose estragen 
treatment, increasing age, genetic susceptibi lity, obesity, high serum triglyceride levels, 
low levels of high density cholesterol, rapid weight cycling, high ca lorific diet, refined 
carbohydrate diet, lack of physical activity, cirrhosis, Crohn's disease, and ethnicity w ith 
higher prevalenee in Caucasians and lower prevalenee in Africans and Asians . Hemolysis 
and chronic bacterial or parasitic i nfections are considered the ma in risk factors for 
pigment stones 4 -6 
EPIDEMIOLOGY AND DIAGNOSIS 
Depending on risk factors, the estimated prevalenee of gallstones ranges between 5 
and 22%.6• 7 Approximately 80% of these patients remain asymptomatic during their 
lifetime. Annually, about 2-4% of patients with gallstones will develop symptoms.8-10 
This corresponds to 29,000 patients in the Netherlands a year, who are diagnosed with 
symptomatic cholel ithiasis. 11 Cholelithiasis is complicated by acute ca lculous cholecystitis 
(0.3-0.4% annually), 5· 12-15 acute biliary pancreatit is (0 .04-1 . 5% annually), 5· 15 common bile 
duet stanes (0.1 -0.4% annually), 5• 13- 15 and cholangitis (0.3-1.6% annually).16 Although 
the incidences are low, these complications can be serious and life threaten ing. Symptoms 
that suggest the presence of complications include fever, rigors, hypotension, dark urine, 
acholie stools, jaundice, or a positive Murphy's sign . Approximately 85% of patients with 
symptomatic gallstone disease have symptoms without signs of compl ications.9 These 
patients mainly report bil iary colicky pain, defined as severe steady pain, lasting 15-30 
minutes or more, usually located in epigastrium and/or right upper quadrant, 17· 18 pain 
radiating to the back and a positive reaction to simple analgesics. 19 However, many 
patients report less specific abdominal symptoms ranging from dyspeptic symptoms to 
chronic abdominal pain that are often attributed to the coexisting ga llstones.20 
The diagnosis of uncomplicated symptomatic cholel ithiasis is basedon symptomatology 
and radiological detected gallstones.20 Patients that present with symptoms suggestive 
of gallstones, who do not have features of complications, can be investigated w ith 
ultrasonography in an elective setting. Transabdominal ultrasonography is the first line 
methad for detecting gallstones with a sensitivity of 84% and specificity of 99% 2 1 Aft er 
gallstones have been confi rmed, patients can be referred toa surgeon for treatment. 
TREATMENT 
Conservative treatment is currently recommended for patients with asymptomatic 
gallstones. Only in patients with porcelain gallbladders or ga llstones of > 3 cm 
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14 
cholecystectomy may be considered, due to the association with gal I bladder ca neer. 22· 23 
No evidence exists that lifestyle modifications such as decreasing fatty food intake or 
increasing exercise decreases or prevents the incidence of symptoms in people with 
asymptomatic gallstones. Surgical intervention for asymptomatic gallstones is not 
recommended because of potential surgery-related complications. These compl ications 
include bleeding, infection or bile duet injury. 24 · 25 In addition, the majority of patients w il I 
never become symptomatic during their lifetime.8•10 Therefore, treatment of patients with 
asymptomatic cholelith iasis is generally considered not to be appropriate. 26 
A treatment option for symptomatic cholelithiasis is extracorporeal shock wave 
lithotripsy. However, only 24% of carefully selected patients were free of stanes after 
extracorporeal shock wave lithotripsy27 Another disadvantage is the high rate of recurrent 
gallstones: In more than 40% of patients gallstones recurred within four years .28 
Bile acid dissalution therapy with ursodeoxycholic acid has also been suggested as 
treatment option for symptomatic cholelithiasis . However, only 38% of patients had 
dissalution of stanes after treatment of ursodeoxycholic acid for more than 6 months.29 
Gallstones also aften recurred and many patients remained symptomatic: Over three 
months, only 26% of patients remained colic free after treatment w ith ursodeoxycholic 
acid compared with 33% after placebo.30 In add ition, 2% of patients had gal lstone 
complications after treatment with ursodeoxycholic acid, which is sim ilar to the annual 
rate of complications in those nat taking the drug 31 These options are not recommended 
for the treatment of symptomatic cholelithiasis. 26 
A feasible option is to wait and see, especially in patients with cholelithiasis with more 
aspecific abdominal symptomsY· 33 Abdominal symptoms can be caused by a variety 
of alternative diseases, also in presence of ultrasound proven gallstones. Symptoms 
may be caused by functional dyspepsia, irritable bowel syndrome, peptic ulcer, chronic 
obstipation, or esophageal spasms. In these cases, the detected gal lstones seem to be 
asymptomatic and just an incidental finding.32· 34 
The first choice therapy for symptomatic cholelithiasis is cholecystectomy and is 
defined as the surgical remaval of bath gallbladder and gallstones. Cholecystectomy is 
generally performed by keyhole eperation (laparoscopie cholecystectomy), because of 
the shorter length of hospita! stay, decreased pain, earlier return to work, and better 
cosmesis as compared to open cholecystectomy. 24 Cholecystectomy is associated with 
5.5% morbidity and 0.2% mortality.35· 36 This surgical procedure is performed frequently 
with more than 22,000 cholecystectomies in the Netherlands a year. 11 The direct- hospita I 
related- casts of cholecystectomy are approximately 55 million euroY More than 60% of 
the total casts of employed patients are caused by indirect casts related to sick leave of 
employees.38 In successful cholecystectomy, time befare return to work ranges from 1 up 
to 10 weeks. 39 Consequently, the total casts related to cholelithiasis are many t imes higher 
than 55 million Euro. 
In complicated symptomatic cholel ithiasis the indication for cholecystectomy is strict, 
since the main aim of this procedure is to prevent recurrence of potentia l life-threatening 
complications. In uncomplicated symptomatic cholelithiasis cholecystectomy is also aften 
performed, mainly to cure abdominal symptoms. However, 10-40% of patients are not 
relieved from their symptoms, despite cholecystectomy.40 These patients are considered 
to have had an unnecessary cholecystectomy with associated risks of compl ications and 
unnecessary healthcare expenses. In addition, Dutch insurance companies have noted 
a considerable practice variation in cholecystectomies in the Netherlands. In 2009, 
the number of cholecystectomies va ried between 48 and 262 operations per 100,000 
inhabitants among different areas. which is a f ivefold difference. This remarkable 
discrepancy could not fully be expla ined by variations in patient characteristics as these 
data were corrected for age, gender, socia l economie status, and diabetes. This suggests 
similar patients with gallstones and abdominal symptoms receive cholecystectomy in one 
area. whereas treatment had been more conservative in another region. Consequently, 
these variations in practice are attributable toa lack of evidence and to preferences that 
differ by surgeon (Figure 1)41 
PATIENT-REPORTED OUTCOME MEASURES 
Patient-reported outcomes have been suggested as a tooi to reduce variat ions in practice. 
Clinical outcome data that have been collected for a long time in health care have 
Legend: Corrected number of 
surgeries per 100.000 inhabitants 
48 - 117 {PO-P20) 
117 - 135 {P20-P40 ) 
• 135 - 152 {P40-P60) 
• 152 - 170 {P60-P80) 
• 172 - 262 (P80-P100) 
Score practice variation/ 100.000 
insured on municipalitv level 
Mean 144 
Min 48 
P25 (1'' quartile) 123 
P75 (3'" quartile) 166 
Max 262 
Figure 1. Practice variatien in the number of cholecystectomies at the municipal level (number of 
operations per 100,000 insured) in the Netherlands in 2009. Th is is the municipality where the patient 
lives. not to municipality where the intervention took place4 1 
!I 
I 
0 
' m 
' =i 
I 
~ 
~ 
VI 
~ 
z 
0 
~ 
;>:J 
~ 
ë5 
z 
VI 
z 
-o 
;>:J 
~ 
!I 
-1 
n 
m 
I 
~ 
z 
z 
-1 
;>:J 
0 
0 
c 
!I 
-1 
ë5 
z 
15 
Î\ 
I 
0 
r-
m 
' =i 
I 
)> 
~ 
Vl 
}> 
z 
0 
~ 
;;o 
~ 
ë5 
z 
Vl 
z 
-u 
;;o 
}> 
Î\ 
-i 
n 
m 
I 
}> 
z 
z 
-i 
;;o 
0 
0 
c 
Î\ 
-i 
ë5 
z 
16 
mainly centered on death. Other clinical indicators include infection rates, readmissions, 
re-operations, and adverse events. The aim of most health care services is to imprave 
patients' health. However, routine measurement on the degree of impravement patients 
experience after treatment has not be initiated until quite recently. In fact, patients 
themselves are best able to judge how they feel. The patient's perspective of health is 
highly re levant for improving the quality and effectiveness of health care.42 
Patients' viewpoints and priorities of patients may not be the same as the perspectives 
of their clinicians. Furthermore, t here is often little correlation between symptom severity 
and disease severity.43 This has led to increased interest in patient-reported outcome 
measures (PROMs). PROMs are important to clinicians as feedback on the care they have 
provided. PROMs are generally measured using generic and disease-specific standardized 
questionnaires, through which patients report on their symptoms, health-related qua lity 
of life, and satisfaction. The responses in addition to clinical outcome data can be used to 
predict which patient will benefit from a certain treatment and which patient wi ll not 4 3 
In case of patients diagnosed with symptomatic cholelithiasis PROMs can be applied 
to assess preoperative symptoms. Subsequently, PROMs can measure which patient has 
benefited from cholecystectomy and which patient did not. Eventually, these resu lts may 
personalize healthcare by predicting which future type of patient w ith cholelith iasis wi ll 
likely benefit from surgical treatment versus patients that will likely not. 
MAIN AlM 
Therefore, the main aim of this thesis is to assess which patients diagnosed w ith 
uncomplicated symptomatic cholelithiasis will benefit from cholecystectomy using 
PROMs. In addition, we aimed to evaluate a strategy to reduce the number of non-
beneficia! cholecystectomies and consequently unnecessary health care expenses. 
THE APPROACH 
In order to address the abovementioned issues we used three different study designs. 
1. Systematic review with or without meta-analysis 
We performed a systematic review of cohort studies to assess the effectiveness of 
cholecystectomy in patients with uncomplicated symptomatic cholelithiasis in terms 
of persistent and de novo symptoms. A systematic review with a sim ilar aim had been 
performed previously. However, this review did not distinguish between persistent and 
de novo symptoms. Furthermore, this review was dated 2003, highlighting the need for 
an updated review.44 
In addition, a systematic review w ith meta-analysis was performed to assess the va lue of 
esophagogastroduodenoscopy (EGD) in patients referred for cholecystectomy. Literature 
shows contradictory results about the value of routine EGD in patients referred for 
cholecystectomy highlighting the need for a systematic review and meta-analysis.45 
The advantage of this type of study method is the overview of evidence this model yields. 
Furthermore, we consider this methad as an ideal starting point for add it ional studies as 
reviews summarizes the available evidence. 
2. Prospective cohort study 
In order to assess characteristics that are associated with absence of pain after 
cholecystectomy, we performed a prospective cohort study with a short term foll ow-up 
as well as a cohort study with a long term follow-up. We used PROMs routinely to assess 
abdominal symptoms of patients that will undergo cholecystectomy. We chose to use 
the McGill Pain Questionnaire as disease specific PROM to measure pain characteristics, 46· 
47 because the diagnosis of uncomplicated symptomatic cholelithiasis is based on 
abdominal pain in presence of ultrasound proven gallstones. As generic PROM we chose 
the Gastrointestinal Quality of life Index (GIQL1), 48· 49 because this questionna ire measures 
not only the braad spectrum of abdominal symptoms, but also emotional, physical and 
social well-being . These two questionnaires have been used separately in previous studies 
with cholelithiasis patients. We also used the Patient Experience of Surgery Questionnaire 
(PESO) to ask patients if their abdominal symptoms had improved and how they rated 
the result of the cholecystectomyso. 51 Since the abdominal pa in associated w ith gallstones 
frequently appears in episodes we also performed a cohort study wi th a long term fo llow-
up. A short fol low-up study may lead to beneficia! cholecystectomies initiall y, but these 
may be not beneficia! had the fol low-up been longer. We asked patients to complete 
paper-based PROM questionnaires. The advantage of using paper-based questionnaires is 
that respondentscan complete the questionnaire at a moment they prefer. Furthermore, 
bath younger as well as older patients know how to complete such a questionnaire. 
The disadvantage is that respondents can skip questions or provide answers that are not 
readable, leading to incomplete questionnaires. Although these disadvantages are absent 
with internet based surveys, this type of questionnaire may be more prone to selection 
bias as a subset of the general popu lation is unable to use the internet properly.52· 53 
We have considered case-control as study model to assess our research question. 
However, this t ype of study has some disadvantages. First, selective reporting wil l bias 
the results. Second, this model would have been a challenge for logistical reasons to 
ascertain patients with postoperative pain. Therefore, we considered a prospective cohort 
study the best design for addressing our study aim. 
3. Decision analytic modelling 
A decision analytic model was performed to evaluate the cost-effectiveness of a strategy, 
basedon predietors of postoperative absence of pa in, toselect patients for cholecystectomy 
versus the usual care strategy with variations in cholecystectomy indication. Decision 
analytic modeling compares the expected casts and consequences of decision options by 
synthesizing information from multiple sourees and applying mathematica! techniques 
with computer software. The aim of this type of study model is to provide decision makers 
with the best available evidence to reach a decisions4 For our study this wou ld indicate to 
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18 
decide whether the st rategy to select patients for cholecystectomy, based on predietors 
of postoperative absence of pain, should be adopted. 
Economie evaluations can also be conducted alongside randomized controlled 
trials, providing researchers with individual patient data to estimate cost-effectiveness. 
However, randomized controlled trials do not always provide a sufficient basis for 
economie evaluations used to inform regulatory and reimbursement decisions. A single 
trial might not compare all the available options, provide evidence on all relevant input, 
or be conducted over sufficient t ime to capture differences in economie outcomes. 
Furthermore, rel iance on a single trial may indicate ignoring evidence from other trials, 
meta-analysis and observational studies. Finally, an initial trial might be challenging to 
conduct randomizing patients between st rategies . Under these circumstances, decision 
analytic modeling provides an alternative framewerk for economie evaluation. 54 
OUTLINE 
The background and framewerk for the thesis is described in Chapter 1. In Chapter 2 
we systematically reviewed the effectiveness of elective cholecystectomy for patients with 
cholecystolith iasis in terms of persistent and de novo symptoms. Chapter 3 describes 
a perspective on how to reduce variatien in clinica l practice using outcomes reported 
by patients. In Chapter 4 we used PROMs to assess the association of preoperative 
pain characteristics with absence of pain after cholecystectomy in a Dutch multicenter 
prospective cohort study. Since abdominal symptoms associated w ith ga llstones often 
occur in episodes, we also assessed which characteristics were associated with absence 
of pain and patient-reported success of surgery after at least 5 years of follow-up in 
Chapter 5. The easy access to ultrasonography and the overlap between symptomatology 
of cholelithiasis with other upper gastrointestinal diseases may be the reason for the low 
threshold towards cholecystectomy. Gastritis, esophagitis, or peptic ulcer might be 
alternative diagnoses for these abdominal complaints and these diseases can be easi ly 
diagnosed with EGD. In addition, literature on the value of routine EGD in patients 
referred for cholecystectomy is conflicting, highlighting the need fora systematic review 
and meta-analysis. We present these results in Chapter 6. In Chapter 7 we used decision 
analytic modelling to evaluate the cost-effectiveness of a new diagnostic strategy to 
reduce the number of non-beneficia I cholecystectomies. Research should not only further 
explore which patients will benefit from cholecystectomy, but also which patients w ill 
benefit most. In Chapter 8 w e aimed to assess the associations of f requency, maximum 
duration and intensity of abdominal pain episodes w ith impravement of health status in 
order to define the population with uncomplicated symptomatic cholecystolithiasis that 
benefit most from cholecystectomy. In addition to these stud ies we assessed the best 
evidence for management of cholel ithiasis. The last Dutch guideline on management of 
cholelithiasis stems from 2007. Chapter 9 describes the most recent developments on 
diagnosis and treatment of cholelithiasis of the 2007 revised Dutch guideline. Fina lly, 
we completed the thesis by a general discussion and future perspectives in Chapter 10. 
This chapter summarizes the results and offers suggestions for further reducing practice 
variations in management of cholelithiasis. 
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PERSISTENTAND DE NOVO SYMPTOMS 
AFTER CHOLECYSTECTOMY: A SYSTEMATIC REVIEW 
OF CHOLECYSTECTOMY EFFECTIVENESS 
Mark P Lamberts1.2·5, 
Marjolein Lugtenberg2, 
Maroeska M. Rovers3, 
Jan A. Roukema4, 
Joost P. H. Drenth 1, 
Gert P Westert2, 
Cornelis J. H. M. van Laarhoven5 
' Department of Gastroenterology and Hepatology, Radboud University Medical Centre, 
Nijmegen, the Netherlands 
2Scientific lnstitute for Quality of Healthcare (IQ healthcare), Radboud University Medical Centre, 
Nijmegen, the Netherlands 
3Department of Operating rooms and Epidemiology, biostatistics and HTA, Radboud University 
Medical Centre, Nijmegen, The Netherlands 
4Department of Surgery, St. Elisabeth Hospital, Tilburg, The Netherlands 
5Department of Surgery, Radboud University Medical Centre, Nijmegen, The Netherlands 
Surgical Endoscopy, 2013;27(3):709-18 
-u 
m 
;:o 
l/) 
Vi 
-I 
m 
z 
-I 
}> 
z 
CJ 
CJ 
m 
z 
0 (§ 
l/) 
-< 
~ 
~ 
0 
~ 
l/) 
}> 
Tl 
-I 
m 
;:o 
Î\ 
I 
0 
r-
m 
Î\ 
-< 
l/) 
-I 
m 
Î\ 
-I 
0 
~ 
-< 
24 
ABSTRACT 
Background 
Cholecystectomy is the preferred treatment option for symptomatic gallstones, but 
the exact relationship between cholecystectomies and symptoms sti ll is unclear. This 
study aimed to assess the effectiveness of elective cholecystectomy for patients with 
cholecystolithiasis in termsof both persistentand de novo symptoms. 
Methods 
A systematic literature search was conducted in Pubmed and Embase. The search included 
studies comprising patients 18 years of age or older undergoing elective cholecystectomy 
for symptomatic cholecystolithiasis. The proportions of symptoms after cholecystectomy 
were calculated and then subdivided into persistent and de novo symptoms. 
Results 
A total of 38 studies reported the presence of postcholecystectomy symptoms. The results 
showed that upper abdominal pa in, thema in indication for cholecystectomy in the majority 
of the patients, mostly disappeared after surgery. However, it persisted in up to 33% of 
the patients and arose de novo in up to 14%. Diarrhea (85%) and constipation (76%) 
were the persistent symptoms most often reported, whereas upper abdominal pa in and 
vomiting we re the least often reported . Flatulence (62 %) was the most of ten reported 
new symptom. However, we found large variations in symptoms between studies. 
Conclusions 
The review indicates that cholecystectomy often is ineffective w ith regard to persistent 
and de novo symptoms. The finding that the types and proportions of persistent 
symptoms differ from those that arise de novo suggests that this distinction may be usefu l 
in predicting which patients wou ld and which would notbenefit from a cholecystectomy. 
BACKGROUND 
About 5-22% of the adult Western population have gallstones. 1• 2 Only 13-22% of these 
patients with gallstones become symptomat ic during their lifetime.3 · 4 Cholecystectomy 
currently is the preterred treatment option for symptomatic cholecystol ith iasis. 5 
Annually, more than 800,000 cholecystectomies are performed in the United States, and 
the associated costs are estimated to be more than $6 billion .1.6 
Despite the high number of cholecystectom ies performed worldwide, this approach 
appears to be ineffective in up to 50% of patients7 Symptoms may persist or arise 
de novo after cholecystectomy8 · 9 
The fi rst challenge in evaluating patients with upper abdominal symptoms found 
to have gallstones is to determine whether the stones are the cause of the symptoms 
or merely an incidental finding. 10• 11 The second challenge is to identify symptoms after 
cholecystectomy that may have arisen de novo. Regardless whether the preoperative 
symptoms have disappeared, new symptoms may arise as a resu lt of the surgical 
procedure. 12 To red uce the number of patients with persistent or new symptoms, more 
evidence of the exact relationship between cholecystectomies and symptoms is needed. 
The effect of elective cholecystectomy on abdominal symptoms has been evaluated in 
a previously conducted review in this journal. 13 However, th is review did not distingu ish 
between persistent and de novo symptoms. Moreover, because th is review was dated 
2003, new evidence may be available, highlighting the need for an updated review. 
This study therefore aimed to systemat ically assess the effectiveness of elective 
cholecystectomy for patients with symptomatic cholecystolithiasis in terms of both 
persistent and de novo symptoms. 
MATERIALS AND METHOOS 
Literature search 
A systematic literature search was conducted in the electronic databases Pubmed (January 
1968-November 2011 ) and Embase ( 1980-November 2011) using several combinations of 
keywords, as shown in Table 1. The preterred reporting items for systematic reviews and 
meta-analyses (PRISMA) checklist was foliowed for all the steps reported in this rev iew. 14 
Selection of studies 
Two reviewers (M.P. L. and M.L.) independently screened the titles and abstracts of 
the art icles and selected potentially relevant articles. They included studies assessing 
the effectiveness of elective cholecystectomy for patients 18 years of age or older with 
symptomatic cholecystolithiasis. Studies that contained patients subjected to acute 
cholecystectomy and patients with symptomatic gallstone disease undergoing elect ive 
cholecystectectomy also were included. Symptomatic gallstone disease was defined as 
the presence of one or more stones in the gallbladder confirmed by transabdominal 
ult rasonography and symptoms attributable to them. 
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Table 1. The search strategy 
Hits Pubmed Hits Embase 
Search (7 Nov 2011) (1968-2011) (1980-2011) 
No. Request 
Cholelithiasis 32,846 25,290 
Cholelithiases 32,848 10 
Stone 75,938 62,452 
Stones 20,637 24,400 
Gallstone 18,161 16,381 
Gallstones 34,781 8,272 
C holecystolithiasis 9,092 830 
Calculi 47,762 14,361 
#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 104,206 104,648 
C holecystectomy 28,065 33,831 
C holecystectomies 28,304 2,036 
#100R#12 28,304 33,998 
Persistent• 282,968 315,050 
lmproved• 1 '139,701 1,346,906 
Red u eed• 1,910,761 2,271,662 
Remaining• 918,230 1,025,979 
Rel ieved• 35,807 41,680 
Re lief 59,457 68,418 
#13 OR #14 OR #15 OR #16 OR #17 OR #18 3,705,623 4,273,680 
#9 AND #12 AND #19 2,574 3,151 
• To include all conjugations the search terms (Persist*), (lmprov*), (Reduc*). (remain*), and (Reliev*) were used 
1-20: Subpartsof the search strategy including different (combinations of) keywords 
The two reviewers further selected the articles according to the following exclusion 
criteria. They excluded all studies other than (retrospective and prospective) cohorts 
or randomized control led trials; studies that comprised only patients with systemic 
chronic diseases such as AIDS, liver cirrhosis, cystic fibrosis, sickle cel l disease because 
the postoperative symptoms in these patients may be significant as a cause of 
the underlying systemic disease; and studies in which the results precluded a comparison 
between pre- and post-operative symptoms. 
In addition, the reviewers consulted the reference lists of all art icles retrieved for 
more detailed information. Discrepancies were resolved by discussion and consensus. lf 
disagreement persisted, a third reviewer (M.M.R.) was available to make the fina l decision. 
Data extraction 
Data from each artiele regarding characteristics of the studies, participants, intervention, 
and symptoms were extracted by one reviewer (M .P.L.) and verified by a second reviewer 
(M.L.).The study characteristics included the authors, year of publ ication, country, study 
design, number of centers, length of the follow-up period, and methad used to measure 
the symptoms postoperatively. The intervention characteristics comprised the type and 
kind of intervention, intraoperative cholangiography, complications, and number of 
conversions. The patient characteristics included the inclusion and exclusion criteria 
used, the number of patients foliowed up and the losses to follow-up evaluation, mean 
age, and proportion of wamen. Symptoms comprised pre- and postoperative symptoms 
(upper abdominal pain, vomiting, nausea, dyspepsia, food intolerance, fat intolerance, 
heartburn, bloating, flatulence, constipation, diarrhea, belching, loss of appetite and, 
acid regurgitation), subdivided whenever possible into persistentand de novo symptoms. 
Discrepancies were resolved by discussion and consensus. 
Methodologie quality 
The methodologie quality of the eligible stud ies was assessed by one reviewer (M.P.L.) and 
checked by a second reviewer (M .L. ) using the strengthening the reporting of observational 
studies in epidemiology (STROBE) checklist. 15 Four items considered the most re levant for 
assessing the methodologie quality of the studies included in this review were selected: 
The design of the study preferably had to consist of a prospective cohort. 
The eligibility criteria and methods used for participant selection had to be described. 
The methods of assessment of pre- and postoperative symptoms had to bedescribed 
and validated or based on validated measurements. 
The numbers and reasans for loss to follow-up evaluat ion had to be addressed. lf no 
dropouts occurred, this had to bedescribed as well. 
Data synthesis and analysis 
The proportions of total postoperative symptoms and the proportion of persistent 
and de novo symptoms were calculated, separately. The proportion of symptoms after 
cholecystectomy was defined as the proportion of patients exh ibiting the symptom 
postoperatively divided by the proportion of patients with the symptom preoperatively. 
The proportion of persistent symptoms was defined as the proportion of patients 
exhibiting the symptom befare and after surgery divided by the proportion of patients 
with the symptom preoperatively. The proportion of symptoms de novo was defined as 
the proportion of patients exhibiting the symptom after but not befare surgery divided by 
the proportion of patients with the symptom preoperatively. 
A sensitivity analysis of the fo llowing quality criteria was performed: 
• Retrospective cohort studies were compared with studies that had 
a prospective design. 
• Studiesusinga nonva lidated measurement tooi were compared with studies that used 
a validated instrument. 
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In addition, we performed the following subgroup analysis regarding the type 
of surgery: 
• Studies that included only patients with an elective cholecystectomy were compared 
with studies that evaluated both patients who had emergency surgery and those who 
underwent elective cholecystectomy. 
• Studies that included patients with a laparoscopie intervention were compared with 
studies that evaluated patients with an open cholecystectomy. 
RESULTS 
Selected studies 
The initia I search yielded 5, 72 5 articles. Aft er remaval of duplicates and studies in other 
languages than English or Dutch, and after applying the first eligibilit y screen ing, the ful l 
texts of 83 articles were screened. After application of the exclusion criteria , 51 of the 83 
studies were excluded. An additional nine publications were identified from the reference 
lists. lf the study results were described in more than one article, they were considered 
as one study. This was the case w ith two articles describing the long-term results of 
three conducted trials. 16' 20 Thus, 38 studies ( described in 41 articles) were included in this 
review, as shown in Fig. 1. 
Characteristics of the studies 
Thema in characteristics of the included studies, participants, and interventions are shown 
in Table 2. The length of follow-up was at least 6 months for 32 and at least 1 year for 
24 studies. In 26 studies, self-administered questionnaires were used postoperatively. Two 
studies included more than 1 ,000 patients. Laparoscopie cholecystectomy was performed 
in 23 studies. 
Quality assessment 
Nine (24%) of the included cohort studies had a retrospective study design.21 ' 29 
The methods of participant selection were poorly or not reported in 
11 studies (29%).7· 9• 23· 30-37 One study (3%) lacked an assessment description of pre- and 
post-operative symptom measurement,34 and in four studies (11 % ), the measurement 
was val idated or based on validated measurements.8• 25· 30· 38 The number of patients 
lost to follow-up evaluation and the reasans for these losses were not reported in 
13 studies (34%).21· 24· 26· 32· 34· 35· 37•43 All four methodologie quality criteria were fulfilled in 
1 (3%) of the 38 studies8 
Proportion of symptoms after cholecystectomy 
As shown in Fig. 2, the proportions of symptoms after cholecystectomy varied greatly 
across symptoms and across studies. The most reported postoperative symptom was 
5725 potentially re levant articles 
identified 
Pubmed (n = 2574) 
EMSASE (n = 3151) 
2555 articles excluded 
Studies in ether languages than Englishar Dutch (n = 1190) 
Duplications (n = 1365) 
3170 articles screened on tilleiabstract 3079 articles excluded 
Studies nat evaluating the effect of cholecystectomy on symptoms in 
patients ~18 years with symptomatic gallstone disease (n = 3079) 
88 articles screened on full text 51 studies excluded 
Other study design than RCT ar cohort study (n = 19) 
Systemic chronic diseases (n = 5) 
Camparisen between pre- and postoperalive results could nat be 
32 articles included 
made (n = 24) 
Overlapping patient groups as other included study (n = 3) 
9 articles retrieved by relerenee checking I 
41 articles included in this review 
Figure 1. Selection of the studies. 
Table 2. Main characteristics of the included studies 
lncluded 
Study patients Measurement Follow-up 
Reference Year design (n} postoperative (months)• Intervention 
Southam37 1968 Pros 12 Nonstructured NR Open 
interview 
Bouchier et al. 32 1968 Pros 17 Nonstructured (6-24) Open 
interview 
Rhind & Watson27 1968 Retro 66 Interview 12 Open 
Johnson24 1971 Retro 108 Interview or postal Mean 14.6 Open 
questionnaire (3-42) 
Gunn & Keddiess 1972 Pros 107 Interview (12-24) Open 
Kingston & Windsor35 1975 Pros 100 Interview Mean 13 Open 
(3-36) 
Feretis et al. 34 1983 Pros 47 NR (3-6) Open 
Ros & Zambon' 1987 Pros 93 Questionnaire & 24 Open 
interview 
Gillil& & Traverso22 1990 Retro 525 Medical records, Mean 45 Open 
questionnaire, (15-79) 
long-term follow-up 
study was obtained 
by mail or telephone 
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Table 2. (continued) 
lncluded 
Study patients Measurement Follow-up 
Reference Year design (n} postoperative (months)• Intervention 
-o 
m 
Bates et al. 51 1991 Pros 274 SCQ 12 & 24 Open ;:o l/) 
Vi J0rgensen et al. 59 1991 Pros 115 Interview (6-12) Open 
-I 
m 
Vander Velpen et al. 28 1993 Retro 56 open; SCQ Open: Median Open & LC z 
-I 
}> 68 LC 14 (6-29); LC 
z 9 (6-30) CJ 
CJ Scriven et al.36 1993 Pros 75 SCQ 12 Open m 
z Qureshi et al.26 1993 Retro 100 SCQ Median 12 LC 0 
< (1 0-19) 0 
l/) Plaisier et al.60 1993 Pros 26 Pain diaries, SCQ (0-3) & (3-6) Open & LC 
-< & (6-12) & ~ 
-o (12-18) -I 
0 
~ Black et al31 1994 Pros 486 SCQ 1.5 Open 
l/) 
Ure et al. 61 1995 Pros 468 SCQ Mean 19 LC 4-trocar }> 
Tl (350-988 days) -I 
m 
;:o Abu Farsakh et al.39 1995 Pros 30 Interview (3-9) NR 
Î\ 
I Fenster et al.33 1995 Pros 188 Physician-derived 3 LC 0 
r- questionnaire, m 
Î\ patient -derived 
-< 
l/) 
questionnaire -I 
m 
Î\ Luman et al44 1996 Pros 97 St&ard questionnaire, Median 7 LC 
-I 
0 outpatient review, or (6-1 0) ~ 
-< telephone interview 
Gui et al 23 1998 Retro 92 Structured interview Mean 3 1.1 Open & LC 
(12-83) 
Victorzon et al.29 1999 Retro 26 1 SCQ Median 24 LC 4-trocar 
(6-NR) 
Borly et al 62 1999 Pros 80 SCQ 12 LC. SIC & CO 
Weinert et al9 2000 Pros 2.481 SCQ 6 Open & LC 
Traverso et al63 2000 Pros 69 1 Patient- & Mean 3 LC & CO 
physician-derived 
questionnaires 
Ahmed et al. ' 6·17 2000 Pros 57 Questionnaire Mean 60 Open 
Niranjan et al 45 2000 Pros 11 1 Interview 1.5 &3&12 LC 4-trocar 
Mjaland et al 4 2 2000 Pros 487 Interview & 3 & 36 LC & CO 
questionnaire 
Burney & Jones40 2002 Pros 140 SCQ 2&6 LC 
Lublin et al.25 2004 Retro 573 Validated SCQ Mean 48 LC 
(6-86) 
Vetrhus et al. 18"20 2005 Pros 124 Structured interview Mean 6 1 LC & CO 
Finan et al 8 2006 Pros 55 Validated SCQ Mean 17.1 LC & CO 
(2-32) 
Vignolo et al 43 2008 Pros 29 SCQ 6 LC 
Bitzer et al30 2008 Pros 130 Validated SCQ 0.5 & 6 LC & CO 
30 
Table 2. (continued) 
lncluded 
Study patients Measurement Follow-up 
Reference Year design (n} postoperative (months)• Intervention 
Halldestam et al.41 2008 Pros 200 SCQ 3 & 12 LC & CO 
Mertenset al.64 2009 Pros 126 SCQ (1 5-2.5) LC 3-trocar 
& co 
Amir21 2009 Retro 200 Interview using 1 & 3 & 6 LC & SIC 
predesigned 
performa 
Thistle et al.38 2011 Pros 1,008 Validated SCQ 3 & 12 Open, LC & 
SIC 
Pros prospective, NR not reported, Retro retrospective, SCQ self-completed questionnaire, LC laparoscopie 
cholecystectomy, SIC small-incision cholecystectomy, CO converted open cholecystectomy, 
• Va lues in parentheses are ranges. 
....... 
111 ~ 140 
E!. 
0 > 120 b.e [.S 100 
lil u 
.... ~ 80 
0 111 c~ 
0 CU 60 
"fo 
0 .c 40 
c.U 
e ~ 20 
a.;: 
111 0 
Figure 2. Proportion of symptoms after cholecystectomy as reported in the studies. Each dot represents 
the estimate of the symptom proportion as reported in one article. A proportion of more than 100% 
means that more patients exh ibit the symptom postoperatively than preoperatively. References 
of the included studies: Upper abdominal pain, UAP 1. 8, 16. 18, 21-23. 26, 21. 29-34, 36, 38. 39, ••. • 2. ••. 45. 51. 58-64; 
vomiting 8. 9. 21. 23. 25. 26. 28. 29. 31. 39·••. 44. 45. 51. 61. 64 ; nausea 8. 9. 21. 23. 25. 26. 28-31. 36. 39·••- 44. •5. 51. 60. 61. 64; 
dyspepsia 1. 21. 23. 2•. 26. 21. 35. 39. 43 ; food intalerance 9. 25, 26. 29, •o. ••. 44. 6' ; fat intalerance 8, 21 . 23, 25. 28, 3o. 36, 39. 60; 
heartburn 9. 21. 23. 25. 28. 29. 37.39-41,44,45, 58. 64; bloating 8. 23. 26. 3o. 36. • •.4•. 5 1,6o; flatulence 8. 9. 2 1. 23. 26. 28. 3o. 31.•o. • •. 45, s1.61, 64; 
constipation 8. 23. 29. 4 1. 44; diarrhea 8, 23. 25. 29. •o. • •. 44. 64 ; belching 8. 9. 36. • o. 45; loss of appetite 8. 3o. 36, ••- 6' ; 
acid regurgitation 8· 41 · 45 
diarrhea. The postcholecystectomy proportions of diarrhea, constipation, and flatulence 
exceeded 100%! 25· 44 indicating that more patients experienced these symptoms 
postoperatively than preoperatively. One study45 demonstrated that cholecystectomy did 
not resolve acid regurgitation as the proportion of patients reporting this symptom did 
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not change with surgery. Upper abdominal pain, vomiting, nausea, food intolerance, and 
loss of appetite showed the lowest postoperative proportions. 
Diarrhea showed the largest variatien between studies (30-140%), whereas food 
intalerance varied the least (1 7-43%). Upper abdominal pain, the most prevalent 
symptom of patients preoperatively (data not shown), demonstrated postcholecystectomy 
proportions ranging from 0 to 41%. 
Proportion of persistent and de novo symptoms 
For 11 of the 38 studies, a distinction was made between persistent and de novo 
symptoms. The proportions of persistentand de novo symptoms are presented in Fig . 3. 
The proportion of de novo symptoms was lower than that of persistent symptoms. 
Diarrhea and constipation were the persistent symptoms most often reported, 
whereas upper abdominal pain and vomiting were the least often reported . Diarrhea 
Figure 3. Persistent (A) and de nova (B) symptom proportions reported in 11 studies. Each dot represents 
the estimate of the symptom proportion reported in one article. References of the included studies: Upper 
abdominal pa in, UAP 8. 21. 23. 26. 29. 39, 45; vomiting 8. 9. 21. 23. 26. 28. 29. 39. 45. 61 ; nausea 8. 9. 21. 23, 26. 28. 29. 39. 45. 61 ; 
dyspepsia 21. n. 26. 39; food intalerance 9. 25. 26. 29. 61 ; fat intalerance 8. 21. 23. 25. 28. 39; hea rtburn 9. 21. 23. 25. 28. 29. 39.45; 
bloating 8· 23· 26; flatulence 8· 9· 21· 23· 26· 28· 45· 61; constipation 8· 23· 29; diarrhea 8· 23 · 25· 29; bekhing 8· 9· 45; 
loss of appetite 8· 61 ; acid regurgitation 8· 45 
demonstrated the largest variation across studies (26-85%). whereas constipation varied 
the least (57-76%). Upper abdominal pain showed proportions ranging from 0 to 33%. 
The most common de novo symptom after surgery was flatulence, whereas upper 
abdominal pain and vomiting only rarely ensued after cholecystectomy. There was 
a wide range in the proportion of patients reporting flatulence (0-62%), whereas food 
intalerance showed the least variation (2-1 0%). Upper abdominal pain demonstrated 
proportions ranging from 0 to 14%. 
The effects of the sensitivity and subgroup analysis 
The effects of the sensitivity analysis on the quality criteria and subgroup ana lysis 
regarding the type of surgery were assessed for upper abdomina l pain because it is 
the main indication for cholecystectomy in the majority of pat ients . Prospective studies 
showed postoperative upper abdominal pain proportions ranging from 0 to 41%, whereas 
retrospective studies demonstrated figures varying between 2 and 38%. Studies using 
nonvalidated measurement tools showed proportions ranging from 0 to 41% compared 
with 4 to 35% in studies using validated instruments. 
In addition, the proportions of upper abdominal pain in the studies t hat included 
only patients with an elective cholecystectomy ranged from 0 to 38%, whereas these 
proportions varied between 4 and 27% for studies that also included emergency 
cholecystectomies. Studies comprising either laparoscopie or open cholecystectomy 
showed upper abdominal pain proportions varying from 1 to 35%, and from 
0 to 41 %, respectively. 
DISCUSSION 
The review findings indicated that cholecystectomy often is ineffective with regard to 
persistent and de novo symptoms. Although upper abdominal pain disappeared after 
surgery for a large proportion of the patients, it persisted for up to 33% and arose 
de novo in up to 14% of the patients. The types of persistent symptoms also differed 
from those that arise de novo. Diarrhea (85%) and constipation (76%) were the most 
often reported as persistent symptoms, whereas upper abdominal pain and vom it ing 
were described the least often. Flatulence (62%) was the de novo symptom mostoften 
reported. However, we found large variations in symptoms between studies. 
The results regarding postoperative upper abdominal pain and other symptoms 
are consistent with those of a previous review. 13 Among the persistent symptoms, 
upper abdominal pain, vomiting, nausea, and food intalerance were the least likely to 
persist according to a large prospective cohort study, 9 which is in line wit h our resu lts. 
These four symptoms also are the only symptoms related to gallstones according to 
a meta-analysis46 
Among the de novo symptoms, upper abdominal pain and flatulence were shown 
to be significantly more prevalent in surgically treated compared with non-surgical ly 
treated patients with gallstones and upper gastrointest inal symptoms in a cohort studyY 
Heartburn, regurg itat ion, bloating, and belching did not occur significantly more often.47 
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These results, in addition to our results of high new flatulence proport ions and upper 
abdominal pain proportions up to 14%, indicate that surgery to cure non-pain symptoms 
seems improper. 
Some potential limitations of our review also should be discussed. First, despite our 
braad search, nine of the 41 included articles were retrieved by searching reference lists. 
However, the majority of these articles were published in Pubmed w ithout an abstract. 
Second, most of the studies included in our review had low methodologie quality, 
with only one study fulfi lling all four quality criteria. Our sensitivity analysis of qua lity 
criteria, however, did not show significant effects . 
Third, the heterogeneity of the studies precluded a forma! meta-analysis. lnstead, 
we reported scatter plots showing the proportions of symptoms. The large variat ion of 
symptoms between studies found in our review could not be explained by the subgroup 
a na lysis regarding the type of performed surgery. However, the scatte red results may have 
been due to large variations in regional practice 4 8 These variations suggest a different 
diagnostic workup, a quicker referral, and a faster operative intervention in one study 
region and a more conservative treatment in another region. Fourth, by studying only 
the befare and after effects, bias might have been introduced via the natura! course of 
symptoms, 31 a placebo effect of surgery,49 or expectancy of patients.20· 50 However, this 
could not be changed due to eth ica! reasons. 
The major strength of our review was that we differentiated between persistent 
and de novo postoperative symptoms. To our knowledge, we are the f irst making this 
distinction. The finding that the types and proportions of persistent symptoms differ 
from those that arise de novo suggests that these two entities may have different causes. 
lrritable bowel syndrome or gastroesophageal diseases such as peptic ulcers or gastritis 
can cause abdominal symptoms. These symptoms aften are attributed to the presence of 
gallstones4 2· 51"54 On the other hand, de novo symptoms may be caused by postoperative 
changes in the intestinal environmentY· 55· 56 By making this distinction, we bel ieve we 
render this group of patients with postoperative symptoms less heterogeneous. This way 
of measuring yields significant valuable information to al low differentiation of patients 
with symptoms after cholecystectomy. 
Future research should further explore the two aforementioned entities using patient-
reported outcomes measured with standardized validated questionnaires. The use of 
patient-reported outcomes measures can be threefold. First, the use of standardized 
validated questionnaires reduces the variations in measurement and definitions 
of symptoms. 
Second, symptom relief, as investigated in this review, is considered a patient-
reported outcome critica! for decision making.57 The systematic use of patient-reported 
cholecystectomy outcomes in termsof quality impravement initiatives has been advocated 
by a previous study in th is journal.30 An accurate report of patient-reported outcomes 
may be important to clinicians and hospitals as feedback on the care they have provided, 
decreasing variations in practice. 
Third, a systematic registration of patient-reported outcomes combined w ith 
demographic and clinical variables may be associated with patterns of persistent or de 
nova symptoms and could be usefu l in differentiating patients who would and would 
nat benefit f rom an operation . Surgeons may use this information to inform patients 
about the prognosis of their symptoms and thereby create realistic expectations befare 
a potential operation. Consequently, this could reduce the proportion of unnecessarily 
performed cholecystectomies as a result of better diagnostics or indications. 
In conclusion, our results indicate that cholecystectomy aften is ineffective because 
some symptoms persistand others occur de nova. This review gives a f irst ind ication that 
the types and proportions of persistent symptoms differ from those that arise de nova, 
suggesting that this distinction may be useful in predicting which patients wou ld and 
would nat benefit from a cholecystectomy. Future research should further explore these 
two entities using patient-reported outcome measures. 
DISCLOSURES 
Mark P. Lamberts, Marjolein Lugtenberg, Maroeska M. Rovers, Jan A. Roukema, Joost 
P. H. Drenth, Gert P. Westert and Cornelis J. H. M. van Laarhoven have no conf licts of 
interest or financial ties to disclose. 
""0 
m 
::>:> 
V\ 
Vi 
-i 
m 
z 
-i 
:t> 
z 
0 
0 
m 
z 
0 
;§ 
V\ 
-< 
:s: 
~ 
0 
:s: 
V\ 
:t> 
::::j 
m 
::>:> 
("") 
I 
0 
r-
m 
("") 
-< 
V\ 
-i 
m 
("") 
-i 
0 
:s: 
-< 
35 
-u 
m 
;:o 
l/) 
Vi 
-I 
m 
z 
-I 
}> 
z 
CJ 
CJ 
m 
z 
0 (§ 
l/) 
-< 
~ 
~ 
0 
~ 
l/) 
}> 
Tl 
-I 
m 
;:o 
Î\ 
I 
0 
r-
m 
Î\ 
-< 
l/) 
-I 
m 
Î\ 
-I 
0 
~ 
-< 
36 
REFERENCES 
1. Everhart JE, Ru hl CE. Burden of digestive diseases 
in the United StatesPart 111: Liver. biliary traà, and 
pancreas. Gastroenterology 2009; 136:11 34-44. 
2. Shaffer EA. Gallstone disease: Epidemiology 
of gallbladder stone disease. Best Pract Res 
Clin Gastroenterol 2006;20:981-96. 
3. Halldestam I, Enell EL, Kuilman E, et al. 
Development of symptoms and complications 
in individuals with asymptomatic gallstones. 
Br J Surg 2004;91 :734-8. 
4. Heaton KW, Braddon FE, Mountford RA, 
et al. Symptomatic and silent gal l stones in 
the community. Gut 1991;32:316-20. 
5. Wittenburg H. Hereditary liver disease: gallstones. 
Best Praà Res Clin Gastroenterol2010;24:747-56. 
6. Everhart JE, Ruhl CE. Burden of digestive 
diseases in the United States part 1: overall 
and upper gastrointestinal diseases. 
Gastroenterology 2009;136:376-86. 
7. Ros E, Zambon D. Postcholecystectomy 
symptoms. A prospective study of gal! stone 
patients before and two years after surgery. 
Gut 1987;28: 1500-4. 
8. Finan KR, Leeth RR, Whitley BM, et al. 
Impravement in gastrointestinal symptoms 
and quality of life after cholecystectomy. Am J 
Surg 2006;192:196-202. 
9. Weinert CR, Arnett D, Jacobs D. Jr .• et al. Relationship 
between persistenee of abdominal symptoms and 
successful outcome after cholecysteàomy. Arch 
Intern Med 2000;160:989-95. 
10. Berger MY, Olde Hartman TC, van der Velden 
JJ, et al. Is biliary pain exclusively related to 
gallbladder stones? A controlled prospective 
study. Br J Gen Pract 2004;54:574-9. 
11. Wallander MA, Johansson S, Ruigomez A, et 
al. Dyspepsia in general practice: incidence, 
risk factors. comorbid ity and mortality. Fam 
Pract 2007;24:403-11. 
12. Fort JM, Azpiroz F. Caselias F, et al. Bowel habit after 
cholecystectomy: physiological changes and clinical 
implications. Gastroenterology 1996; 111 :617-22. 
13. Berger MY, Olde Hartman TC, Bohnen AM. 
Abdominal symptoms: do they disappear after 
cholecysteàomy? Surg Endosc 2003; 17:1723-8. 
14. Moher D, Liberati A, Tetzlaff J, et al. Preterred 
reporting items for systematic reviews and 
meta-analyses: the PRISMA statement. PLoS 
Med 2009;6:e1 000097 . 
15. von Elm E, Altman DG, Egger M, et al. 
The Strengthening the Reporting of 
Observational Studies in Epidemiology (STROBE) 
statement: guidelines for reporting observational 
studies. J Clin Epidemiol 2008;61 :344-9. 
16. Ahmed R, Freeman JV, Ross B, et al. Long term 
response to gallstone treatment--problems 
and surprises. Eur J Surg 2000; 166:447-54. 
17. Nicholl JP, Brazier JE, Milner PC. et al. 
Randomised controlled trial of cost-
effectiveness of lithotripsy and open 
cholecystectomy as treatments for gal! bladder 
stones. Lancet 1992;340:801 -7. 
18. Vetrhus M, Berhane T, Soreide 0, et al. Pain 
persists in many patients five years after 
removal of the gallb ladder: observations 
from two randomized controlled trials of 
symptomatic, noncomplicated gallstone 
disease and acute cholecystitis. J Gastraintest 
Surg 2005;9:826-31. 
19. Vetrhus M, Soreide 0, Nesvik I, et al. Acute 
cholecystitis: delayed surgery or observation. 
A randomized clin ical trial. Scand J 
Gastroenterol 2003;38:985-90. 
20. Vetrhus M, Soreide 0, Solhaug JH, et al. 
Symptomatic, non-complicated gallbladder 
stone disease. Operation or observation? 
A randomized clinical study. Scand J 
Gastroenterol 2002;37:834-9. 
21. Amir M. lnfluence of cholecystectomy on 
symptomatic cholelithiasis: can all symptoms 
be improved? Rawal Med J 2009;34: 141-144. 
22. Gilliland TM, Traverso LW. Modern standards for 
comparison of cholecystectomy with alternative 
treatments for symptomatic cholelithiasis with 
emphasis on long-term reliet of symptoms. Surg 
Gynecol Obstet 1990; 170:39-44. 
23. Gui GP, Cheruvu CV, West N, et al. Is 
cholecystectomy effective treatment for 
symptomatic gallstones? Clinical outcome 
after long-term follow-up. Ann R Col! Surg 
Engl1998;80:25-32. 
24. Johnson AG. Gallstones and flatulent 
dyspepsia: cause or coincidence? Postgrad 
Med J 1971;47:767-72. 
25. Lublin M, Crawford DL, HiattJR, et al. Symptoms 
befare and after laparoscopie cholecystectomy 
for gallstones. Am Surg 2004;70:863-6. 
26. Qureshi MA, Burke PE, Brindley NM, et 
al. Post-cholecystectomy symptoms after 
laparoscopie cholecystectomy. Ann R Coll 
Surg Engl 1993;75:349-53. 
27 . Rhind JA, Watson L. Gall stone dyspepsia. Br 
Med J 1968;1 :32. 
28. Vander Velpen GC, Shimi SM, C uschieri 
A. Outcome after cholecystectomy for 
symptomatic gall stone disease and effect of 
surgical access: laparoscopie v open approach. 
Gut 1993;34: 1448-51. 
29. Victorzon M, Lundin M, Haglund C. et 
al. Short and long term outcome after 
laparoscopie cholecystectomy. Ann Chir 
Gynaecol 1999;88:259-63. 
30. Bitzer EM, Lorenz C. Nickel S, et al. 
Assessing patient-reported outcomes of 
cholecystectomy in short-stay surgery. Surg 
Endase 2008;22:2712-9. 
31. Black NA, Thompson E, Sanderson CF. 
Symptoms and health status befare and 
six weeks after open cholecystectomy: 
a European cohort study.ECHSS Group. 
European Collaborative Health Services Study 
Group. Gut 1994;35: 1301-5. 
32. Bouchier IA, Rhodes K, Brien M. A study of 
symptomatic and "si lent" gallstone. Scand J 
Gastroenterol 1968;3:299-304. 
33. Fenster LF, Lonborg R, Thirlby RC. et al. What 
symptoms does cholecystectomy cure? lnsights 
from an outcomes measurement project and 
review of the literature. Am J Surg 1995; 169:533-8. 
34. Feretis CB, Feretis AB, Paisis BJ, et al. 
Managing dyspepsia in gallstone patients. Mt 
Sinai J Med 1983;50:400-1. 
35. Kingston RD, Windsar CW. Flatulent dyspepsia 
in patients with gallstones undergoing 
cholecystectomy. Br J Surg 1975;62:23 1-3. 
36. Scriven MW, Burgess NA, Edwards EA, et al. 
Cholecystectomy: a study of patient satisfaction. 
J R Coll Surg Edinb 1993;38:79-81 . 
37. Southam JA. Oesophageal symptoms befare and 
after cholecystectomy. Br J Surg 1968;55:863-4. 
38. Thistle JL, Longstreth GF, Romera Y, et 
al. Factors t hat predict rel ief f rom upper 
abdominal pain after cholecystectomy. Clin 
Gastroenterol Hepatol 2011;9:89 1-6. 
39. Abu Farsakh NA, Stietieh M, Abu Farsakh 
FA. The postcholecystectomy syndrome. 
A role for duodenogastric reflux. J Clin 
Gastroenterol1996;22:197-201. 
40. Burney RE, Jon es KR. Ambulatory and admitted 
laparoscopie cholecystectomy patients have 
camparabie outcomes but different functional 
health status. Surg Endase 2002; 16:921 -6. 
41. Halldestam I, Kuilman E, Borch K. Defined 
indications for elective cholecystectomy for 
gallstone disease. Br J Surg 2008;95:620-6 . 
42. Mjaland 0, Hogevold HE, Buanes T. Standard 
preoperative assessment can 
outcome after cholecystectomy. 
Surg 2000; 166:129-35. 
imprave 
Eur J 
43. Vignolo MC, Savassi-Rocha PR, Coelho LG, et al. 
Gastric emptying befare and after cholecystectomy 
in patients with cholecystolithiasis. 
Hepatogastroenterology 2008;55:850-4. 
44. Luman W, Adams WH, Nixon SN, et al. 
lncidence of persistent symptoms after 
laparoscopie cholecystectomy: a prospective 
study. Gut 1996;39:863-6. 
45. Niranjan B, Chumber S, Kriplani AK. Symptomatic 
outcome after laparoscopie cholecystectomy. 
Trap Gastroenterol2000;21 :144-8. 
46. Kraag N, Thijs C. Knipschild P. Dyspepsia--
how noisy are gallstones? A meta-analysis 
of epidemiologie studies of bi liary pain, 
dyspeptic symptoms, and food intolerance. 
Scand J Gastroenterol 1995;30:411-21. 
47. Fein M, Bueter M, Sailer M, et al. Effect of 
cholecystectomyon gastricand esophageal bile 
reflux in patients with upper gastrointestinal 
symptoms. Dig Dis Sci 2008;53:1186-91. 
48. Quintana JM, Cabriada J, Arostegu i I, 
et al. Health-related quality of life and 
appropriateness of cholecystectomy. Ann 
Surg 2005;241 : 110-8. 
49. Turner JA, Deyo RA, Loeser JD, et al. The importance 
of placebo effects in pa in treatment and research. 
JAMA 1994;271: 1609-14. 
-o 
m 
::>:> 
V\ 
Vi 
-i 
m 
z 
-i 
:t> 
z 
0 
0 
m 
z 
0 
;§ 
V\ 
-< 
:s: 
~ 
0 
:s: 
V\ 
:t> 
::::j 
m 
::>:> 
!I 
I 
0 
r-
m 
!I 
-< 
V\ 
-i 
m 
!I 
-i 
0 
:s: 
-< 
37 
-u 
m 
;:o 
l/) 
Vi 
-I 
m 
z 
-I 
}> 
z 
CJ 
CJ 
m 
z 
0 (§ 
l/) 
-< 
~ 
~ 
0 
~ 
l/) 
}> 
Tl 
-I 
m 
;:o 
Î\ 
I 
0 
r-
m 
Î\ 
-< 
l/) 
-I 
m 
Î\ 
-I 
0 
~ 
-< 
38 
50. Vetrhus M, Soreide 0, Eide GE, et al. Pain and 
quality of life in patients w ith symptomatic, 
non-complicated gallbladder stones: results 
of a randomized controlled trial. Scand J 
Gast roenterol 2004;39:270-6. 
51. Bates T. Ebbs SR, Harrison M, et al. lnfluence 
of cholecystectomy on symptoms. Br J 
Surg 1991;78:964-7. 
52. Corazziari E, Attili AF, Angeletti C. et al. 
Gallstones, cholecystectomy and irritable 
bowel syndrome (IBS) MICOL population-
based study. Dig Liver Dis 2008;40:944-50. 
53. Kirk G, Kennedy R, McKie L, et al. Preoperative 
symptoms of irritable bowel syndrome 
predict poor outcome after laparoscopie 
cholecystectomy. Surg Endosc 2011 ;25:3379-84. 
54. Bisgaard T. Rosenberg J, Kehlet H. From acute to 
chronic pa in after laparoscopie cholecystectomy: 
a prospective follow-up analysis. Scand J 
Gastroenterol 2005;40: 1358-64. 
55. Jazrawi S, Walsh TN, Byrne PJ, et al. 
Cholecystectomy and oesophageal reflux: 
a prospective evaluation. Br J Surg 1993;80:50-3. 
56. Thune A, Saccone GT, Scicchitano JP. et al. 
Distension of the gall bladder inhibits sphincter 
of Oddi motility in humans. Gut 1991 ;32:690-3 . 
57. Guyatt GH, Oxman AD, Kunz R, et al. What is 
"quality of evidence" and why is it import ant 
to clinicians? BMJ 2008;336:995-8. 
58. Gunn A, Keddie N. Some clinical observations on 
patients with gallstones. Lancet 1972;2:239-41. 
59. Jorgensen T, Teglbjerg JS, W ille-Jorgensen P, 
et al. Persist ing pain after cho lecystectomy. 
A prospective investigation . Scand J 
Gastroenterol 1991 ;26: 124-8. 
60. Plaisier PW, van der Hul RL, Nijs HG, et al. 
The course of biliary and gastrointestinal 
symptoms after treatment of uncomplicated 
symptomatic gallstones: results of a randomized 
study camparing extracorporeal shock wave 
lithotripsy with conventional cholecystectomy. 
Am J Gastroenterol 1994;89:739-44. 
61. Ure BM, Troidl H, Spangenberger W, et 
al. Long-term results after laparoscopie 
cholecystectomy. Br J Surg 1995;82 :267-70. 
62. Borly L, Anderson IB, Bardram L, et al. 
Preoperative prediction model of outcome after 
cholecystectomy for symptomatic gallstones. 
Scand J Gastroenterol 1999;34: 11 44-52. 
63. Traverso LW, Lonborg R, Pettingeil K, et al. 
Utilization of cholecystectomy-a prospective 
outcome a na lysis in 132 5 patients. J 
Gastraintest Surg 2000;4: 1-5. 
64. Mertens MC, De VriesJ, Scholtes VP, et al. Prospective 
6 weeks follow-up post-cholecystectomy: 
the predictive value of pre-operative symptoms. J 
Gastraintest Surg 2009; 13:304-11 . 




CHAPTER 3 
OUTCOME OF TREATMENT REPORTED BY PATIENTS: 
AN INSTRUMENT TO REDUCE VARIATIONS 
IN CLINICAL PRACTICE 
Mark P. Lambertsl.2.3, 
Joost P. H. Drenth 1, 
Cornelis J.H.M. van Laarhoven2, 
Gert P. Westert3 
'Department of Gastroenterology and Hepatology, Radboud University Medical centre, 
Nijmegen, The Netherlands 
2Department of Surgery, Radboud University Medical Centre, Nijmegen, The Netherlands 
3Scientific lnstitute for Quality of Healthcare (IQ healthcare), Radboud University Medical Centre, 
Nijmegen, The Netherlands 
Nederlands Tijdschrift voor Geneeskunde, 2013; 157:A5369 
0 
c 
-I 
n 
0 
s:: 
m 
0 
"T1 
-I 
::>::> 
m 
~ 
s:: 
m 
z 
-I 
::>::> 
m 
-u 
0 
::>::> 
-1 
m 
0 
OJ 
-< 
}'; 
-I 
m 
z 
-I 
Vl 
)> 
z 
z 
Vl 
-I 
::>::> 
c 
s:: 
m 
z 
-I 
ö 
::>::> 
m 
0 
c 
n 
m 
)',; 
::>::> 
~ 
0 
z 
Vl 
z 
n 
c 
z 
?'i 
)> 
r 
-u 
::>::> )> 
n 
-I 
?'i 
m 
44 
ABSTRACT 
Medical treatment and its results varies between countries, but also between regions 
within countries. Because of these variations in clinical practice the quality of healthcare 
is suboptimal, unnecessary expenses are made and patients are at risk of complications 
caused by unnecessary interventions. Patient Reported Outcome Measures (PROMs) 
can help clarify whether patients have benefited from a certa in treatment. Systematic 
measurement of PROMs is necessary to accurately determine therapy effects. By evaluating 
therapy effects and regional variations in practice, important insights wil I emerge of where 
too many and where to few patients are treated. We expect that systematic measurement 
of PROMs will be a valuable tooi to imprave the quality of Dutch healthcare. 
lt is relevant where you as a patient wi ll be treated. The frequency of medica! 
interventions and their results vary significantly between countries, but also between 
regions within a country. Surgery for spinal compression, secondary caesarean sections, 
and the prescription behavior of general practitioners are some interventions with 
a significant geographical practice va riation. 1 Data from our country show that procedures 
for common diseases are sametimes conducted 2 to 5.5 more frequently in one region 
than in others.2 Figure 1 shows how frequently 8 surgical procedures are performed in 
each region of The Netherlands when compared to the national average. Insome regions 
these 8 procedures are performed four times less frequently than in others even when 
adjusted for age, gender, and socioeconomie status . Despite the differences between 
these 8 types of surgery a clear regional pattern can be distinguished. 
Variations in practice partly exist because we as cl inicians are evaluated and paid for 
delivering care and not, as you would expect, for the result of that care: impravement 
of health . Consequently, healthcare is driven by what we supply and less by what we 
demand: results for our patients.3 
Cumulative index 
• 46-85 
85-95 
95- 105 
105 - 120 
• 120 - 163 
• hospita! 
... 
Figure 1. Regional differences in the performance of 8 common operations. Each region is represented by 
a cumulative index how often these 8 operations in total are performed annually per region and compared 
to the national average. The data are from Zorgverzekeraars Nederland and edited by Praktijkindex and 
IQ healthcare. 
0 
c 
--{ 
n 
0 
:s: 
m 
0 
Tl 
--{ 
:x> 
m 
~ 
:s: 
m 
z 
--{ 
:x> 
m 
" 0 
:x> 
--{ 
m 
0 
CXl 
-< 
~ 
--{ 
m 
z 
--{ 
l/'1 
p 
z 
z 
l/'1 
--{ 
:x> 
c 
:s: 
m 
z 
--{ 
ö 
:x> 
m 
0 
c 
n 
m 
)3; 
:x> 
~ 
i3 
z 
l/'1 
z 
n 
c 
z 
?'i p 
r 
" :x> p 
n 
--{ 
?'i 
m 
45 
0 
c 
-I 
n 
0 
s:: 
m 
0 
"T1 
-I 
::>::> 
m 
~ 
s:: 
m 
z 
-I 
::>::> 
m 
-u 
0 
::>::> 
-1 
m 
0 
OJ 
-< 
}'; 
-I 
m 
z 
-I 
Vl 
)> 
z 
z 
Vl 
-I 
::>::> 
c 
s:: 
m 
z 
-I 
ö 
::>::> 
m 
0 
c 
n 
m 
)',; 
::>::> 
~ 
0 
z 
Vl 
z 
n 
c 
z 
?'i 
)> 
r 
-u 
::>::> )> 
n 
-I 
?'i 
m 
46 
Variation seems widest when t here is limited evidence for the effectiveness of 
a certain treatment 4 The question remains how to reduce these differences in our 
modern healthcare system. The quality of healthcare is suboptimal, unnecessary expenses 
are made, and patients risk comp lications due to unnecessary procedures, because 
of these variationss·6 
Outcomes reported by patients can help clarify whether they may benefit from 
a certain treatment. lnternationally, patient-reported outcome measures are known as 
PROMs. Usi ng PROMs we actua lly ask our patients to aid us in determining the resu lt 
of a procedure. When it is found, for instanee that few pat ients report significant 
impravement after a certain procedure, clinicians may use this information to refine 
the indication for this procedure. 
In this contri bution we argue that routine measurement of PROMs is necessary to show 
relevant differences in treatment effects. The combined use of differences in treatment 
effects and regional variations in practice, may clarify where too many and where too few 
surgeries are being performed. Without these outcome measurements, it is not possible 
answer this important question. 
WHAT ARE PROMS? 
The outcome of treatment is traditionally based on history, physica l examination, and 
objective criteria, such as Iabaratory or radiological results. However, the perspective 
of patients is crucial to assess the result of a given treatment. Patients are best suited 
to evaluate whether their symptoms have improved and thus whether their quality of 
life has changed after treatment. This patient' perspective often strongly differs from 
the clinician's perspective. A patient may not feel effect ively treated, even if the clinician 
deems the therapy a success7 
PROMs are a tooi for patients to evaluate systematically whether they have benefited 
from a certain treatment. For this purpose, patients complete a questionnaire both before 
and af ter the intervention at fixed timepoints. The difference between the pretest and 
posttest shows if and how much benefit a patient has had from treatment. lt is also 
possible to assess factors that predict outcomes for certain patients. For example, when 
using PROMs in combination with clinica l data, it is possible to select certain subgroups 
in whom treatment is more effective. In short, PROMs in combination wit h cli nical data 
can be used both to evaluate therap ies as well as to predict outcomes. 
GENERIC VERSUS CONDITION-SPECIFIC 
PROMs are basically subdivided into generic and condition-specific outcome measures. 
Since this may sound somewhat abstract, we wi ll give an example. Generic PROMs 
measure health aspects irrespective of the specific disease. For example, the generic 
EQ-SD questionnaire that measures quality of life can be used to campare the health 
of patients with arthrit is of the hip and those with inguinal hernia. The disadvantage 
of these generic outcome measures is that questionnaires may include items that are 
not particularly relevant, or vice versa, lack items that are very important. A question 
on the EQ-SD-questionnaire about mobility is far more relevant for patients with hip 
problems than for those with inguinal hernia. Generic outcome measures are therefore 
often combined with condition-specific PROMs. Currently, suitable questionnaires are 
not available for all diseases that can be evaluated using condition-specific PROMs. 
The development and val idation of these questionnaires requires a significant effort of 
both clinicians and patients, as previously reported in the NTvG.8 
REDUCTION OF INAPPROPRIATE VARIATIONS IN PRACTICE 
PROMs provide the possibility to campare outcomes between healthcare facilities so that 
inappropriate variations in practice may be reduced. How can this be achieved? The initia! 
step is to have patients f ill out questionnaires regarding treatment. Subsequently, one 
must correct for patient characteristics, such as age, gender, socioeconomie status, and 
level of care. Finally, one can show which facilities have the best outcomes reported by 
patients fora certain procedure. The healthcare processcan be improved and treatment 
policy adjusted accordingly. 
PROMs can be useful to reduce inappropriate variations in practice on an international 
level as wel!. The universa! nature of PROMs provide the possibility to campare outcomes 
of conditions not only within countries, but also between countries. The National 
Health Service (NHS) in Great-Brittain and the 'Patient reported outcome measurements 
information system' (PROMIS), initiated by the Nationallnstitutes of Health in the United 
States, develop and test measurement applications of PROMs in different pat ient 
groups9 ·10 Dutch healthcare should notlag behind . IQ healthcare in Nijmegen has initiated 
an international collaboration with NHS and PROMIS to accelerate this process by sharing 
international experiences and expertise. 
In addition, comparisons of PROMs obtained befare initia! treatment provide a starting 
point for additional studies of decision making in healthcare facilities. For example, 
variations in decision making of general practitioners may impact patient referral to 
secondary care or patient t reatment at different moments in the chain of care. Such 
variations have consequences for the equal access of patients to secondary care and also 
for the effective use of limited healthcare capacity. 
PROMs should therefore be used in the context of health care expenses to achieve 
effective use of limited healthcare capacity. In this way, ditterences in cost-effectiveness 
between regions can be shown. For example, the results of treatment can be good, 
but achieved at high costs, or results may be poor and achieved at low costs. Regional 
cost-effectiveness can be shown this way. Additionally, these data may provide 
insight into the cost-effectiveness of different therapies. Clinicians, policy makers, 
and insurers can thus focus on quality and cost-effectiveness, and reduce variations 
in practice simultaneously. 
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THE LIMITAllONS OF PROMS 
Although routine measurements of PROMs seem promising, this methad does have 
limitations. Environmental factors b ias outcome measures reported by patients. These 
factors partially determine how and what a patient will report. For example, a depressed 
patient will complete a questionnaire about spinal compression differently than patients 
without a depression. This can only be partially corrected. 
In addition, outcomes are measured at only a limited number of t ime points. However, 
we know that the timing of outcome measurement is very important. Patients can be 
positive shortly after surgery, because they may be unconsciously relieved and satisfied 
that they survived surgery unharmed, even though symptoms may have remained . More 
frequent and long term measurements could limit this effect. 11 
Finally, the outcome of watchful waiting remains unknown. For example, in patients 
with ga llstones and abdominal pain watchful waiting may be non-inferior or even better 
than surgery. PROMs may be used, to campare a strategy of watchful wa iting with 
adequate analgesia to cholecystectomy. 12•14 
Currently, it is a significant challenge to imprave and refine systematic measurement 
of patient-reported outcomes. ldeally, this should be conducted in interdisciplinary teams 
of statisticians, clinicians and patients. Development of questionna ires cannot succeed 
without the latter. Consequently, the development and application of PROMs are still 
a fertile research topic. 
CONCLUSIONS 
'Patient reported outcome measures' (PROMs) are a prom1s1ng addition to existing 
objective indicators for quality of healthcare. A far better insight into outcomes of 
healthcare may be achieved by systematic measurement of the degree of hea lth. Thus, 
it may become possible to choose the optimal care process, and reduce variations in 
clin ical practice. Although PROMs do have limitations, they may provide a better insight 
of the patients' perspective on therapy results. We believe PROMs w ill be a valuable tooi 
to imprave the quality of Dutch healthcare. 
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ABSTRACT 
Background 
Up to 33% of patients with uncomplicated symptomatic cholecystolithiasis report 
persistent pa in aft er cholecystectomy. The aim of th is study was todetermine characteristics 
associated with patient-reported absence of abdominal pain after cholecystectomy, 
improved abdomina l symptoms, and pat ient-reported positive cholecystectomy results in 
a prospective cohort multicentre study. 
Methods 
Patients aged 18 years or more with symptomatic cholecystolithiasis who had 
a cholecystectomy between June 2012 and June 2014 in one of three hospitals were 
included . Befare surgery all patients were sent the Gastrointestinal Qua lity of Life 
Index (GIQLI) questionnaire and the McGill Pain Questionnaire (MPQ). At 12 weeks 
after surgery, patients were invited to complete the GIQLI and Patients' Experience 
of Surgery Questionnaire (PESQ). Logistic regression analyses were performed 
to determine associations. 
Results 
Questionnaires were sent to 552 patients and returned by 342 befare and after surgery. 
Postoperative absence of abdominal pain was reported by 60.5% of patients. A high 
preoperative GIQLI score, episodic pain, and duration of pain of 1 year or less were 
associated with postoperative absence of pain. These factors showed no association with 
improved abdominal symptoms (reported by 91 .5% of patients) or a positive surgery 
result (reported by 92.4%). 
Conclusions 
Preoperative characteristics determ ine the odds for re lief of abdomina l pa in aft er 
cholecystectomy. However, these factors we re not associated w ith patient -reported 
impravement of abdominal symptoms or patient-reported positive cholecystectomy 
results, highlighting the variation of internal standards and expectations of pat ients 
befare cholecystectomy. 
BACKGROUND 
C holecystectomy is th e treatment of choice for patients with sym ptomatic cholecysto I ith iasis. 
Cholecystectomy is performed about 60,000 times a year in the UK alone, w ith significant 
costs. 1 Other Western countries have fa irly similar patterns of care.2•4 Patients w ith a history 
of complicated symptomatic cholecystolithiasis are oftered cholecystectomy to prevent 
recurrent complications. 5 The main purpose of a cholecystectomy for uncompl icated 
symptomatic cholecystolithiasis is to relieve abdominal pain, as the diagnosis is based 
on abdominal pain combined with ultrasound-confirmed gallstones6 ·9 Despite the high 
number of cholecystectomies in the Western world, up to 33% of patients still report 
abdominal pain after cholecystectomy. 10 
The large proportion of patients with persistent postoperative pain is caused by 
a variation in the indication for, and timing of, cholecystectomy resulting f rom the lack of 
evidence and differing opinions among surgeons. 11 ' 13 Th is variation may lead to unnecessary 
cholecystectomies, risk of complications and healthcare costs. Severa l characteristics have 
been shown to be associated with a good outcome following cholecystectomy, including 
sex, 14' 16 age at surgery, 14• 16 preoperative absence of pa in in the previous 2 weeks, 14• 16 centre 
where treated, 16 American Society of Anesthesiologists (ASA) classif ication, 17· 18 baseline 
Gastrointestinal Quality of Life Index (GIQLI) score, 15• 19 duration of pa in of 1 year or less, 16 
pain occurring during episodes16 and pain-induced awakening at night. 16 However, study 
results are often inconsistent and the generalizability of these associations may be lim ited 
because of the heterogeneity of patient characteristics, settings, and patient-reported 
outcome questionnaires used. 16 
The present study aimed to assess the association between preoperative characteristics 
with absence of pain after cholecystectomy in a Dutch prospective multicentre cohort 
study. The association of these characteristics with patient-reported improved abdomina l 
symptoms and w ith patient-reported positive cholecystectomy results was a lso determined. 
METHOOS 
Study sites and subject selection 
All patients aged 18 years or more with symptomatic cholel ith iasis, w ho visited 
the surg ical outpatient clinic at a tertiary referral centre (Radboud Un iversity Medical 
Centre, Nijmegen) or one of two non-academie teaching hospitals (St Elisabeth Hospita!, 
Ti lburg and Medisch Spectrum Twente Hospita!, Enschede) between June 2012 and June 
2014, and we re scheduled for elective cholecystectomy we re eligible for participat ion 
in the study. Cholelithiasis was defined as abdominal pain associated with gallstones, 
confirmed by ultrasound imaging. 
Patients with a history of complicated symptomatic cholelithiasis (acute cholecystitis, 
cholangitis, biliary pancreatitis, choledocholithiasis requiring endoscopie retrograde 
cholangiopancreatography)20· 21 were excluded. Other exclusion criteria were ASA f itness 
grade 111 or IV, insufficient knowledge of the Dutch language, non-Dutch residency, 
blindness, pregnancy, cirrhosis, cancer treatment, schizophrenia, or any other disorder 
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that might predispose the patient to unreliable responses. Eligible patients were asked to 
complete a questionnaire befare and 12 weeks after cholecystectomy. Patients who did 
not return the questionnaire befare and after surgery were excluded from the analyses. 
The preoperative questionnaires included the GIQLJ and the McGil l Pain Questionnaire, 
as generic and disease-specific patient-reported outcome questionnaires respectively, in 
line with the taxonomy.22 In addition, the GIQLI and Patients' Experiences of Surgery 
Questionnaire (PESO) were completed after surgery. 
The GIQLI, which was developed in Germany,23 has been translated and validated in 
the Dutch language. 24 lt contains 36 questions on gastrointestinal symptoms for both 
the upper and lower digestive tracts, and on general, physical, emotional and social 
functioning in the previous 2 weeks . Each question consists of five response categories. 
Questions are scored using a response scale ranging from 0 (worst appraisal) to 4 (best 
appraisal) points for each question, giving an overall score of 0-144 points. The higher 
the score, the betterthe health status. The characteristics of abdominal pa in were measured 
using the MPQ 2 5· 26 This questionnaire consists of four sections: a section of general 
questions regarding pain; a section on the effect of pain on quality of life; a section on 
visual analogue scales for pain; and a section that includes a list of adjectives describing 
pain. In the present study, the first two sections were used to assess the duration of pain, 
its episodic nature, and pain-induced awakening at night. The PESO includes questions 
on complications of surgery, abdominal symptoms in relation to cholecystectomy, 
and patient-reported results of surgeryY· 28 The latter two questions consisted of five 
response categories. 
The study was approved by the medical ethics committees of three hospitals 
(Radboud Un iversity Medical Centre, Medisch Spectrum Twente Hospita! and St Elisabeth 
Hospita !) and conducted in accordance with the recommendations in the Strengthening 
the Reporting of Observational studies in Epidemiology (STROBE) gu idelines.29 
Outcomes and variables of interest 
The primary outcome was defined as absence of abdominal pa in, as reported on the GIQLJ 
12 weeks after cholecystectomy. The results were dichotomized as absence of pa in versus 
presence of pain. 
Secondary outcomes included impravement of abdominal symptoms, and outcome 
of the operation as reported by patients. Responses were dichotomized as positive 
(successful) versus negative (not successful) ratings. Positive rating of current abdominal 
symptoms consisted of the combined response categories 'slightly better' and 'much 
better.' Positive rating of surgery results included the combined response categories 
'excellent,' 'very good' and 'good.' Postoperative absence of abdominal pain was added 
to the selected independent variables to confirm the association w ith patient-reported 
successof the procedure . 
Based on previous publ ications, the independent variables included sex, 14.16 age at 
operation, 14· 16 preoperative absence of pa in in the previous 2 weeks, 14• 16 centre, 16 ASA 
fitness grade, 17• 18 baseline GIQLI score, 15• 19 duration of symptoms of 1 year or less, 16 
episodic pa in 16 and pain-induced awakening at night. 16 
Power analysis 
An appropriate sample si ze was calculated for the proportion of patients with postoperative 
pain. Assumptions were based on the f indings of a systematic review. 10 The proportion 
of patients with persistent pain was estimated at 33% with an error rate of 5% and 
a 95% Cl, resulting in a sample size of 340 patients. In anticipation of an incomplete 
response rate of 40%, at least 476 patients were invited to participate in the study. Given 
the sample size in the smaller of the two response groups (approximately 112 patients 
without relief of abdominal pain), there were sufficient observations to accommodate 
the development of a model with up to 11 variables. 
Statistica! analysis 
Differences between responders and non-responders were examined using x2 tests or 
Fisher's exact tests for categorical data and the Student t test for continuous data. For 
responders, logistic regression analyses were applied to determine wh ich variables were 
associated with absence of pa in after cholecystectomy. Variables with a P-value < 0.100 in 
univariabie analyses were included in multivariable logistic regression analyses. Backward 
elimination was used as the variabie selection method, retaining age, sex, centre and 
preoperative abdominal pain as reported on the GIQLI as co-variables. Postoperative 
absence of abdominal pain in relation to an increasing number of significantly associated 
preoperative pain characteristics was also assessed. The results of the analyses were 
reported as adjusted odds ratios (ORs) and 95% Cl P < 0.050 was considered statistically 
significant. Similar methods were used to determine which variables were associated 
with the patient-reported impravement of abdomina l symptoms and with the results of 
surgery. All missing values were considered to be completely at random and excluded 
from analyses. All statistica! analyses were done with SPSS® statistica! software version 
20.0 (IBM, Armonk, New York, USA). 
RESULTS 
A total of 870 patients were considered for participation. After exclusion of 318 patients, 
questionnaires were sent to 552 patients . Some 423 (76.6%) returned the questionnaires 
before surgery, and 342 (62 .0%) did so both before and after surgery (Fig. 1 ). Baseline 
characteristics both of these 342 study patients and the 21 0 non-reponders are shown in 
Table 1. Statistical ly significant differences were found between responders versus non-
responders for mean ± SD age at surgery49.7 ± 14.3 versus 43.5 ± 15.1 years; P < 0.001) 
and ASA fitness grade (53 .2% of responders we re classified as ASA 11 compared with 
44.3% of non-responders; P = 0.042). 
Associations with absence of pain after cholecystectomy 
A total of 207 patients (60.5%) reported absence of pa in at 12 weeks aft er cholecystectomy. 
Univariabie analysis showed preoperative GIQLI score, episodic pa in, and duration 
of pain of 1 year or less to be associated with absence of pain (Table 2). Preoperative 
GIQLI score (OR 1.02, 95% Cl 1.01-1.03; P = 0.004), episodic pain (OR 2.13, 95% Cl 
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Patients considered for participation 
n = 870 
Patients excluded n = 318 
Complicated symptomatic cholelithiasis n = 218 
'if 
lnsufficient knowledge of Dutch language n = 44 
Other exclusion criteria n = 56 
Patients given preoperalive 
questionnaires 
n = 552 
..... Did nol return questionnaires n = 129 , 
'~ 
Returned preoperalive questionnaires 
and sent postoperalive questionnaires 
at 12 weeks postcholecystectomy 
n = 423 
... 
Did nol returned questionnaires n = 81 , 
'if 
Returned questionnaires n = 342 
Figure 1. Flow chart showing inclusion of patients in the study 
Table 1. Characteristics of responders and non-responders to the questionnnaires 
Responders (n = 342) Non-responders (n=210) 
Age (years)* 49.7 ± 14 .3 43.5±15.1 
Sex ratio (M : F) 74: 268 50: 160 
ASA fitness grade 
I 160 (46.8) 117 (55.7) 
182 (53 2) 93 (443) 
Centre 
Radboud UMC 67 (19.6) 46 (21.9) 
MST 155 (45 3) 99 (47 1) 
St Elisabeth 120 (35.1) 65 (31 O) 
I 
I 
P-valuet 
<0.001:1: 
0.553 
0.042 
n.a. 
n.a. 
n.a. 
Values in parentheses are percentages unless indicated otherwise; *values are mean ± SD. ASA, American 
Society of Anesthesiologists; UMC, University Medical Centre; n.a. not applicable; MST, Medisch Spectrum 
Twente Hospita!. 
tx2 test, except =!=independent t test. 
Table 2. Univariabie and multivariable analysis of factors associated with patient-reported absence of pain 
after cholecystectomy 
Abdominal pain Univariabie analysis Multivariable analysis 
Absent Present Odds ratio Odds ratio 
(n = 207) (n = 135) (95 % Cl) P-value (95% Cl) P-value 
Age (years)* 50.0 ± 14.1 49.3 ± 14.6 1.00 (0.99-1.02) 0.670 1.00 (0.99-1.02) 0.725 
Sex 0.029 0 .1 29 
F 154 114 0.54 (0.31 -0 94) 0.60 (0.32-1 16) 
M 53 21 1 . 00 (reference) 1 . 00 (reference) 
Hospital type 0.206 0.041 
Tertiary referral 36 31 0.71 (041-1 21) 0.52 (0.28-0.97) 
cent re 
Non-academie 171 104 1 . 00 (reference) 1 . 00 (reference) 
Preop. pain in 0.002 0.420 
the last 2 weeks 
No 39 9 3.2 5 (1.52-6.95) 1.46 (0.58-3.66) 
Yes 168 126 1 . 00 (reference) 1 . 00 (reference) 
ASA fitness grade 0. 113 
11 103 79 0. 70 (045-1.09) 
I 104 56 1 . 00 (reference) 
Baseline 106.6 ± 20.2 95.2 ± 21.3 103 (1 02-1.04) < 0.001 1.02 (1 01-1.03) 0.004 
GIQLI score* 
Duration 0.011 0.006 
of pain (years):l: 
":; 1 163 91 193 (1.16-3.20) 2.22 (1.25-3.94) 
> 1 39 42 1 . 00 (reference) 1 . 00 (reference) 
Type of pain:l: < 0.001 0.003 
Episodic 132 58 2.31 (1 47-3.61) 2.13 (1.29-3.52) 
Non-episodie 72 73 1 . 00 (reference) 1 . 00 (reference) 
Awakened 0465 
because of pain 
Yes 105 74 0.85 (0.55-132) 
No 97 58 1 . 00 (reference) 
Va lues are *mean(s.d.); :I:A few patients did not complete all questions for this factor. ASA, American Association 
of Anesthesiologists; GIQLI. Gastrointestina l Quality of Life Index. 
1.29-3.52; P = 0.003) and duration of pain of 1 year or less (OR 2.22, 95% Cl 1.25-3.94; 
P = 0.006) remained associated with postoperative absence of pain in multivariable 
analysis. Absence of abdominal pain was also assessed in relation to an increasing 
number of significantly associated pain characteristics (episodic pain, duration of pain 
of 1 year or less). The odds of pain relief increased progressively as the number of pain 
characteristics increased (Table 3). 
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Table 3. Multivariable logistic regression analysis of the association of increasing number of preoperative 
pain characteristics with postoperative absence of abdominal pain 
No. of characteristicst Absence of abdominal pain Odds ratio (95% Cl) P-value 
2 100 of 138 (72.5) 6.23 (2.37-16.38) < 0.001 
1 195 of 306 (63. 7) 3.57 (1.49-8.54) 0.004 
0 9of31(29) 1 . 00 (reference) 
Values in parentheses are percentages unless indicated otherwise; tEpisodic pain, and duration of pa in of 1 
year or less. 
Associations with improved abdominal symptoms and with positive 
surgery results 
A total of 313 patients (91.5%) rated their abdominal symptoms after cholecystectomy 
to be 'much better' or 'slightly better' compared w ith their preoperative experience. 
Univariabie analysis revealed postoperative absence of abdominal pain to be associated 
with patient-reported improved abdominal symptoms, and this remained associated in 
multivariable analysis (OR 4 .52, 95% Cl 1.81-11.29; P = 0.001) (Table 4). 
The postoperative result was rated as 'good.' 'very good' or 'excellent' by 316 patients 
(92.4%). In univariabie analysis, baseline GIQLI score and postoperative absence of pain 
were associated with a patient-reported positive rating of the cholecystectomy result. 
Postoperative absence of pain remained associated in multivariable analysis (OR 19.01, 
95% (14.20-85.93; P < 0.001) (Table 5) . 
DISCUSSION 
In this prospective multicentre cohort study, only 60.5% of patients reported complete 
relief of pain at 12 weeks after cholecystectomy. However, most of the patients reported 
improved abdominal symptoms and a successful outcome after surgery. A higher 
preoperative GIQLI score, duration of pain of 1 year or less, and episodic pain were 
signif icantly associated with postoperative absence of pain, but not with improved 
abdominal symptoms or positive surgery results. 
The proportion of patients with complete pain relief after cholecystectomy, with 
improved abdominal symptoms and a positive cholecystectomy result in the present study 
is consistent withother published literature. A systematic review10 showed that 59-1 00% 
of patients experienced complete pa in relief. In addition, 90 to 97% of patients reported 
improved abdomi na I symptoms and 88-97% rated the cholecystectomy resultas positive. 30' 32 
A large cohort study16 reported a 2% difference between the proportion of patients with 
postoperative pa in at 12 weeks and 1 year after cholecystectomy. In addition, a long-term 
follow-up studyl 7 showed no significant differences in the proportion of patients reporting 
pa in at 12 weeks and 10 years after cholecystectomy. These results suggest that pa in 
rel ief at 12 weeksof follow-up persists for 10 years after cholecystectomy. Th is study a lso 
reported similar proportions of patient-reported improved symptoms and positive surgery 
results, ind icating consistency of these outcomes as well. 17 
The association of episodic pa in and duration of pa in of 1 year or less w ith postoperative 
absence of pain was confirmed by the present study, increasing the genera lizabil ity of 
these predictors. 16 Pa in associated with gallstones is most typical ly characterized by its 
episodic nature and relief following cholecystectomy6 · 7· 9 Non-episodie abdomina l pa in 
is aften caused by functional gastroi ntestinal disorders, 33• 34 which are chronic conditions 
and may have a significant impact on patients' health status35 Patients w ith funct ional 
disorders are likely to continue to report abdominal pain after surgery. This was confirmed 
by the finding that patients w ith a duration of pain of 1 year or less and a higher 
preoperative health status score were more likely to report complete pain relief after 
cholecystectomy compared with patients with a langer duration of pain and a lower 
health status . 
Remarkably, factors that were associated w ith absence of abdominal pain after 
cholecystectomy did not show an association with improved abdominal symptoms or 
a positive surgery result, despite the association of postoperative absence of pain with 
the latter two outcomes. The placebo effect of surgery or natural decline of symptoms may 
account for this discrepancy.36-38 ln addition, these findings suggest a diff erence in internal 
standards and variabie expectations from cholecystectomy.39· 40 Many patients may not 
expect all types of abdominal pain to be relieved completely fo llowing cholecystectomy. 
lt is therefore important to explore and set realistic expectations befare the operation. 
This discrepancy also raises doubt regard ing which patient-reported outcome to use for 
effective patient selection for cholecystectomy. Cholecystectomy appears to be far less 
successful when absence of abdominal pain is used as the benchmark compared w ith 
improved abdomina l symptoms or positive surgery results as standard. 
There are limitations of this study. First, selection bias may have occurred as a resu lt 
of the limited response rate. The response rate of younger patients and those with ASA 
grade I might have been improved if bath paper-based and web-based questionnaires had 
been used.41 Second, the study was performed in a national setting w it h strict incl usion 
and exclusion criteria to limit reeal l b ias. This may limit the generalizabil ity of t he resu lts, 
although w idely available patient-reported outcome questionnaires were employed . 
Third, multiple measurements might have added additional informat ion, but could 
also have introduced additional bias as co-morbidities unrelated to gal lstone disease or 
surgery may manifest themselves and cause abdominal pain . Finally, ORs in this study may 
overestimate risk ratios, and thus should not be interpreted as risk ratios. 
Strengths of the study include the prospective multicentre design, limiting potential 
information bias and increasing external validity. Additional strengths are use of 
the MPQ, GIQLI and PESQ. Abdominal pain is the characteristic feature of uncompl icated 
symptomatic cholecystolithiasis and the main predietor of an unsuccessful outcome6 ·9· 18 
Other abdominal symptoms may co-exist42 Finally, transient episodes of abdomina l 
symptoms could easi ly be undetected if measured at short intervals. This emphasizes 
the importance of MPQ as pain-specific, the GIQLI as generic for abdominal symptoms 
and the PESQ as sequentia! follow-up questionnaires. Consequently, the authors believe 
that use of this combination of questionnaires w ill address al l aspects of uncomplicated 
symptomatic cholelithiasis. 
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Table 4. Univariabie and multivariable a na lysis of patient and clinical variables with patient-reported 
abdominal symptoms 
Age (years)* 
Sex 
F 
M 
Hospital type 
Tertiary referral centre 
Non-academie 
Preop. pain in Jast 2 weeks 
No 
Yes 
ASA fitness grade 
ASA 11 
ASA I 
Baseline GIQLI score* 
Duration of pain (years)=l= 
~ 1 
> 1 
Type of pai n=l= 
Episodic 
Non-episodie 
Awakened because of pain 
Yes 
No 
Postop. pain in last 2 weeks 
No 
Yes 
Abdominal symptoms 
About the same, slightly worse 
Much or slightly better (n = 313) or much worse (n = 26) 
50.1 ± 14.3 46.2 ± 14.0 
244 21 
69 5 
61 6 
252 20 
42 5 
271 20 
164 17 
149 9 
102.2 ± 21.5 103.8 ± 19.8 
232 21 
74 5 
172 16 
135 10 
168 9 
137 16 
198 8 
115 18 
~ Va lues are *mean ± SD; unless indicated otherwise; =I=A few patients did notcomplete all questions for this 
factor. ASA, American Society of Anesthesiologists; GIQLI, Gastrointestinal Quality of Life Index. 
62 
Future research should explore further not only which pat ients wi ll respond 
favourably to cholecystectomy, but also which will benefit the most. Patients with 
uncomplicated symptomatic cholelithiasis may wonder whether a cholecystectomy is 
really necessary after one or few episodes of pain, or whether su rgery can be delayed . 
A watchful waiting strategy43 was shown to be a feasible option in 31% of patients 
with uncomplicated symptomatic cholelithiasis during 14 years of follow-up. At the same 
time, patients with uncomplicated symptomatic gallstone disease at risk of complicated 
symptomatic cholelithiasis should be considered for earlier surgery44 Selection for earlier 
cholecystectomy of those patients who are most likely to benefit from it will further 
increase the cost-effectiveness of this common surgical procedure. 
Univariabie analysis Multivariable analysis 
Odds ratio (95% Cl) P-value Odds ratio (95% Cl) P-value 
1.02 (0.99-1.05) 0. 192 1.02 (0.99-1.05) 0.185 
0.739 0.837 
0.84 (0.31 -2.32) 1.12 (0.38-3 .28) 
1.00 (reference) 1.00 (reference) 
0.659 0.907 
0.81 (0.31-2.10) 1.06 (0.39-2 88) 
1 . 00 (reference) 1.00 (reference) 
0.413 0.112 
0.65 (0.23-1.82) 0.41 (0.13-123) 
1.00 (reference) 1.00 (reference) 
0.58 (0.25-1.35) 0.206 
1.00 (reference) 
1.00 (0.98-1.02) 0.731 
0.570 
0. 75 (0.27-2.05) 
1.00 (reference) 
0.587 
1.26 (055-2.86) 
1.00 (reference) 
0.108 
1.96 (0 86-4.46) 
1.00 (reference) 
0.002 0.001 
3.87 (1.63-9.19) 4.52 (1.81-11.29) 
1 . 00 (reference) 1.00 (reference) 
This study highlights the variation in internal standards and patient expectations. 
Doctors should explore and help create realistic expectations befare admitting patients 
for cholecystectomy. Strict selection by the t reating surgeon based on preoperative 
pain characteristics, whilst advocating the merits of a watchful waiting approach, 
is, for the present, the best way to avoid unnecessary surgery in patients with 
uncomplicated cholecystolithiasis. 
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Table 5. Univariabie and multivariable analysis of patient and clinical variables associated with 
patient-reported results of surgery 
Age (years)* 
Sex 
F 
M 
Hospital type 
Tertiary referral centre 
Non-academie 
Preoperative abdominal pain in last 2 weeks 
No 
Yes 
ASA fitness grade 
ASA 11 
ASA I 
Baseline GIQLI score* 
Duration of pain (years)=l= 
~ 1 
>1 
Type of pain=l= 
Episodic 
Non-episodie 
Awakend because of pain* 
Yes 
No 
Postop. pain in last 2 weeks 
No 
Yes 
5urgery results 
Good, very good or 
excellent (n = 316) 
49.9 ± 14.3 
246 
70 
59 
257 
45 
27 1 
166 
150 
103.2±21.2 
238 
71 
174 
136 
164 
144 
204 
112 
Moderate or bad (n = 22) 
48.6 ± 14.7 
18 
4 
8 
14 
2 
20 
14 
8 
91 .9 ± 19.1 
14 
8 
13 
9 
13 
9 
2 
20 
~ Values are *mean ± SD; =I=A few patients did notcomplete all questions for this factor. ASA, 
American Society of Anesthesiologists; GIQLI, Gastrointestinal Quality of Life Index. 
64 
Univariabie analysis Multivariable analysis 
Odds ratio (95% Cl) P-value Odds ratio (95% Cl) P-value 
1.01 (0.98-1 .04) 0.668 1.01 (0.97-1.04) 0.773 
0.664 0.694 p 
0. 78 (O 26-2.38) 1.20 (035-4.09) -u :::tl 
1.00 (reference) 1.00 (reference) 0 VI 
-u 
0.050 0.128 m n 
0.40 (0.16-1.00) 0.46 (0. 17-1 25) -i < 
1 . 00 (reference) 1.00 (reference) m 5::: 
0.504 0.774 c 
1.66 (0.38-7.35) 0. 79 (0.16-3 99) !::j R 
1.00 (reference) m z 
-i 
0.316 :::tl m 
0.63 (0.26-1.55) n 0 
1.00 (reference) :r: 0 
1.02 (1.00-1 .05) 0.020 :::tl 
-i 
0. 161 VI 
-i 
1.92 (0.77-4. 75) c 0 
1.00 (reference) -< 0 
0.787 " ~ 1.13 (0 47-2. 72) ::j 
m 
1.00 (reference) z 
-;-i 
0.596 :::tl m 
0. 79 (0.33-1.90) -u 0 
1.00 (reference) :::tl -i m 
< 0.001 < 0.001 0 0 
18.21 (4.18-79.35) 19.01 (4.20-85.93) c 
-i 
1 . 00 (reference) 1.00 (reference) n 0 
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ABSTRACT 
Background 
Up to 41% of patients report pa in after cholecystectomy and in most studies follow-up for 
these symptoms did not exceed 5 years. The episodic nature of abdominal pa in associated 
with symptomatic cholelithiasis warrants long-term follow-up studies . We assessed which 
patient and surgical factors were associated w ith absence of pain and patient-reported 
successof surgery after ~ 5 years of fo llow-up. 
Methods 
Patients of ~ 18 years of age with symptomatic cholelithiasis, classified as ASA I or 11 , w ho 
had previously returned a preoperat ive questionnaire were sent a questionna ire consisting 
of the Gastrointestinal Quality of Life Index (GIQLI) and patient ratings of curren t versus 
presurgical abdominal symptoms and of surgery resu lt. Logistic regression analysis was 
performed to determine associations. 
Results 
Questionnaires were sent to 197 pat ients and returned by 126 (64 .0%) pat ients (73.8% 
female, mean age at surgery 47.5 ± 12.2 years) at a mean of 10.0 ± 1.0 yea rs after 
cholecystectomy. Absence of abdomina l pain was reported by 60.3% of the patients. 
Patients classified as ASA 11 as opposed to ASA I were less likely to report absence of pain 
(OR 0.41, 95% Cl 0.17-0.99). A positive rating of long-term postsurgical versus presurgica l 
abdominal symptoms was given by 89 .7% of the pat ients and 90.5% considered 
the cholecystectomy result to be good. No variables were significantly associated w ith 
these latter two outcome measures. 
Conclusions 
We found a high patient-reported surgery success rate after > 5 years of follow-up after 
cholecystectomy despite residual abdominal pain in some of these patients. None of 
the patient and surgery-related characteristics were consistently associated w ith al l th ree 
outcome measures. This discrepancy between patient' outcomes highlights the need for 
realistic expectations prior to cholecystectomy. 
BACKGROUND 
About 5-22% of the adult Western population have gallstones and approximately 
13-22% of these patients become symptomatic. 1· 2 Symptomatic patients ma inly report 
episodic abdomina l pain.3 • 4 Cholecystectomy is often performed to rel ieve this pa in. 5 
Annually, this corresponds to more than 800,000 cholecystectomies in the Un ited States 
alone and the associated costs are estimated to be approximately $6 bill ion. 1• 6 Other 
developed countries show similar trendsl· 8 
Despite the high volume of cholecystectomies in the Western world, up to 41% of 
the patients report postoperative abdominal pain . These figures are mainly based on 
studies with a follow-up of less than 5 years after cholecystectomy.9 However, the episodic 
nature of abdominal pain associated with symptomatic cholelithiasis warrants longer 
term follow-up studies. 10 To our knowledge on ly five studies fol iowed pat ients for 5 
years or more after cholecystectomy.11-15 These studies showed patient-reported absence 
of pa in ranging between 78 and 81 .5%, 11 · 15 while 88% was satisfied with the resu lt 
of the procedure. 15 None of these studies assessed mu ltivariable associations with 
patient-reported outcome measures. Since there are variations in reg iona l practice, more 
long-term fol low-up data are needed to optimize the indication of a cholecystectomy and 
to minimize unnecessary surgery. 16-18 
This study therefore aimed to assess the association of patient and surgery-related 
characteristics with absence of pain afterat least 5 years of fo llow-up. We a lso determined 
the association of these characteristics with patient-reported successof cholecystectomy. 
Finally, we assessed the effect of surgery on pain at long-term fo llow-up compared to 
short term follow-up . 
MATERIALS AND METHOOS 
Study site and subject selection 
We used the database of a previous cohort study conducted at the St Elisabeth Hospita! 
Ti lburg, The Netherlands. Details of study design were reported previously in this 
journal. 19 In short, included patient s had visited the department of surgery between 
January 2001 and March 2004. Patients had to be 18 years or older, w ithout re levant 
allergies, classified as American Society of Anesthesiologists (ASA) I or 11, and diagnosed 
with symptomatic cholelithiasis. Patients had been asked to complete the Gastrointestinal 
Quality of Life Index (GIQLI) questionnaire preoperatively, and at 1 day, 2, 6, and 12 weeks 
after cholecystectomy. 19 
Patients that had retu rned a preoperative questionnaire we re considered for participation 
in the current study. Patients with a malignancy, those with a mental disorder, those who 
had emigrated, those who eventually did not receive a cholecystectomy, and those who 
passed away during follow-up were excluded. Subsequently, we mailed the GIQLI and 
Patients' Experiences of Surgery Questionnaire (PESO) to the remaining patients in March 
2013. The GIQLI has been developed in Germany, and has been translated and va li dated in 
Dutch. 20· 21 lt includes 36 questions on general physical, emotional and social functioning 
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and on gastrointestinal symptoms, for bath the upper and lower digestive tracts inthe last 
2 weeks. Each question consisted of five response categories . The questions can be 
answered using a response scale from 0 to 4 for each question (where 0 is the w orsta nd 
4 is the best appraisal). An overal l score (ranging from 0 to 144 points) can be calculated : 
The higher the score, the higher the health-related quality of life. The PESO was used to 
assess how patients rated their abdominal symptoms in relation to cholecystectomy and 
to measure the patient-reported result of the procedure22· 23 Bath questions consisted 
of five response categories . lf no questionnaire was returned within 4 weeks, patients 
were approached by telephone and asked for participation. The study was approved by 
the medical ethics committee. 
Variables of interest 
Clinical data were extracted from the database or patient records. Based on a previous 
publication 19 and on clinical sensibil ity, the independent variables included gen der, a ge 
at surgery, body mass index (BMI), ASA classification, history of complicated ga llstone 
disease, preoperative endoscopie retrograde cholangiopancreatography (ERCP), duration 
of symptoms :;; 1 year, histological inflammation, type of surgery (laparoscop ie or 
small-incision cholecystectomy), conversion, serious intraoperative and postoperative 
complications including the need for an ERCP, preoperat ive absence of abdominal pain in 
the last 2 weeks, and the baseline GIQLI score. 
Outcomes 
The primary outcome was absence of abdominal pain as reported on t he GIQLI after at 
least 5 years of follow-up. We dichotomized results into absence of pain versus presence 
of pain. 
Secondary outcomes defining success of cholecystectomy incl uded patient ratings 
of bath postsurgical abdominal symptoms versus presurgical symptoms and surgery 
result. We dichotomized the responses into positive versus negative ratings. The positive 
rating of current abdominal symptoms consisted of the combined response categories 
"slightly better'' and "much better." The positive rating of the surgery resu lts included 
the combined response categories "excellent", "very good" and " good." Absence of 
abdominal pain at long-term follow-up was added to the selected independent variables 
to confirm the association w ith patient-reported successof the procedure. 
Finally, absence of abdominal pain af ter at least 5 years after cholecystectomy 
was compared to the short term follow-up time points . The extent to which patients 
with or without pain were similar at long-term follow-up and short term fo llow-up 
were described. 
This study follows those as stipulated by the guideline "strengthening the reporting of 
observational studies in epidemiology" (STROBE).24 
Statistkal analysis 
Chi square tests or Fisher's Exact Test for categorical data and Student's t test for 
continuous data we re used to exami ne significant differences between responders versus 
non-responders and dropouts. Patient and surgery-related characteristics were compared. 
The primary analysis focused on identifying associations of variables with absence of 
abdominal pa in using logistic regression models. Variables with a p-value < 0.1 in un ivariabie 
analyses were included in multivariable regression analysis. Backward elimination was 
used as the variabie selection method retaining age, gender and preoperative abdominal 
pain as reported on the GIQLI as covariates. The results were reported as adj usted odds 
ratios (ORs) and 95% confidence intervals (Cis). Similar methods were used to assess 
which variables were associated with the patient-reported rating of abdominal symptoms 
compared to before cholecystectomy and with the surgery result. MeNernar's test was 
used to determine whether absence of pain sign ificantly differed between long-term 
fol low-up and 1 day, 2, 6, and 12 weeks after cholecystectomy, respectively. A p-value of 
< 0.05 was considered statistically significant. All missing values were considered to be 
completely at random and were excluded from analyses. All statistica! analyses were done 
with IBM SPSS statistics version 20.0 . 
RESULTS 
Baseline data 
A total of 225 patients we re considered for participation . Aft er exclusion of 28 patients, 
197 patients were sent the long-term follow-up questionnaire. Questionna ires we re 
returned by 126 (64.0%) patients (Fig . 1 ). Baseline characteristics of the responders are 
shown in Table 1. Mean a ge at surgery was 47.5 ± 12.2 years with a mean fol low-up of 
10.0 ± 1.0 years. The proportion of female patients was 73.8% . No statist ical ly significant 
differences were shown between responders versus non-responders and drop-outs. 
Associations with absence of abdominal pain after cholecystectomy 
and with success 
A total of 76 (60.3%) patients reported absence of postoperative pain using the GIQLI. 
Univariabie analysis revealed ASA classification and the baseline GIQLI score as factors 
with a p-value < 0. 1 (Table 2). Multivariable analysis showed that patients with 
ASA 11 were less likely to report absence of pa in at long-term follow-up (OR 0.41, 
95% Cl 0.17-0.99). 
Abdominal symptoms after cholecystectomy were rated "much better'' or "sl ightly 
better'' by 113 (89. 7%) patients. Absence of abdominal pa in at baseline and absence of 
abdominal pain at long-term follow-up were univariably associated with patient-reported 
positive rating of abdominal symptoms compared to before cholecystectomy (Table 3). 
In multivariable analysis, absence of abdominal pain at long-term follow-up rema ined 
associated (OR 7.66, 95% Cl 1.47-39.88). A total of 114 patients (90.5%) reported 
the result of the surgery as "good," "very good" or "excellent." Univariabie ana lysis 
~ 
:::! 
m 
z 
,-i 
;;x:J 
m 
-o 
0 
;;x:J 
-i 
m 
0 
0 
c 
ri 
0 
s: 
m 
VI 
:!:i 
r 
0 
z 
Cl 
-i 
m 
;;x:J 
s: 
" 0 
r 
5 
~ (: 
-o 
73 
~ 
:::! 
m 
z 
-;1 
:;J:;J 
m 
-o 
0 
:;J:;J 
-f 
m 
0 
0 
c 
ri 
0 
s: 
m 
l/) 
~ 
r 
0 
z 
Cl 
-f 
m 
revealed age, absence of abdominal pain at baseline, and absence of abdominal pain at 
long-term follow-up to be associated with a positive rating of the cholecystectomy result. 
No variables remained associated in multivariable analysis. 
Figure 1. The reeruitment of patients 
225 patients we re considered for 28 patients excluded: 
participation • 15 deceased 
• 9 emigrated 
.... 
, 
• 2 malignancy 
" 
• 1 dementia 
197 patients we re sent long-term • 1 no cholecystectomy 
follow-up questionnaire 
.. 
71 patients did not 
,. 
return questionnaire 
" 
126 patients returned long-term 
follow-up questionnaire 
~ Table 1. Characteristics of the responders 
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Gender, M/F (%F) 
Age in years, mean ± SD 
BMI in kg/m2, mean ± SD 
ASA, 1/11 (%11) 
History of complicated gallstone disease, n (%) 
Preoperalive ERCP, n (%) 
Ou ration of symptoms s;1 year, n (%) 
lnflammation, n (%) 
Follow-up in years, mean ± SD (range) 
Type of surgery, SIC/LC (%LC) 
Conversion, n (%) 
Serious complications, n (%) 
Preoperative absence of abdominal pain in the last two weeks, n (%) 
Baseline GIQLI score, mean ± SD 
Responders 
33/93 (73 .8) 
47.5 ± 12.2 
27.8 ± 4.3 
87/39 (31.0) 
12 (9 5) 
10 (7.9) 
92 (730) 
26 (20.6) 
10.0 ± 10 (8-12) 
67/59 (46.8) 
22 (17.5) 
15 (119) 
23 (18.3) 
104.2 ± 15.8 
P-value 
0.61 
0.34 
0.86 
0.31 
0.39 
0.20 
0.55 
0.39 
NA 
0.69 
0.12 
0.85 
0.36 
0.71 
50 Standard deviation BMI Body Mass Index ASA American Association of Anesthesiologists ERCP Endoscopie 
Retrograde Cholangiopancreatography NA Not applicable SIC Small-incision cholecystectomy LC Laparoscopie 
cholecystectomy GIQLI Gastrointestinal Qua lity of Life Index 
Table 2. Univariabie and multivariable association of patient and surgical variables with postcholecystectomy 
patient reported absence of pa in 
Female gender, n (%) 
Age in years, mean ± SD 
BMI in kgfm2 
ASA 11, n (%) 
History of complicated 
gallstone disease, n (%) 
Preoperative ERCP, n (%) 
Ou ration of symptoms s 1 year, 
n(%) 
lnflammation, n (%) 
LC, n (%) 
Conversion, n (%) 
Serious complications, n (%) 
Preoperative absence of 
abdominal pain in the last two 
weeks, n (%) 
Baseline GIQLI score, mean ± SD 
Absence of 
abdominal 
pa in 
55 (724) 
48.5 ± 12.5 
27.9 ± 4.5 
19 (25.0) 
8 (10.5) 
6 (7.9) 
53 (79.1) 
19 (25 0) 
36 (47.4) 
16 (21 1) 
9 (11.8) 
17(22.4) 
Presence of Univariabie 
abdominal analyses 
pain (p-value) 
38 (76.0) 0.65 
46.0 ± 11.7 0.25 
27.6 ± 3.9 0.70 
20 (40.0) 0.08 
4 (8.0) 0.76 
4 (80) 1.00 
39 (83.0) 0.61 
7 (14 0) 0.14 
23 (46.0) 0.88 
6 (12 0) 0.19 
6 (12.0) 0.98 
6 (12 0) 0.14 
106.3 ± 16.7 101.0 ± 13.9 0.08 
Odds ratio 
(95% Cl) P-value 
1.00 (0.38-2 .68) 0.99 
0.99(0.96-1.03) 0.71 
0.41 (0. 17-0.99) 0.049 
2.38 (0.73-7.78) 0.15 
SD Standard deviation BMI Body Mass Index ASA American Society of Anesthesiologists ERCP Endoscopie 
Retrograde Cholangiopancreatography LC Laparoscopie cholecystectomy GIQLI Gastrointestinal Quality of Life 
Index 
Effectiveness of cholecystectomy on pain after at least 5 years of 
follow-up compared to short-term follow-up 
Absence of abdominal pain after cholecystectomy was not significantly more reported at 
long-term follow-up compared to 12 weeksof fo llow-up (p = 0.1 0). In contrast, absence 
of pain was significantly more reported at long-term follow-up compared to 1 day 
(p = < 0.001), 2 weeks (p = < 0.00 1) and 6 weeks (p = < 0.001) after cholecystectomy, 
respectively. The extent to which patients with or without pain were similar at long-term 
fol low-up and 12 weeksof follow-up are shown in Fig . 2. 
DISCUSSION 
This study demonstrates that only 60.3% of the patients reported complete absence 
of pa in at an average of 10 years after cholecystectomy, but that approximately 90% 
of the patients rated the abdominal symptoms and the surgery result as positive. We 
found that presence of ASA 11 was associated with abdominal pain after cholecystectomy. 
None of the variables of interest were associated with a positive rati ng of the abdominal 
symptoms compared to before surgery or with the positive rating of the cholecystectomy 
result. The proportion of patients reporting absence of pain at long-term follow-up versus 
12 weeksof follow-up was not significantly different in contrast to prior timepoints. 
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Table 3a. Univariabie and multivariable association of patient and surgical variables with patient-reported 
much or slightly better symptoms compared to befare the cholecystectomy 
Much or About the sa me, 
slightly slightly worse 
better or much worse Univariabie 
abdominal abdominal analyses Odds ratio 
symptoms symptoms (p-value) (95% Cl) P-value 
Female gender, n (%) 84 (74.3) 7 (63.6) 0.48 2.43 (0.57-1 0.40) 0.23 
Age in years, 47.5±12.2 46.0 ± 13.3 0.70 101 (0.95-1 06) 0.86 
mean ± SD 
BMI in kg/m2, mean ± SD 28.0 ± 4.3 26.7±3.5 0.31 
ASA 11, n (%) 33 (29.2) 5 (45.5) 0.31 
History of complicated 11 (9 7) 1 (9 1) 100 
gallstone disease, n (%) 
Preoperative ERCP, n (%) 9 (8 0) 1 (9.1) 1.00 
Duration of symptoms ::;; 1 80 (79.2) 10 (90 9) 0.69 
year, n (%) 
lnflammation, n (%) 22 (19.5) 4 (36.4) 0.24 
LC. n (%) 54 (47.8) 4 (36.4) 0.47 
Conversion, n (%) 19 (16.8) 3 (27.3) 0.41 
Serious complications, n (%) 14 (12.4) 1 (9.1) 1.00 
Preoperative absence of 20 (17 7) 1 (9 1) 0.10 2.49 (0.25-24 82) 0.44 
abdominal pain in the last 
two weeks, n (%) 
Baseline GIQLI score, 105.0 ± 15.9 96.8 ± 15.3 0.12 
mean ± SD 
Postoperative absence of 72 (63.7) 2 (18.2) 0.001< 7.96 (1.61-39.40) 0.01 
abdominal pain in the last 
two weeks, n (%) 
50 Standard deviation BMI Body Mass Index ASA American Society of Anesthesiolog ists ERCP Endoscopie 
Retrograde Cholangiopancreatography LC Laparoscopie cholecystectomy GIQLI Gastrointestinal Qual ity 
of Life Index 
The proportion of patients with abdominal pain after cholecystectomy in our study 
is consistent with literature. A systematic review indicated that up to 41% of patients 
report abdominal pain after cholecystectomy,9 while studies with a fo llow-up :<: 5 years 
showed lower figures (18 .5-22 %). 11 •1s We did not find any relation with gender, age, 
nor complicated gallstone disease and abdominal pain in our study. Th is is in contrast 
with previous studies . In one study patients whose symptoms hardly improved 5 years 
after cholecystectomy were most likely to be women.11 Another study concluded that 
persisting abdominal pain 5 years after cholecystectomy was mainly nonspecific, found 
mostly in younger women who had experienced uncomplicated gallstone disease. 15 
The use of different patient-reported outcome measurement tools between studies or 
variations in the indication to perfarm a cholecystectomy may explain these different 
Table 3b. Univariabie and multivariable association of patient and surgical variables w ith patient-reported 
good, very good or excellent result of surgery 
Good, 
very good 
or excellent Moderate Univariabie 
result or bad result analyses Odds ratio 
of surgery of surgery (p-value) (95% Cl) P-value 
Female gender, n (%) 85 (74 6) 7 (63.6) 0.48 1.66 (0.39-7.00) 0.49 
Age in years, mean ± SD 46.9 ± 12.6 53.3 ± 5.7 0.006 0.95 (0.89-1 01) 0.08 
BMI in kg/m2, mean ± SD 27.9 ± 4.3 26.8 ± 3.8 0.40 
ASA 11, n (%) 34 (29 8) 4 (36.4) 0.73 
History of complicated 11 (9.6) 1 (9 1) 1.00 
gallstone disease. n (%) 
Preoperative ERCP, n (%) 9 (7 9) 1 (9.1) 1.00 
Ou ration of symptoms ~1 82 (80.4) 9 (81.8) 1.00 
year, n (%) 
lnflammation, n (%) 22 (19.3) 4 (36.4) 0.24 
LC, n (%) 54 (47.4) 5 (45 5) 1.00 
Conversion, n (%) 19 (16.7) 3 (27.3) 0.41 
Serious complications, 13 (11.4) 2 (182) 0.62 
n(%) 
Preoperative absence of 20 (1 7 5) 2 (18 2) 0.06 0.83 (0.14-5 14) 0.84 
abdominal pain in the last 
two weeks, n (%) 
Baseline GIQLI score, 104.8 ± 15.9 98.5 ± 15.4 0.24 
mean ± SD 
Postoperative absence of 71 (62.3) 4 (36.4) 0.001< 3.62 (0.93-1406) 0.06 
abdominal pain in the last 
two weeks, n (%) 
50 Standard deviation BMI Body Mass Index ASA American Society of Anesthesiolog ists ERCP Endoscopie 
Retrograde Cholangiopancreatography LC Laparoscopie cholecystectomy GIQLI Gastrointestinal Quality 
of Life Index 
results. 25 Younger wamen with gallstones may have been treated more conservatively in 
our study, as suggested by variations in practice. 16• 17 
A large prospective cohort study detected an association of ASA classification w ith 
abdominal pain 6 months after cholecystectomy that was independent of the patient-
reported successof the surgery.26 Patients-reported success rates ranges between 82 and 
93%. 1s· 26-28 These findings are consistent with our results. Since ASA classification has no 
effect on patient ratings of surgery success, the association of ASA 11 classification with 
abdominal pain may be related to concurrent co morbidity. In add it ion, postoperative 
abdominal pa in has been shown to be strongly associated with the patient-reported 
success of the operation26 The success of a procedure may depend on symptom rel ief . 
complications and cosmetic resultY By asking patients explicitly how they wou ld rate 
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Pain absent at 12 weeks 
• and long-term folow-up 
Pain present at 12 weeks 
~ and long-term folow-up 
Pain absent at 12 weeks. 
O ~~ent at long-term 
Pain present at 12 weeks, 
IZI 1>11 absent at long-term 
folow-up 
Figure 2. Comparison of patients w ith or w ithout pa in after cholecystectomy at 12 weeks and long-term 
follow-up. A total of 39 (37.5%) patients reported absence of pain at bath timepoints. whi le pain rema ined 
present in 28 (26.9%) patients. Patients reporting absence of pain at 12 weeks after cholecystectomy 
showed presence of pain in 13 (13.5%) cases at long-term follow-up. Patients showing presence of pain 
at 12 weeks after cholecystectomy reported absence of pa in at long-term follow-up in 24 (22. 1 % ) cases. 
The remaining 22 patients had not returned the questionnaire at 12 weeks of follow-up . 
their symptoms and how they would judge the surgery result, we aimed to elucidate 
which element was rated as successful. 
Some limitations of our study should a lso be discussed. First, bias may have occurred due 
to the limited response rate of our population. However, a comparison between responders 
versus non-responders and drop-outs did not show any significant differences. Second, 
since this study was performed in a single-center the generalizability may be limited. lt is 
documented that variations in regional practice and in postoperative pain management 
may depend on the diagnostic work-up, the time of referral, and the indication for an 
operative intervention .16- 18 Third, by only measuring the before and after resul ts, bias 
might have been introduced. 14• 29 This study confirmed the natural episodic course of 
abdominal pain. Bias could be reduced by measuring symptoms at multiple fo llow-up 
moments. In order to curtail this possibi lity we conducted this long-term fol low-up study. 
Strengths of our study included the use of widely translated and va li dated standardized 
questionnaires. We measured absence of pain as primary outcome using the GIQLI 
and success using the PESQ in order to obtain valid patient responses . The systematic 
measurement of patient-centered cholecystectomy outcomes using validated 
questionnaires in differentiating who would and would not have benefited from surgery 
has been advocated in previous studies in this journal.9 · 27 Moreover, our study included 
a prospective measurement of pain at 5 years or langerafter cholecystectomy. Abdominal 
pa in may come in episodes, sametimes with intervals of several years29 Pa in may therefore 
be relieved after cholecystectomy at short term follow-up, but may re-emerge at long-
term. Furthermore, we surmise that the placebo effect of cholecystectomy w il I have faded 
5 years after cholecystectomy.30 
The discrepancy between the proportion of patients with pain and proportion of 
patients rating the surgery as successful highlights the need for realistic expectations 
priortoa potentia l cholecystectomy. lt seems that many patients w ill accept some degree 
of pain, since it may be caused by concurrent co morbidity. Future research should focus 
on further optimizing the indication and timing of cholecystectomy in large numbers of 
patients diagnosed with symptomatic cholelithiasis systematically using validated patient-
reported outcome measures. The characteristics of pain pre- and postoperatively have to 
be the main scope. Persistenee of abdominal pain should be measured afterat least 12 
weeks following cholecystectomy, as this prediets the persistenee of th is symptom until 
10 years after the procedure. With this information physicians could inform patients 
basedon evidence about the odds of pain relief and thereby create real istic expectations. 
Furthermore, patients that benefit the most from a cholecystectomy could be selected 
improving the cost-effectiveness of this common surgical procedure.31 This would reduce 
the variations of cholecystectomy indications in patients diagnosed w ith symptomatic 
cholelithiasis and thereby decrease healthcare expenses. 
In conclusion, we found a high patient-reported operative success rate of 90% 
at >5 years of follow-up after cholecystectomy despite residual abdominal pain 
in a substantial percentage of these patients. This discrepancy between outcome 
measures highlights the need for setting realistic expectations prior to cholecystectomy. 
Systematic measurement of validated patient-reported outcomes is needed to further 
optimize the indication and timing of cholecystectomy in patients diagnosed with 
symptomatic cholelithiasis. 
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ABSTRACT 
Background 
As many as 33% of patients with symptomatic cholel ithiasis report persisting abdominal 
pain after cholecystectomy, suggesting alternative causes forthese symptoms. EGD may 
serve as a tooi to identify additional symptomatic abdominal disorders befarehand to 
avoid unnecessary gallbladder surgery. There is controversy as to whether routine EGD 
befare cholecystectomy is appropriate. 
Objective 
To perfarm a systematic review and meta-analysis to assess the value of EGD befare 
cholecystectomy. 
Design 
A systematic literature search was conducted to identifystudies that reported t he proportion 
of patients who were referred for cholecystectomy, but in whom initial surgery could be 
avoided after treatment of abnormalities detected with EGD. Paoled estimates with 95% 
confidence intervals (Cis) were ca lculated by using random effects models. 
Setting 
Meta-analysis of 12 cohort studies. 
Patients 
A total of 6317 patients with cholelithiasis underwent EGD. 
Results 
The pooled estimate of abnormalities detected with EGD was 36.3% (95% Cl, 28.0-
45.0). In a total of 3.8% (95% Cl, 1.4-7.6) of patients referred for cholecystectomy who 
underwent previous EGD, gallbladder surgery was avoided. 
Limitations 
Lack of information regarding characteristics of patients referred for cholecystectomy, 
criteria for performing EGD, algorithms for the treatment of identified patholog ies, and 
response criteria for the decision to avoid cholecystectomy in included studies. 
Conclusions 
Our study indicates that, despite the high diagnostic yield of EGD, its value as a tooi 
to prevent gallbladder surgery is limited. EGD should only be considered selectively in 
patients with cholelithiasis referred for cholecystectomy. 
INTRODUCTION 
In as many as 22% of patients with gallstones, symptoms will develop eventually. 1 
Treatment of first choice is a cholecystectomy. Th is strategy results in more than 800,000 
cholecystectomies in the United States annually, with associated casts that are estimated 
to exceed $6 bill ion 2 · 3 Data from other countries are no different4 · 5 However, as 
many as 33% of patients continue to have abdominal pain despite cholecystectomy,6 
which sheds doubt on whether the initial diagnosis of symptomatic cholelith iasis was 
correct. Symptomatology of cholelithiasis may be confounded with symptoms related 
to other upper Gl diseases. The easy access to US for detecting gallstones and the low 
threshold for performing a therapeutic procedure may contribute to the high number 
of cholecystectomies . There is a large variation in surgical treatment of patients w ith 
gallstones, giving rise to doubt about the diagnostic accuracy and concerns about 
the inappropriate use of health care resources_?-9 Gastritis, esophag it is, and peptic ulcer 
might be alternative diagnoses for the abdominal symptoms, and these diseases can be 
easily diagnosed by EGD.10· 11 The medicalliterature on the value of routine EGD in patients 
referred for cholecystectomy is conflicting, 12 highl ighting the need fora systematic review 
and meta-analysis. 
This study, therefore, aimed to systematically assess and analyze the value of EGD in 
patients diagnosed with symptomatic cholelithiasis who we re referred for cholecystectomy. 
Value was defined as the proportion of avoided cholecystectomies after treatment of 
abnormalities detected by EGD. 
METHOOS 
Medical literature search 
We conducted a systematic literature search of the databases of Pubmed, Embase, 
Web of Science, ClinicaiTria ls.gov, and the Cochrane Library (March 2014) by using 
the combination of the following keywords: cholel ithiasis, cholecystolithiasis, 
biliary, gallstone, gall stone, calculi, AND cholecystectomy AND gastroscopy, 
gastroduodenoscopy, oesophagogastroduodenoscopy, esophagogastroduodenoscopy, 
oesophagoduodenoscopy, esophagoduodenoscopy. We foliowed the Meta-analysis of 
Observational Studies in Epidemiology checklist for all steps reported in this systematic 
review and meta-analysis.13 
Selection of the studies 
Two reviewers (M.P.L. and C.O.) independently screened the titles and abstracts of 
the studies and selected potentially relevant articles, irrespective of the language. We 
included studies assessing the proportion of patients in whom a cholecystectomy was 
avoided because of EGD findings in patients diagnosed with symptomatic cholelithiasis. 
Letters, books, conference abstracts, and double publications were excluded. 
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In addition, we checked the reference lists of all articles that were retrieved 
for additional studies. Discrepancies were resolved by discussion and consensus. lf 
disagreement persisted, a third reviewer (WK.) was available to make the f inal decision. 
Data extraction 
Data from each study regarding characteristics of the studies and EGD were extracted by 2 
reviewers (M.P.L. and C.O.) independently. The study characterist ics included the authors, 
year of publication, country, number of patients referred for cholecystectomy, sex, 
mean age, type of cholecystectomy, and duration of fo llow-up. The EGD characteristics 
comprised the number of patients undergoing EGD; the number of patients having 
abnormal findings on EGD; the different EGD findings including gastric ulcer, duodenal 
ulcer, gastritis, esophagitis, hiatal hernia, and malignancy; and the number of patients 
in whom initial cholecystectomy was avoided after treatment of the EGD find ings. 
Discrepancies were resolved by discussion and consensus. 
Methodological quality 
The methodological quality of the el igible studies was assessed by t he 2 reviewers (M.P.L. 
and C.O.) independently, by using the Newcastle-Ottawa Scale for assessing the risk of 
bias of nonrandomised studies.14 The items included the representativeness of the exposed 
cohort, selection of the nonexposed cohort, ascertainment of exposure, demonstration 
that the outcome of interest was not present at start of study, and comparabi lity of 
cohorts on the basis of the design or analysis, assessment of outcome, and duration 
and adequacy of follow-up. Each item of high quality was given 1 star, except for 
comparability, which was given 2 st ars. A total of 9 stars could be given . Appropriate 
selection criteria of cohorts were considered to be consecutive series of patients with 
controls from the same or similar popu lation. A star was given for matching on age and 
sex and a star for matching on pre-endoscopie additional diagnostics or treatment, when 
assessing comparability. The fol low-up had to be at least 3 months, and adequacy of 
fol low-up had to be more than 80% of the origina l cohort to be allocated a star each. 
The overall risk of bias rating that was given was basedon the number of stars assigned. 
A rating of low risk of bias required 7 to 9 stars, moderate risk cohort studies required 4 
to 6 stars, and high risk required 3 or fewer stars. Disagreements between the 2 reviewers 
were resolved by consensus. 
Data analysis 
Pooled estimates of proportions w ith 95% confidence intervals (Cis) were calculated 
according to the random effects model of DerSimonian and Laird. 15 Heterogeneity 
among studies was estimated by using the 12 statistic. We performed a subgroup ana lysis 
regarding study characteristics to assess the influence on outcomes: ( 1) studies conducted 
in the same country because these patients may be more homogeneous; (2) studies 
reporting laparoscopie cholecystectomy (LC) as the type of surgery because the indication 
to perfarm gallbladder surgery has broadened with LC. 16 and (3) the 50% most recent 
studies versus the 50% least recent studies because the diagnostic properties of EGD may 
have improved in time. 
All calculations were performed with StatsDireet statistica! software V.2.8.0 (StatsDirect 
Ltd, Cheshire, United Kingdom). 
RESULTS 
Selected studies 
The initial search yielded 2561 articles. After remaval of duplicates and after applying 
the initia l step of eligibility screening, 22 articles remained for full-text screening. After 
application of the exclusion criteria, 11 of 22 studies were excluded. An additional 
publication was identified through citation snowballing, leaving 12 studies to be included 
in this review (Fig. 1 ). 
2561 potentially relevant articles 
identified (March 1" ) 
Pubmed (n = 2395) 
Embase (n = 138) 
Web of Science ( n = 26) 
Cochrane Library (n = 1) 
ClinicaiTrials.gov (n = 1) 
76 articles excluded 
Duplications (n = 76) 
2485 articles screened on tilleiabstract 
2463 articles excluded 
Studies nol evaluating the value of EGD prior to cholecystectomy in 
pa tienis with symptomatic gallstone disease (n = 2463) 
22 articles screened on full lex! 11 studies excluded 
Conference abstracts, letters. bockreports (n = 3) 
Double publications (n = 3) 
Studies nol reporting the proportion of patients in whom a 
11 articles included cholecystectomy was avoided because of EGD findings (n = 5) 
1 artiele retrieved by citation snowballing I 
12 articles included in this review 
Figure 1. Flow diagram of the studies identified in the systematic review. 
Charaderistics of the studies and EGO 
The characteristics of the included studies are shown in Table 1. A total of 8 studies 
were performed in Germany.12• 17 -23 In 4 studies cholecystectomy was performed 
laparoscopically.19• 23-25 The number of patients having a prior EGD ranged from 57 up 
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Table 1. Characteristics of the included studies 
No. of patients referred 
Study and setting for cholecystectomy Sex, M /F Mean age, y 
Dimitriou et al, 12 Germany, 2012 766 NR NR 
AI-Azawi et al, 24 1reland, 2006 400 47/171 49.8 (16-79) 
Sosada et al,25 Poland, 2005 2800 47 5/2325 51 (14-87) 
Fahlke et al, 19 Germany, 2001 700 141/559 42 
Thybusch et al, 22 Germany, 1996 338 110/228 51 (14-87) 
Lankisch et al/ 0 Germany, 1996 100 27173 58 (38-86) 
Niv and Fraser27 1srael, 1995 57 20/37 59.2± 15.2 (1 0-90) 
Beyermann et al, 17 Germany, 1992 670 206/464 55 (15-93)t 
Ure et al, 23 Germany, 1992 376 94/282 51 (18-87)t 
Diettrich et al, 18 Germany, 1990 100 32/68 58.3 
Rassek et al, 21 Germany, 1988 960 1:3 NR 
Coleman et al,26 Australia, 1981 100 25/75 NR 
MIF. Male/female; NR, not reported; C. cholecystectomy; LC, laparoscopie cholecystectomy. 
'Gastric and duodenal ulcers combined. 
' median age. 
to 2,800 patients. The number of abnormalities detected varied between 22 and 1187, 
and the number of avoided cholecystectomies ranged between 0 and 125. Gl ulcer was 
the most common diagnosis that led to avoidanee of cholecystectomy. 
Quality assessment 
Table 2 describes the methodological quality of the included stud ies. Al l stud ies drew 
their cohort from the referred general popuiatien and were from single centers wh ich 
may have resulted in selection bias. All studies ascertained EGD using health care records. 
One study reported to have excluded patients having had an EGD with in 3 months of 
admission that was reported to have normal findings 23 None of the studies showed 
comparability of cohorts on the basis of the design or analysis. In al l stud ies, t he outcome 
was adequately assessed by using record linkage. Three studies reported a fo ll ow-up 
duration of at least 3 months.24· 26· 27 The lengthof fo llow-up of the cohorts was adequate 
in 7 studies .18· 20· 22· 23· 25-27 The overall risk of bias was high to moderate, with scores 
ranging from 2 to 4 out of 9. 
Outcomes and subgroup analysis 
The pooled proportion of detectable Gl abnormalities was 36.3% (95 % confidence 
interval [Cl) 28.0-45.1 %) of a total of 63 17 patients w ith cholelithiasis who underwent 
EGD (Table 3). In 11 .0% of patients w ith abnormalities (95% Cl 3.9-21 .1 %), the initial 
cholecystectomy was avoided leading to 3.8% (95% Cl 1.3%-7 .6%) of waived gal I bladder 
surgery in all patients previously undergoing an EGD EGD (Fig . 2). 
Type of No. of patients w ith 
surgery Follow-up, mo (range) No. of patients undergoing EGO abnormal EGO findings, (% ) 
c NR 766 330 (43 .1 ) 
LC 374 days (1 50-61 3) 218 120 (55.0) 
LC NR 2800 1187 (42.4) 
LC NR 487 40 (82) 
c NR 338 160 (47 .3) 
c NR 100 45 (45.0) 
c 12 57 30 (52.6) 
c NR 386 159 (41.2) 
LC NR 376 60 (16.0) 
c NR 100 31 (31.0) 
c NR 589 259 (44.0) 
c 11 (5-21) 100 22 (22 0) 
The effects of the subgroup analyses are shown in Table 3. The proportions of 
abnormalities in German studies, in LC studies, and in the 50% least recent studies were 
lower compared with the proportion of abnormalities of the total group. The paoled 
proportion of the 50% most recent studies showed a higher percentage. The proportion 
of avoided cholecystectomies was lower in German, LC only, and 50% most recent 
studies. The paoled results of the 50% least recent studies showed a higher proportion 
compared with the proportion of avoided cholecystectomies of the total group. 
DISCUSSION 
Our study indicates that the value of EGD as a strategy to prevent cholecystectomies is 
limited. Although a total paoled proportion of 36.3% of abnormalities was detected with 
EGD, cholecystectomy was prevented in only 3.8% of patients. The finding of a Gl ulcer 
was the most common reason that led to avoidanee of a cholecystectomy. 
The routine or selective use of EGD needs to be considered in li ght of its expense. 
A total of 100 I 3.8% = 26 (95% Cl 13-77) EGDs are needed to avoid 1 cholecystectomy. 
In our hospita!, a cholecystectomy w ithout overnight stay casts $4,533 (€3,238), whereas 
EGD expenses are $2,744 (€1960). To be cost-effective, only up to 1.7 (4,533 ~ 2,744) 
EGDs need to be performed to avoid 1 cholecystectomy. Therefore, routine EGD in 
patients referred for cholecystectomy cannot be recommended . 
The value of EGD befare cholecystectomy is limited compared with its effectiveness 
in patients with persistent symptoms after cholecystectomy. In fact, EGD appears to be 
more useful in patients w ith persistent symptoms after cholecystectomy because studies 
reported between 14% and 31% of patients with abnormalities at endoscopy, expla ining 
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Table 2. Quality assessment of the studies by using the Newcastle-Ottawa scale14 
Selection of 
Representativeness the nonexposed 
Study of the exposed cohort cohort 
Dimitriou et al 12 
AI -Azawi et al24 
Sosada et al' 5 
Fahlke et al19 
Thybusch et al" 
Lankisch et al20 
Niv and Fraser27 
Beyermann et al17 
Ure et al23 
Dietrrich et al'" 
Rassek et al21 
Coleman et al' 6 
* Symbol indicates that quality measure was met. 
Dimitriou et a/12 • 
AI-Azawi et af" ~ 
Sosada et af'" 
Fahlke et al" 
Thybusch et aP> 
Lankisch et af'O 
Nivetaf27 
Beyermann et a/11 
Ure et af23 
Diettrich et al18 • 
Rassek et aP' 
Coleman et af28 l 
Combined (n • 6317) ~ 
0,0 20.0 
• 
40.0 
Proportion (95% confidence interval) 
Outcome not 
Ascertainment present at start 
of exposure of study 
* 
* 
* 
* 
* 
* 
* 
* 
* * 
* 
* 
* 
16.3 (13.8-19. 1) 
2.8 (1.0-5.9) 
0.6 (0.3-0.9) 
0.8 (0.2-2.1) 
7.7 (5. 1-11.1) 
0.0 (0.0-3.6) 
33.3 (21.4- 47.1) 
0.3 (0.0-1.4) 
1. 1(0.3-2. 7) 
7.0 (2.9-13.9) 
1.9 (0.9-3.3) 
1.0 (0.0-5.4) 
3.8 (1.3-7.6) 
60.0 
Figure 2. Forest plot of avoided cholecystectomies in all cholelithiasis pat ients previously undergoing 
an EGD. 
the persistent symptoms.10• 11• 28 At this point, however, patients have al ready experienced 
an unnecessary, more-invasive surgical procedure. The challenge ahead, therefore, w ill 
Comparability Assessment of outcome Follow-up length Follow-up adequacy 
* 
* * 
* * 
* 
* * 
* * 
* * * 
* 
* * 
* * 
* 
* * * 
be to identify patients who will benefit from additional diagnostic assessments befare 
a potential cholecystectomy from patients who will not. 
The number of abnormalities found with EGD in patients diagnosed w ith symptomatic 
cholelithiasis is lower compared with the general popuiatien with abdominal symptoms 
(36.3% vs 58.5%) 3 This discrepancy is due toa difference in indication toperfarm EGD. 
The indication for EGD in the majority of the general pop u lation was reflux symptoms, 3 
whereas abdominal pa in is the ma in feature of symptomatic cholelithiasis. 29· 30 According 
to several guidelines, one of which one has been published in th is journal, EGD is 
appropriate in case of alarm symptoms such as dysphagia or odynophagia, unintentional 
weight loss, or persistent vomiting of unknown cause. In addition, EGD may be considered 
in patients of 50 years of age and older with persistentor recurrent abdomina l symptoms 
despite using antacids who tested negative for Helicobacter pylori. 31 · 32 Therefore, we 
believe that EGD should only be considered in this select group of patients to prevent 
unnecessary, burdensome, and costly endoscopie procedures in patients with US-proven 
cholelithiasis with abdominal symptoms of uncertain cause. 
Our review also has some potential limitations. First, all studies included in our review 
had an inherent high to moderate risk of bias, and in fact none fu lfilled al l quality criteria . 
Second, disease incidence, such as incidence of gastroesophageal malignancies, varies 
between countries and regions. 33 As a consequence, the diagnostic yield and va lue of 
EGD differ among populations. Third, there is variatien in referral behavior, and diagnostic 
work-up may vary among studies. 34 Essential information such as characteristics of patients 
referred for cholecystectomy, criteria for perform ing EGD, algorithms for treatment of 
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Table 3. Paoled results of the included studies 
Abnormalities, Heterogeneity, Avoided cholecystectomies in patients 
% (95% Cl) 12 (95% Cl) with abnormalities, % (95% Cl) 
Total 36.3 (28.0-45. 1) 97.6 (97.1-98.0) 11.0 (3.9-21. 1) 
German 33.3 (21.8-46. 1) 98.1 (97.6-98.4) 10.1 (2.3-22.5) 
LC only 28.4 (1 0.3-51.1) 99.3 (99.1-99.4) 5.0 (1.4-1 0.6) 
Most recent 50% 38.9 (25.9-52. 7) 98.5 (98 1-98.8) 9.2 (0.7-26.1) 
Least recent 50% 33.7 (224-46.0) 95.7 (93.5-96.9) 12.8 (3 3-274) 
Cl, Confidence interval; LC, laparoscopie cholecystectomy 
identified pathologies, and response criteria for the decision to avoid cholecystectomy is 
not or is toa limited extent reported in the included studies. Consequently, the strategie 
effectiveness of EGD varies significantly. A trial randomizing referred patients to EGD and 
no EGD would curtail bias, but we surmise that the strategie yield would be limited. 
The strengths of our study included the systematic assessment of t he va lue of EGD 
in patients referred for cholecystectomy. We think we increase the re liabilit y of the EGD 
findings by pooling results f rom individual studies. The analyses of pooled subgroups 
increases the generalizabil ity of the find ings. Physicians can use these numbers for clinical 
decision making in patients referred for cholecystectomy. 
Future research in this area should focus on the process of clin ical decision making. 
The effectiveness of diagnostics and therapeutics can be increased by critica lly evaluating 
its necessity at each step in treating patients. For patients w ith abdominal symptoms 
this indicates physicians should consider ultrasonography, EGD, initiate pharmacolog ical 
symptomatic treatment or conduct a cholecystectomy. A critica! assessment of patient 
characteristics and symptoms at each step should be part of this research to predict 
the effectiveness of clinical decision making. 
In conclusion, our results indicate that, although many abnormalities are found with 
EGD in patients with cholelithiasis referred for ga llbladder surgery, t reatment of these 
findings rare ly prevents cholecystectomy. Therefore, EGD should only be considered in 
a selective group of patients. ldentif ication of this patient population shou ld be subject 
of future research in order to increase the effectiveness of diagnostic and therapeutic 
modalities in the processof clinical decision making. 
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Total no. of cholecystectomies avoided, 
Heterogeneity, 12 (95% Cl) % (95 % Cl) Heterogeneity, F (95% Cl) 
97.3 (96.7-97 8) 3.8 (1.3-7.6) 
96.7 (95.5-97.4) 3.2 (0.6-7.9) 
82.7 (36.7-91 5) 1.1 (0.4-1 9) 
98.5 (98 1-98 8) 3.3 (0 2-9.8) 
93.8 (89 7-95 7) 4.2(11 -91) 
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ABSTRACT 
Background 
The aim of this study was to determine the cost-effectiveness of a new strategy for 
the preoperative detection of patients that willlikely benefit from a cholecystectomy, using 
simple criteria that can be applied by surgeons. Criteriafora cholecystectomy indication 
are: (1) Having episodic pa in; (2) onset of pa in 1 year or less before the outpatient 
clin ic visit. 
Methods 
The cost-effectiveness of the new strategy was evaluated aga inst current practice using 
a decision analytic model. The incremental cost-effectiveness of applying criteria for 
a cholecystectomy for a patient with abdominal pain and gallstones were compared to 
applying no criteria . The incremental cost-effectiveness ratio (IC ER) was expressed as 
extra costs to be invested to gainone more patient with absence of pain . Scenarios were 
analyzed to assess the influence of applying different criteria. 
Results 
The new strategy of applying 1 out of 2 criteria resu lted in a 4% higher mean proportion 
of patients with absence of pain compared to current practice with similar costs. 
The 95% upper limit of the IC ER was €4, 114 ($4,633) per extra patient with re lief of 
upper abdominal pain. Application of 2 out of 2 criteria resulted in a 3% lower mean 
proportion of patients with absence of pain with lower costs. 
Condusion 
The new strategy of using one out of two strict selection criteria may be an effective 
but also a cost-effective methad to reduce the proportion of patients with pain 
after cholecystectomy. 
BACKGROUND 
Gallstones constitute a significant health problem in developed societies, affecting 5 to 
22% of the adult population, but only an estimated 13 to 22% of gallstone carriers 
will eventually become symptomatic. 1• 2 The diagnosis of uncompl icated symptomatic 
gallstone disease is based on the Rome 11 1 criteria consisting of a steady abdominal pain, 
usual ly located in epigastrium and/or right upper quadrant lasting 30 minutes or langer 
in the presence of radiologica I detected gallstones 3 · 4 However, the sensit ivity of these 
criteria is limited and 40% of the patients w ith symptomatic gallstones report far less 
specific abdominal pa in symptomss· 6 
A cholecystectomy is the therapy of f irst choice for patients diagnosed with 
uncomplicated symptomatic cholecystolith iasis.7 There are no international guidel ines that 
indicate which patient to offer a cholecystectomy or conservative t reatment. Therefore 
the indication to perfarm a cholecystectomy lies within the surgeons' preferenee leading 
to variations in practice and consequently unnecessary cholecystectomies 8 -11 A systematic 
review reported in this journal demonstrated that up to 33% of patients has persistent 
abdominal pain fo llowing cholecystectomy. 12 
A strategy that is effective in selecting patients with abdomina l pain and gallstones 
for surgery most likely to benefit from a cholecystectomy was developed. This strategy 
uses fixed selection criteria based on pain characteristics that are easy to use in clin ical 
practice . Patients with abdominal pain and gallstones are selected for cholecystectomy 
if they fulfill one of the following two selection criteria13· 14: (1) episodic pa in; (2) pain 
onset of 1 year or less befare the outpatient clinic visit. Preoperative ident ificat ion of 
patients with abdominal pain and gallstones who will benefit from a cholecystectomy 
from patients whowil I nat, wi l I probably lead to more effective use of cholecystectomies, 
fewer surgery-related complications and fewer unnecessary healthcare expenses. We 
performed a model based economie evaluation to evaluate a strategy based on fixed 
criteria for selecting patients fora cholecystectomy against current practice . 
MATERIALS AND METHOOS 
The incremental cost effectiveness of the new strategy, restrictive care, compared with 
the usual care strategy was analyzed, following a healthcare perspective for a t ime 
horizon of one year. A decision analytic model was used with effectiveness expressed as 
absence of abdominal pain and costs in Euros (indexed to 2014). Models were bu iltand 
analyzed using the decision analysis program TreeAge Software, lnc W il liamstown, MA, 
USA. 2014 version (Fig. 1.). The study was approved by the medica I ethics committee and 
informed consent for this rnadel ling study was nat needed. 
Cost effectiveness model and model input 
Cholecystectomy or watchful waiting were the treatment possibilities in bot h strateg ies. 
In the usual care strategy, the indication for cholecystectomy was left to the preferenee 
of the treating surgeon, thus without fixed selection criteria. In the restrict ive care 
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strategy, the indication for cholecystectomy was only made after meeting criteria as 
described above. 
Table 1 shows the variables used as input and the specific data sources. A database 
of a prospective multicentre cohort study was used for the probability of getting 
a cholecystectomyn In this database, all patients with cholelithiasis referred for 
cholecystectomy that visited the departments of surgery of one tertiary referral centre 
and two non-academie teaching hospitals between June 2012 and June 2014 were 
recorded . The same prospective database was used for the probabil ity of meeting 
the proposed criteria and the relief of upper abdominal pain afte rwards. The relief of 
pain after cholecystectomy in usual care was based on a systematic review. 12 Fol lowing 
a healthcare perspective, we only used direct medical costs for analysis . A previous study 
and existing guideline prices for the Netherlands were used to value an outpatient cli nic 
visit, a cholecystectomy including an overnight stay, and surgical compli cations. 15· 16 
Application of the criteria itself for cholecystectomy in the restrictive care strategy did not 
lead to additional costs in itself. 
For every modeling study assumptions need to be made, which were the fol lowing 
in this study: Watchful wa iting included an extra outpatient clin ic visit made in one 
year. Additional diagnostic work-up is patient-dependent and only rarely applied and is 
therefore not included in this model. 17 
Table 1. Basic input variables and sourees used in the decision model (shown in Figure 1). 
Input for the cost effectiveness model 
Probabi lity that a patient with abdominal symptoms 
and gallstones: 
Satisfies one out of two criteria (thus receiving cholecystectomy) 
Satisfies two out of two criteria (thus receiving cholecystectomy) 
Data souree 
Prospective multicentre cohort study13 
(306/337=0.908) 
(138/337=0409) 
Probability of receiving cholecystectomy in usual care strategy Prospective database of a multicentre 
cohort study13 (0.9 11) 
Probability of having a complication of the surgery Randomized controlled trial 16 (0. 175) 
Probabi lity of having absence of pain after watchfu l waiting 
Probability of having absence of pain after cholecystectomy in 
usual care 
Probabi lity that a patient has absence of pa in after 
cholecystectomy in restrictive care: 
Satisfies one out of two criteria 
Satisfies two out of two criteria 
Costs of watchful waiting (=1 extra outpatient clinic visit) 
Costs 
Cholecystectomy including overnight stay, withor without 
complications, outpatient clinic visit 
Analyses 
Prospective study25 (0 41) 
Systematic review" (0.59) 
Prospective multicentre cohort study13 
(195/306=0.637) 
(100/138=0.725) 
Cost-effectiveness guidelines15 
€314 ($354) 
Randomized controlled trial 
and cost-effectiveness guidel ines15· 16 
€4, 125 ($4,645) with complications 
€3,936 ($4.432) without 
complications 
The main outcome of both models were the incremental cost-effectiveness ratio 
expressed as the extra costs that need to be invested in order to get one more patient 
with rel iet of abdominal pain. Two analyses were performed. The f irst analysis focused 
on the incremental cost effectiveness of the new strategy in gallstone patients having 
a cholecystectomy if one of two cr iteria would be tu ltilled compared with usual care. 
The second a na lysis focused on the i ncremental co st effectiveness of the new strategy in 
gallstone patients having a cholecystectomy if two out of two criteria would be fulfilled. 
Models were analyzed using a probabi listic sensitivity a na lysis. With this a na lysis the model 
is run a 1,000 times, each t ime picking another value from the distribution underlying 
the input parameters. Beta distributions tor the probabilities of getting a cholecystectomy 
and reliet of abdominal pain were used. For the cost parameters however no data were 
available to construct a distribution. Results t rom the 1,000 runs are graphically presented 
as scatterplots on cost-effectiveness planes and as means w ith 95% percenti les. 
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RESULTS 
The results of the probabilistic sensitivity analysis of the first decision model w ith the new 
strategy of gallstone patients having a cholecystectomy if one of two criteria have 
been satisfied are shown in Figure 2. The new strategy was more effective compare 
with the usual care strategy and also less expensive. The mean percentage of patients 
with absence of pain in the new strategy was 62% (95% percentile 0.57-0.66), whereas 
with the usual care strategy this was 57% (95% percentile 0.55-0.60). The costs of 
the new strategy were €3,61 0 (95% percentile 3,487-3, 722) ($4,065; 95% percenti le 
3,927-4,191), whereas the costs of the usual care strategy was €3,622 (95% percenti le 
3,536-3,706) ($4,078; 95% percenti le 3,982-4, 173). The mean cost difference was -€12 
(95% percentile -134-105) (-$14; 95% percentile -151-118) with a mean effectiveness 
8 difference of 4.0 (95% percentile 0.2-8.0) for the new strategy compared w ith the usual 
~ care strategy. Fifty-three per cent of the simulations are located in the dominant quadrant, 
m 
~ meaning a higher percentage of patient with re lief of upper abdominal pain against 
Cl lower costs. The 95% upper limit of the incremental cost-effectiveness ratio (ICER) is 
< z €4, 114 ($4,633) per extra patient with relief of upper abdominal pain. 
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Figure 2. Probabi listic sensitivity analysis of the model with the new strategy of gallstone patients having 
cholecystectomy if one out of two criteria have been satisfied. 
The results of the probabilistic sensitivity analysis of the second model with the new 
strategy of gallstone patients having a cholecystectomy if both criteria have been satisfied 
is shown in Figure 3. The mean percentage of patients with absence of pain in the new 
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Figure 3. Probabi listic sensitivity analysis of the model with the new strategy of gallstone patients having 
cholecystectomy if both criteria have been satisfied 
strategy was 54% (95% percentile 0.46-0.61), whereas with the usual care strategy 
this was 57% (95% percentile 0.55-0.60) and therefore more effective. The costs of 
the new strategy was €1,675 (95% percentile 1.471-1,886) ($1 ,886; 95% percenti le 
1,656-2, 124), whereas the costs of the usual care strategy was €3,618 (95% percenti le 
3,527-3,700) ($4,074; 95% percentile 3,972-4,167). While in all simu lat ions, the new 
strategy resulted in lower costs, only 16% of the simulations resulted in a higher 
percentage of patients with rel ief of upper abdominal pain. 
DISCUSSION 
Th is study showed that the strategy of using strict selection criteria may be a cost-effective 
method to reduce the proportion of patients with pa in after cholecystectomy. The strategy 
of applying 1 out of 2 criteria resulted in a 4% higher mean proportion of patients with 
absence of pain compared to current practice with similar costs. The majority (54%) of 
the simulations resulted in the restricted care being dominant, meaning less expensive and 
more effective. In those simulations were the restrictive care strategy was more effective 
but a lso more expensive, there was a fair maximum to be paid per extra patient with relief 
of abdominal pain. Application of the more stringent 2 out of 2 criteria resu lted in a 3% 
lower mean proportion of patients with absence of pain, but against lower costs. 
In a previous study we showed that duration of pain of one year or less has a sl ightly 
higher odds ratio for absence of pain after cholecystectomy as compared to episodic 
abdominal pa in (2 .22 versus 2. 13), although this difference is not signif icant. 13 Altogether 
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we would recommend to implement the strategy of applying 1 out of 2 criteria. 
Application of these criteria would offer surgeons less room for personal preferences 
which patient to offer a cholecystectomy and which patient to treat conservatively. This 
strategy would therefore provide a tooi for better patient selection for each treatment 
arm. A recent cost-effectiveness study reported in this journal camparing cholecystectomy 
with observation for uncomplicated symptomatic cholecystolithiasis or acute cholecystitis 
reported that cholecystectomy is the preterred treatment for symptomatic gallstones. 
On average, surgery costs f 1,236 (€1 ,448; $1 ,631) more per patient than conservative 
management, but was more effective. However, the study also reported that 55% of 
the patients randomized to the observation group did not require surgery ind icating t hat 
it may be a valid alternative to surgery.18 Applicat ion of fixed criteria for cholecystectomy 
may increase the cost-effectiveness of cholecystectomy and conservative treatment as 
shown in this study. 
Effectiveness of an intervention is often reported in cost-effectiveness studies as qua lity 
adjusted life years (QALY). 18 However, abdominal pain is the most characteristic feature 
of uncomplicated symptomatic cholecystolithiasis and therefore re li ef of abdominal pain 
is the main aim of cholecystectomy in this patient group.3-6 In addition, absence of pain 
after cholecystectomy is the main predietor of a patient-reported successfu l outcome of 
the operation. 19 The Gastrointestinal Quality of Life Index, a patient-reported outcome 
measure computing quality of life, may not be sufficiently disease specific. 20· 21 Abdominal 
pain, for example, is equally scored as flatulence in this questionna ire. Other patient-
reported outcome measures computing quality of life are no different in weighing 
persistent abdominal pain 22 Furthermore, a quality of life score is less applicable in 
surgical practice compared to presence or absence of abdominal pain. We therefore 
selected absence of postoperative abdominal pain as effectiveness outcome. 
This study must be considered within the context of some limitations. First, the criteria 
for selection for cholecystectomy remain non-specific, although they are more specific 
than current practice entirely based on the surgeons' preference. Second, the criteria of 
the new strategy were not externally validated, although this may have been challenging 
to perfarm due to strong treatment preferences of patients and surgeons23'25 Third, we 
focused on uncomplicated symptomatic cholel ithiasis patients. Patients w ith compli cated 
symptomatic cholel ithiasis were not considered . Exclusion of complicated symptomatic 
cholelithiasis may not have had a large impact as the patient group with uncomplicated 
symptomatic cholelithiasis only have an annua l 1-3% risk on complications because of 
the stones 2 6 Furthermore, the observation group of a randomized controlled t rial of 
patients w ith uncomplicated symptomatic cholecystolithiasis did notsuffer compl ications 
during 14 years of follow-up.V Forth, we excluded patients having a bile duet injury as 
this specific complication of cholecystectomy has a low incidence of 0.04-1.5% .28• 29 Fifth, 
we did not consider additional diagnostic work-up because of Jack of data, variabil ity 
and patient-dependency.17 Finally, the new strategy was evaluated from a healthcare 
perspective for a time horizon of 1 year. lf a societal perspective would be taken into 
account, the restrictive care strategy of having one out of two criteria satisfied would 
probably be even more cost-effective, because this strategy was more effective in terms 
of relief of abdominal pain and prevented cholecystectomies, probably preventing sick 
leave. Patients with ongoing abdominal pain would continue to seek medical help with 
add itional diagnostic interventions . 
This study should be considered a pilot study before assessing the cost-effectiveness 
of the application of these criteria in an actual trial. Apart from confirming these resu lts 
in a prospective randomized multicentre study, future research should focus on further 
maximizing the cost-effectiveness of cholecystectomy. Determination of patients with 
cholelithiasis at risk for complications due to the gal lstones may benefit from earlier 
cholecystectomy. Selection for earlier surgery of those patients who are most likely to 
benefit wi ll further increase the cost-effectiveness of this common surg ica l procedure. In 
add ition, not on ly should be assessed which patient wil I benefit from cholecystectomy, but 
also which patient will benefit most. Episodic abdominal pain due to gal lstones may not 
significantly affect the hea lth status of all patients to that extent that a cholecystectomy is 
required. The necessity may depend on frequency, duration, and intensity of the abdominal 
pain episodes.30 Reliable prediction models combining clinical parameters with patient-
reported outcome measures may faci litate efficient use of scarce healthcare resources 31 
In conclusion, the new strategy was more effective, against simil ar costs, than 
current practice if one out of two criteria were applied. More stringent application of 
criteria resulted into loss of effectiveness. The new strategy of using strict selection 
criteria may be a cost-effective method to reduce to proportion of patients with pain 
after cholecystectomy. 
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CHAPTER 8 
EPISODIC ABDOMINAL PAIN CHARACTERISTICS 
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ABSTRACT 
Background 
Cholecystectomy is the therapy of first choice in patients with uncomplicated symptomatic 
cholecystolithiasis, but it remains unclear which patients truly benefit in terms of health 
status impravement Patients generally present with episod ic abdominal pain of varying 
frequency, duration and intensity. We assessed whether characteristics of abdominal 
pain episodes are determinants of clinically relevant impravement of health stat us 
after cholecystectomy. 
Methods 
In a post-hoc analysis of a prospective multicentre cohort study patients of ;::: 18 years of 
age with uncomplicated symptomatic cholecystolith iasis subjected to cholecystectomy 
were included. Preoperatively, patients received a structured interview and a questionnaire 
consisting of the visual analogue scale (VAS, range 0-1 00) and gastrointestinal qua lity of 
life index (G IQLI). At 12 weeks after cholecystectomy, the GIQLI was again administered. 
Logistic regression analyses were performed to determine significant associations. 
Results 
Questionnaires were sent to 261 and returned by 166 (63.6%) patients (128 females, 
mean age at surgery 49 .5 ± 13.8). A total of 131 (78 .9%) patients reported a cl inically 
relevant impravement of health status. The median (interquarti le range) frequency, 
duration and intensity of abdominal pain episodes were 0.38 (0.18-0.75) a week, 4.00 
(2.00-8.00) hours and 92 (77-99), respectively. None of the characteristics was associated 
with a clinical ly relevant impravement of health status at 12 weeks after cholecystectomy. 
Conclusions 
Characteristics of abdominal pain episodes cannot be used to inform patients w ith 
symptomatic cholecystolithiasis who are skeptic about the timing of cholecystectomy 
for optimal benefit Timing of cholecystectomy should therefore be based on other 
characteristics and preferences. 
INTRODUCTION 
Cholecystolithiasis represents a clinical spectrum that ranges from asymptomatic 
gallstone disease to uncomplicated symptomatic gallstone disease to acute cholecystitis. 
Likewise, therapeutic options may go from conservative treatment to cholecystectomy. 
Patients with asymptomatic cholecystolithiasis benefit least from cholecystectomy in 
terms of impravement of health status and should receive conservat ive care, whereas 
those with acute cholecystitis benefit most and should receive su rgery. 1•4 The optimal 
timing that results in the highest benefit for patients with uncomplicated symptomatic 
cholecystolithiasis remains less clear. 
Uncomplicated symptomatic cholecystolithiasis is frequently characterized by 
abdominal pain episodes of widely varying frequency. These episodes may last minutes or 
several hours, and their intensity is variable. 5 Previous studies have shown that patients 
with a higher frequency of episodic abdominal pain were less likely to obta in pain reliet 
after cholecystectomy6 -1° Conversely, those with a typical episode duration between 
30 minutes and 24 hours were more likely to report absence of pa in after surgery, 
whereas patients with a higher pain intensity were not more likely to report absence of 
pain. 10 Abdominal symptom characteristics may also indicate which patients are most 
likely to display clinically relevant impravement of patient-reported overall hea lth status 
after cholecystectomy: a more comprehensive outcome measure that not only includes 
symptom eva luation, but also emotional, physical, and social functioning. 1 1 
We aimed to assess whether frequency, maximum duration, or intensity of abdominal 
pa in episodes were associated with impravement of health status in order to define which 
patients with uncomplicated symptomatic cholecystolithiasis may benefit most from 
cholecystectomy. We also assessed the associations of these episode characteristics with 
different subscales of health status at 12 weeks after cholecystectomy. 
METHOOS 
Study sites and patient selection 
We performed a post-hoc analysis using the database established during a previous 
multicentre cohort study conducted in The Netherlands. Details of study design were 
reported previously. 12 In short, all individuals aged 18 years and over w ith symptomatic 
cholelithiasis, who visited the surgical outpatient clinic at a tertiary referral centre (Radboud 
University Medical Centre, Nijmegen) or one of two non-academie teaching hospitals 
(St. Elisabeth Hospita!, Tilburg and the Medisch Spectrum Twente Hospita!, Enschede) 
between June 2012 and June 2014, and were scheduled for elective cholecystectomy 
were eligible for participation in the study. Cholelithiasis was defined as abdominal pain 
associated with gal lstones, confirmed with ultrasound imaging. Medical histories were 
obtained by a single physician (MPL) through a structured interview. 
Patients were asked to reeall the duration of symptoms, the number of episodes, 
and longest episode duration. Patients with a history of symptoms for more than 
1 year or who reported to have experienced more than f ive episodes were excluded, 
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because most of these patients could not reeall the frequency. Consequently, these data 
were only sporadically reported in the database. In addition, we excluded those with 
schizophrenia or other mental disorders that may impair recall. Other exclusion criteria 
were as follows: a history of complicated symptomatic cholelith iasis (acute cholecystitis, 
cholangitis, biliary pancreatitis, choledocholithiasis requiring endoscopie retrograde 
cholangiopancreatography (ERCP)), 13• 14 ASA fitness grade 11 1 and IV, insufficient 
knowledge of the Dutch language, non-Dutch residency, blindness, pregnancy, cirrhosis, 
or cancer treatment. Eligible patients were asked to complete a questionnaire befare 
cholecystectomy and 12 weeks after cholecystectomy. Patients who failed to return or 
complete the questionnaire befare and after surgery were excluded. 
The questionnaire consisted of the Gastrointestina l Quality of Life Index (GIQLI). 
The GIQLI has been developed in Germany and has been translated and va li dated in 
Dutch. 15· 16 For an example of the questions and responsecategoriesof this questionnaire, 
we refer to a previous study. 15 The GIQ LI addresses upper and lower gastrointestinal 
symptoms (19 questions), emotional (5 questions), physical (7 questions), social well-
being (4 questions) and effect of medical treatment (1 question) in the previous 2 weeks. 
Each question contains five response categories. Questions can be scored using a response 
scale ranging from 0 (worst appraisal) to 4 points (best appraisal) for each question, 
giving an overall score of 0-144 points. The higher the score, the better overall health 
status is. A clinically relevant impravement after surgery was defined as an increase of 5 
points or more in the overall score or in any of the subscales. 17 We a lso included a visual 
analogue score (VAS) providing a range of scores from 0 to 100 to quantify the maximum 
severity of pain preoperatively. 
The study was approved by the med ical ethics committee and reported in accordance 
with the recommendations in the Strengthening the Reporting of Observationa l studies 
in Epidemiology (STROBE) guidelines for reporting observational studies. 18 
Outcomes and Variables of Interest 
The primary outcome was defined as a cl inically re levant impravement of overal l health 
status. Secondary outcomes included a clinically relevant impravement of upper and 
lower gastrointestinal symptoms, or on the emotional, physical, and social subscales, 
respectively. Based on previous publications, the independent variables included sex, 10• 
19 age at operation, 10· 19 centre, 10 baseline GIQLI score, 19 ASA fitness grade, frequency, 
maximum duration and intensity of abdominal pain episodes. 
Statistica! Analysis 
We examined whether baseline clinical and abdominal pain characteristics differed 
between responders and non-responders to the questionnaire, using x2 tests or Fisher's 
exact tests for categorical data, Student's t tests for continuous data, and Mann-Whitney 
U tests for ordinal data. We determined which variables were associated in un ivariabie 
analysis with a clinically relevant impravement of hea lth status after surgery using 
logistic regression analyses. Significant variables in univariabie a na lysis (P < 0.1 0) we re 
int roduced into a backward multivariable regression model to determine whether the re 
were independent predietors of clinically relevant impravement of overal l health status or 
any of the subscales after surgery. Age at operation, sex, centre, and basel ine GIQLI score 
were the variables that were retained in the model as co-variables. Results were reported 
as adjusted odds ratios (ORs) with corresponding 95% confidence intervals. P < 0.05 was 
considered statistically significant. All missing values were considered to be completely 
at random and excluded from analyses. Statistica! analyses were performed using SPSS 
statistica! software version 20.0 (IBM, Armonk, New York, USA). 
RESULTS 
The database consisted of 870 potentially eligible patients. A total of 261 patients were 
included . Preoperative and postoperative questionnaires were returned and completed 
by 166 (63 .6%) patients (Fig . 1). Baseline characteristics of the responding patients 
are shown in Table 1. One hundred and twenty-eight of the respond ing patients were 
females. Mean age at surgery was 49.5 ± 13.8 years. The median (interquarti le range) 
frequency, duration and intensity of abdominal pa in episodes we re 0.38 (0.18-0. 75) 
a week, 4.00 (2 .00-8.00) hours and 92 (77-99), respective ly. Baseline and abdominal pain 
characteristics did nat differ between responders and non-responders. 
One hundred and thirty-one (78.9%} patients reported an overal l cl inically 
relevant impravement after surgery. Univariabie analysis showed maximum intensity 
of abdominal pa in episodes to be associated with clinically relevant impravement 
of overall health status (OR 1.02, 95% Cl 1.00-1.04; P = 0.069) (Table 2). Maximum 
intensity of abdominal pain episodes did nat remain associated in mu ltivariable ana lysis 
(OR 1.03, 95% Cl 1.00-1.05; P = 0.066) . 
On the gastrointestinal symptoms subscale, 105 (63.3%} patients reported a cl inically 
relevant impravement (Table 3). The emotional subscale showed a clinical ly re levant 
impravement in 37 (22.3%) patients. A clinical ly relevant impravement of the physical 
subscale was reported by 54 (32.5%} patients. Thirty-nine (23.5%} patients showed 
a clinically relevant impravement of the social subscale. 
Duration was associated with clin ical ly relevant impravement of the physical 
(OR 1.07, 95% Cl 1.02-1.12; P = 0 .007) and social subscales (OR 1.09, 95% Cl 1.04-
1.14; P < 0.001) in univariabie analysis (Table 3). Univariabie analysis showed frequency to 
be associated with clin ically re levant impravement of the social subscale (OR 2.39, 95% 
Cl 1.11-5.12; P = 0.025). In multivariable analysis, duration (OR 1.1 0, 95% Cl, 1.03-1.17; 
P = 0.003) and frequency (OR 2.95, 95% Cl 1.08-8.08; P = 0.035) of abdominal pain 
episodes with clinical ly relevant impravement of the social subscale remained associated. 
DISCUSSION 
This study showed a cl inically relevant impravement of overall health status in 13 1 
(78.9%) patients at 12 weeks after cholecystectomy. Episode character istics of pain 
were nat associated with an overall clinically relevant impravement of health status after 
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Patients considered for inclusion Excluded n =609 
n = 870 More than 5 episodes or symptoms for 
more than 1 year n = 291 
... 
Complicated symptomatic cholelithiasis 
, 
n= 218 
'lf lnsufficient knowied ge of the Dutch 
Patients given preoperalive 
language, n =44 
questionnaires 
Remaining exclusion criteria (e.g. 
n = 261 
inability to read) n = 56 
>I Did not return questionnaires n =60 I 
'~ 
Returned preoperalive questionnaires 
and sent postoperalive questionnaires 
at 12 weeks postcholecystectomy 
n = 201 
>I Did nol return questionnaires n =35 I 
'~ 
Returned questionnaires n = 166 
Figure 1. Flow chart showing inclusion of patients in the study. 
surgery, but patients with a higher frequency and a longer duration of abdomina l pain 
episodes were more likely to have a cli nically relevant impravement of social f unctioning 
after surgery. 
The preoperative health status score and impravement of health stat us were similar 
to studies using the same patient-reported outcomes. 1•4 We measured patient-reported 
outcomes at 12 weeks after cholecystectomy as studies suggest that the results at this 
time point persist at long term fol low-up. 10· 20 In studies defining clinica lly re levant health 
outcome after surgery exclusively as pain or symptom relief, abdominal pain episode 
characteristics were associated with a better outcome6 . 10 We showed, however, that 
characteristics of abdominal pain episodes were not associated with overal l health 
outcome when other factors such as emotional and social function ing are a lso taken into 
account. No associations were found between abdominal pain episode characteristics 
and all the subscales of health status, except for the social subscale. This st udy showed an 
association of increased pain episode frequency w ith the social subscale of health status 
Table 1. Characteristics of the respond ing and non-responders to the questionnaires 
Non-responders, 
Characteristic 
Responders, 
n = 166 n = 95 P value 
Age (years) 
Sex 
Male 
Fe male 
ASA fitness grade 
I 
Center 
Radboud UMC 
MST 
St Elisabeth Hospita/ 
Frequency of abdominal pa in episodes a week 
Duration of longest abdominal pain episode in hours 
Maximum intensity of pa in episode ranging 0-1 00 
Baseline GIQLI score 
GIQLJ score 12 weeks after cholecystectomy 
49.5±13.8 46.3 ± 16.3 
38 (22.9) 23 (24 2) 
128(771) 72 (75 8) 
83 (50.0) 52 (54 7) 
83 (50 0) 43 (45 3) 
36 (21.7) 19 (200) 
69 (41.6) 47 (49 5) 
61 (36.7) 29 (32 2) 
0.4 (0 2-0 8) 0.3 (0 2-0.7) 
4.0 (2.0-8.0) 4.0 (2 .0-6.3) 
92 (77-99) 
103.5±22.1 
124.4±13.7 
Data are expressed as mean (standard deviation) or n (%) or median (interquartile range). 
ASA, American Society of Anesthesiologists; GIQLI, Gastrointestinal Quality of Life Index; 
UMC. University Medica I Center; NA, not applicable; MST, Medisch Spectrum Twente hospita/. 
0.09 
0 .8 1 
0.46 
NA 
NA 
NA 
0 .65 
0.48 
NA 
NA 
NA 
improvement. In addition, a longer duration of pain episodes has been associated with 
absence of pain, 10 whereas an association was found with clinically relevant impravement 
of social functioning in this study. The higher frequency and longer duration may have 
been caused by an undetected socia I disabling mild acute cholecystitis. 13 Th is suggestion 
may certainly fit with the spectrum of cholecystolithiasis. 
The main explanation for the discrepant results with literature is the ditterenee in 
patient-reported outcomes. The most comprehensive patient-reported outcome measure 
in patients w ith uncomplicated symptomatic cholecystolithiasis to determine appropriate 
and efficient utilization of cholecystectomy is still under debate. Postoperative absence of 
pain, satisfaction, and health status impravement al l have been previously used as primary 
patient-reported outcome measures. 11 Argument for using patient-reported absence of 
postoperative pa in as primary outcome is that the diagnosis of uncomplicated symptomatic 
cholecystolith iasis is based on abdominal pain21 "23 In addition, postoperative pa in after 
cholecystectomy is the main predietor of a patient-reported unsuccessful outcome.24 
Satisfaction as primary outcome has the advantage of providing information about 
the relationship between patient expectations and the treatment experience. Satisfaction 
incorporates the description of healthcare f rom the patient's viewpoint, measurement of 
the processof care, and evaluation of its outcome. 11 Finally, arguments for using health 
status impravement is that it measures various domains of health and on a continuous 
scale. This outcome allows us to det ermine which patient benefits most from therapyn 
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Table 2. Univariabie and multivariable association of pain episode characteristics with patient-reported 
minimal clinically important impravement of health status 
Clinically relevant Multivariable 
improvement Univariabie analysis analysis 
< 5 points on ~ 5 points on Odds ratio Odds ratio 
GIQLI, n = 35 GIQLI, n = 131 (95% Cl) P-value (95% Cl) P-value 
Age (years) 50.6 ± 13.6 49.2 ± 13.9 0.99 0.586 1.0 0.885 
(O 97-1.02) (0 96-1.04) 
Sex 0.179 0.650 
Female 24 (68 6) 104 (794) 1.77 0.76 
(O 77-4.05) (0 24-246) 
Male 11 (314) 27 (20.6) 1.00 
(reference) 
Hospita! type 0.850 0.812 
Tertiary 8 (22.9) 28 (21.4) 0.92 0.86 
referral center (0.38-2.24) (0 24-3.06) 
Non-academie 27 (77.1) 103 (78.6) 1.00 
(reference) 
Baseline GIQLJ score 126.6 ± 11.8 97.3 ± 20.0 0.88 < 0.001 0.88 < 0.001 
(O 84-0 92) (0 84-0.92) 
ASA fitness grade 0.568 
IJ 16 (45.7) 67 (51.1) 1.24 
(0.59-2.63) 
19 (54.3) 64 (48 8) 1.00 
(reference) 
Frequency of pain 0.4 (0 2-0.5) 0.4 (0.2-1.0) 1.66 0.287 
episodes a week (0.65-4 26) 
Maximum duration of 4.0 (2.5-9.0) 4.0 (2.0-8.0) 1.01 0.648 
longest pain episode (O 96-1.07) 
in hours 
Maximum intensity of 88.5 93.5 1.02 0.069 1 03 0.066 
pain episode ranging (72.0-94.3) (79 0-99 8) (1.00-1 04) (1.00-105) 
0-100 
Data are expressed as mean (standard deviation) or n (%) or median (interquarti le range). 95% Cl, 95% 
conf idence interval; ASA, American Society of Anesthesiologists; GIQLI, Gastrointestinal Quality of Life Index 
Health status impravement was therefore chosen as primary patient -reported outcome 
in this study. 
Our study has some limitations. First, we cannot fully rule out reeal l bias, although 
we limited this type of bias by excluding patients that could not reeall abdominal 
pain frequency. The generalizabil ity of the results may therefore be limited, although 
the patient characteristics are no different compared with the characteristics of other 
studiess-lo Second, the inclusion of referred patients and the limited response rate may 
have caused select ion bias, although we did not find any significant differences between 
the responding and non-responding patients. Third, we performed a post-hoc ana lysis 
Table 3. Univariabie and multivariable association of pain episode characteristics w ith patient-reported 
impravement of health status subscales 
Clinically relevant Multivariable 
improvement Univariabie analysis analysis 
Gastrointestinal < 5 points on ~ 5 points on Odds ratio Odds ratio 
symptoms subscale GIQLI, n = 61 GIQLI, n = 105 (95% Cl) P-value (95% Cl) P-value 
Age (years) 47. 1 ± 15.2 50.9 ± 12.7 1.02 0.087 1.03 (1 00- 0.048 
(1.00-1.05) 1 06) 
Sex 0.056 0.230 
Fe male 42 (68 9) 86 (81.9) 2.05 174(071 -
(0.98-4 27) 4 32) 
Male 19 (31.1) 19 (18.1) 1.00 
(reference) 
Hospita! type 0.143 0.228 m 
Tert iary 17 (27.9) 19 (18.1) 0.56 (0.22- -u 0.57 Vi 
referral center (027-1.21) 143) 0 Cl 
Non-academie 44 (72.1) 86 (81 .9) 1.00 ?'i ~ (reference) CIJ Cl 
Baseline GIQLI score 117.9± 17.8 95.1±19.9 0.94 < 0.001 0.94 (0.91- < 0.001 0 s:: (0 92-0.96) 0 96) z 
ASA fitness grade 0.148 ~ r 
11 26 (42 .6) 57 (54.3) 1.60 ~ 
(0 85-3 02) z (J 
35 (574) 48 (45.7) 1.00 I ~ (reference) :;x:J ~ 
Frequency of pain 0.4 (0. 2-0.7) 0.4 (0.2-0 8) 1.21 0.613 (J 
-! 
episodes a week (0 58-2.50) m :;x:J 
Duration of longest 4.0 (2 0-8.0) 4.0 (2.0-8 0) 1.01 0.828 Vi -! 
?'i pain episode in hours (0.96-1.05) VI 
Maximum intensity of 89.0 94.0 1.01 0.329 
pain episode ranging (77.0-96.5) (78.0-1 00.0) (0.99-1.03) 
0- 100 
Clinically relevant Multivariable 
improvement Univariabie analysis analysis 
< 5 points on ~ 5 points on Odds ratio Odds ratio 
Emotional subscale GIQLI, n = 129 GIQLI, n = 37 (95% Cl) P-value (95% Cl) P-value 
Age (years) 49.6 ± 13.8) 49.0 ± 13.7 1.00 0.790 0.99 0.389 
(0 97-1.02) (0 95-1 .02) 
Sex 0.277 0.568 
Fe male 97 (75.2) 31 (83.8) 170 0.71 
(0 65-44 6) (0 22-2.32) 
Male 32 (24 8) 6 (16. 2) 1.00 
(reference) 
Hospital type 0.991 0.736 
Tertiary 28 (21.7) 8 (21.6) 1.00 1.20 
referral center (041-242) (042-347) 
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Table 3. (cont inued) 
Clinically relevant Multivariable 
improvement Univariabie analysis analysis 
< 5 points on <! 5 points on Odds ratio Odds ratio 
Emotional subscale GIQLI, n = 129 GIQLI, n = 37 (95% Cl) P-value (95% Cl) P-value 
Non-academie 101 (78.3) 29 (78.4) 1.00 
(reference) 
Baseline GIQLI score 109.7 ± 18.5 8 1.9 ± 20.2 0.93 < 0.001 0.93 < 0.001 
(0 91-0.95) (0 90-0.95) 
ASA fitness grade 0.852 
11 65 (50.4) 18 (48.6) 0.93 
(0.45-1.94) 
64 (49.6) 19 (51.4) 1.00 
m (reference) 
-u 
Frequency of pain 0.4 (0.2-0.7) 0.4 (0.2-1.0) Vi 1.01 0.978 
0 
episodes a week (0.44-2.31) CJ 
r; Duration of longest 4.0 (2 0-8.0) 5.0 (2.0-8.0) 1.02 0.362 )> 
ro pain episode in hours (0 97-1 08) CJ 
0 Maximum intensity of 92.0 95.0 1.01 0.524 s:: 
z pain episode ranging (770-99.0) (79 0-99.3) (0 99-1.03) )> 0-100 r 
~ Clinically relevant Multivariable z 
Î\ improvement Univariabie analysis analysis I 
)> 
:;J:;J < 5 points on <! 5 points on Odds ratio Odds ratio )> 
Î\ Physical subscale GIQLI, n = 112 GIQLI, n = 54 (95% Cl) P-value (95% Cl) P-value 
-; 
m 
:;J:;J 
Vi 
-; Age (years) 49.6 ± 14.4 49.3 ± 12.5 0.99 0.916 0.99 0.524 
r; (0 98-1 02) (0 96-1.02) 
l/) 
Sex 0.353 0.584 
Fe male 84 (75.0) 44 (81.5) 1.47 0.76 
(0 65-3 29) (O 28-2.03) 
Male 28 (25.0) 10 (18.5) 1.00 
(reference) 
Hospita! type 0.278 0.310 
Tertiary 27 (24.1) 9 (1 6.7) 0.63 0.61 
referral center (0.27-1.45) (0.23-1.59) 
Non-academie 85 (75.9) 45 (83.3) 1.00 
(reference) 
Baseline GIQLI score 111.2 ± 19.7) 87.5 ± 17.9 0.94 < 0.001 0.94 < 0.001 
(0.92-0.96) (0.92-0.96) 
ASA fitness grade 1.000 
11 56 (50.0) 27 (50.0) 1.00 
(0.52-1.91) 
56 (50.0) 27 (50.0) 1.00 
(reference) 
Frequency of pain 0.38 0.33 1.27 0.514 
episodes a week (0.19-0.67) (O 18-1 00) (0.62-2 62) 
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Table 3. (continued) 
Clinically relevant Multivariable 
improvement Univariabie analysis analysis 
< 5 points on <! 5 points on Odds ratio Odds ratio 
Physical subscale GIQLI, n = 112 GIQLI, n = 54 (95% Cl) P-value (95% Cl) P-value 
Duration of longest 4.0 (2.0-6.0) 5.0 (2.4-13.5) 1.07 0.007 
pain episode in hours (1.02-1.1 2) 
Maximum intensity of 91.0 94.0 1.01 0.316 
pain episode ranging (770-1 00.0) (86.0-99.0) (0 99-1.03) 
0-100 
Clinically relevant Multivariable 
improvement Univariabie analysis analysis 
< 5 points on <! 5 points on Odds ratio Odds ratio m 
-u 
Social subscale GIQLI, n = 127 GIQLI, n = 39 (95% Cl) P-value (95% Cl) P-value Vi 
0 
Cl 
Age (years) 47.5 ± 12.6 50.1 ± 14.1 0.99 0.303 0.97 0.096 ?'i 
(0.96-1.01) (094-1 .01) ~ CIJ 
Sex 0.207 0.622 Cl 0 
Fe male 95 (74 8) 33 (84.6) 1.85 1.40 s:: z (0.71-4.83) (0.37-5.28) ~ 
r 
Male 32 (25.2) 6 (15.4) 1.00 ~ (reference) z 
Hospital type 0.132 0.069 (J I 
Tertiary 31 (24.4) 5 (12 .8) 0.46 0.28 ~ :;x:J 
referral center (0. 16-1.27) (0.07-1.10) ~ (J 
Non-academie 96 (75.6) 34 (87.2) 1.00 -I m 
:;x:J 
(reference) Vi 
-I 
Baseline GIQLI score 109.8 ± 19.7 82.7 ± 15.9 0.93 < 0.001 0.93 < 0.001 ?'i VI 
(0.91 -0.96) (0.91 -0 96) 
ASA fitness grade 0.855 
11 63 (49.6) 20 (51.3) 1.07 
(0.52-219) 
64 (50.4) 19 (48.7) 1.00 
(reference) 
Frequency of pain 0.33 0.50 2.39 0.025 2.95 0.035 
episodes a week (0.17-0.63) (0.21-1.00) (1.11-5.12) (1.08-8.08) 
Duration of longest 4.0 6.0 1.09 < 0.001 1.10 0.003 
pain episode (hours) (2 .0-6.0) (3.0-23.0) (1 .04-1.14) (1 03-1 .17) 
Maximum intensity of 91.5 95.0 1.01 0.546 
pain episode ranging (770-98.0) (79 3-1 00.0) (0.99-1.03) 
0-100 
Data are expressed as mean (standard deviation) or n (%) or median (interquartile range). 95% Cl, 95% 
confidence interval; ASA, American Society of Anesthesiologists; GIQLI, Gastrointestinal Quality of Life Index 
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using a database of a previous multicent re cohort study. A formal power ana lysis was 
therefore not conducted. Fina lly, the natural course of symptoms/ 5· 26 placebo effect 
of surgery, 27 or expectancy of patients28 may have biased the questionnaire answers. 
Concerning the wax and waning of abdominal pain episodes,5 we corrected for 
preoperative health status. Unfortunately, randomized trials to limit biased questionnaire 
answers were prohibited due to ethical reasons. 
This study included several strengths as well. First, the database of a prospective 
observational study was used limiting confaunding bias. Second, we used a standardized 
and validated questionnaire al lowing reliable comparisons with other studies using this 
widely translated and validated questionna ire. 15· 16 Third, using a single interviewer in 
all three eentres excluded interobserver bias. Finally, patients were recru ited from both 
tertiary and general hospitals increasing the generalizability. 
Since patients that benefit most in terms of health status impravement cannot be 
predicted using abdominal pain episode characteristics, future studies should assess 
which uncomplicated symptomatic cholecystolithiasis patients are at increased risk for 
complicated cholecystolithiasis. Although the risk of complications because of gallstones 
in uncomplicated symptomatic cholecystolithiasis patients is estimated to be only 1-3% 
a year, these complications can be serious and life threatening as previously reported 
in this journal 2 9· 30 Preventing uncomplicated symptomatic cholecystolith iasis patients to 
proceed to complicated symptomatic cholecystol ithiasis by early cholecystectomy would 
increase the cost-effectiveness of this common surgical procedure. 
In conclusion, frequency, maximum duration, and intensity of abdominal pa in episodes 
are not associated with a patient-reported clinically relevant impravement of health status 
at 12 weeks after cholecystectomy. Characteristics of abdominal pa in episodes cannot 
be used to inform patients with symptomatic cholecystolithiasis who are skeptic about 
the timing of cholecystectomy for optimal benefit Timing of cholecystectomy for these 
patients should therefore be based on other characteristics and preferences. 
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ABSTRACT 
In this updated Dutch guideline for diagnosis and treatment of gallstone disease we provide 
recommendations for management of cholelithiasis. The number of new cholecystectomy 
techniques, the development regarding the treatment of biliary pancreatitis, and many 
other recent studies on gallstone disease warranted an updated guidel ine. Recently, 
the Dutch health care insurance companies have noted considerable variations in practice 
of cholecystectomies in the Netherlands. Guidelines are eminently a tooi to reduce 
practice variations by offering recommendations for diagnosis and treatment, and levels 
of evidence of the studies on wh ich the guidelines are based. This guideline, formu lated 
on behalf of The Dutch Association of Surgery, The Dutch Association of Gastroenterology 
and Hepatology and The Dutch Association of Radiology serves as an evidence-based 
manual for clinicians for diagnosis and treatment of gallstone disease. 
INTRODUCTION 
Gallstone disease is one of the most prevalent gastrointestinal diseases in Western 
countries. 1· 2 Gallstones are most frequently diagnosed by ultrasonography. Most gallstones 
are asymptomatic and are treated conservatively. Treatment of symptomatic ga llstone 
disease (symptomatic cholecystolithiasis) is customized . The trad itional treatment of 
symptomatic cholecystol ithiasis is a cholecystectomy.3 Until the end of the '80's open 
cholecystectomy was considered the gold standard for treatment of cholecystolithiasis. 
By adopting minimal invasive techniques for cholecystectomies patients reeavered more 
quickly and morbidity decreased 4 The challenge to even further minimize incisions 
resulted in a number of new minimal invasive cholecystectomy techn iques. In addition, 
there have been several exciting studies regarding the management of bi lia ry pancreatitis. 
These and other recent innovations highlighted the need of an updated guideline on 
gallstone disease. The last Dutch guideline on management of ga llstone disease stems 
from 2007. We provide the reader with a revised guideline with concise recommendations 
for the diagnosis and treatment of gal lstone disease in order to guide the cl inician 
through the updated therapeutic environment. For the complete guideline we refer to 
www.heelkunde.nl. 
BACKGROUND 
In Western countries, approximately 75% of gal lstones are cholesterol stones and 25% 
are pigment stones.5 Cholesterol stanes can arise in case of cholesterol supersaturation 
due to increased cholesterol secretion and decreased bile salt and phospholipid secretion. 
Phospholipids and bile salts solubilize in mixed micelles. In case of excess cholesterol 
secret ion or decreased bile salt or phospholipid secretion, cholesterol crysta ls may nucleate 
from the supersaturated bile (the earliest event in gallstone formation) 6 · 7 lmpa ired 
gallbladder emptying allows aggregation of the cholesterol crystals into macroscopie 
stones. Risk factors for cholesterol gallstones include increasing age, female gender, 
obesi ty, substantial weight loss, pregnancy, ethnicity, parenteral nutrition, consumption 
of estragen or somatostatin analogues, and a positive family history. There is no evident 
association between dietary habits and the genesis of gallstones? 
Non-cholesterol gallstones can be divided into black and brown pigment stones. 
These stanes mainly consist of bil irubin . Black pigment stanes develop in the ga llbladder 
and are associated with hemolytic disorders including thaiassem ia or sickle cel Is disease, 
whereas brown pigment stones occur in the bileductsin general as aresu lt of infection 5 · 7 
Brown pigment stones mainly occur in the far East and often lead to relentless cholangitis 
(" oriental cholangitis" ). 
ASYMPTOMATIC CHOLECYSTOLITHIASIS 
The number of patients with incidentally detected asymptomatic cholecystolithiasis has 
increased, due to the introduet ion of ultrasonography. The prevalenee of asymptomatic 
cholecystolithiasis in people between the age of 20 to 69 years is 13% and rises to 
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22% in patients older than 70 years8 · 9 The overall cumulative 10 years incidence is 
6.6% in men and 8 .1 % in women. 10 In general, treatment of patients with asymptomatic 
cholecystolithiasis is considered to be inappropriate. 
Children and adolescents 
Asymptomatic cholecystolithiasis can also be detected in children and adolescents. 
Pregnant adolescents or patients with Down syndrome, with parentera l nutrition, or 
with hemolytic diseases including sickle cells disease or hereditary spherocytosis, have 
an increased risk of cholecystolithiasis. 11 · 12 In addition, obesity as a risk factor for 
cholecystolithiasis will become more important in children and adolescents, because 
the incidence of obesity is rising 0 Simi lar to adult patients, children and adolescents with 
asymptomatic cholecystolithiasis do not need prophylactic cholecystectomy. 
Diabetes 
Asymptomatic cholecystol ithiasis in healthy adult patients without diabetes should be 
distinguished from asymptomatic patients with diabetes. Asymptomatic cholecysto lithiasis 
is more prevalent in diabetic patients compared to the non-diabet ic population. 14 No 
causal relationship exists between diabetes and cholecystolithiasis. Both diseases including 
cardiovascular disease and obesity, known as the metabolic syndrome, are the result of 
a changed Western lifestyle and diet. 15 Despite a higher prevalenee of cholecystol ithiasis 
no indication exists requiring a different management in diabetic patients. 
Obesity I weight reduction 
The number of obese patients is increasing, particularly in Western countries. Besides 
dietary measures and medication, bariatric surgery offers the final salution to achieve 
weight reduction in a selected group of patients. However, weight lossof more than 1.5 
kilograms I week in combination with a fat intake of less than 7-10 grams a day leads to 
a significantly increased incidence of gallstone formation of up to 3% a week. 16 
The risk of gallstone formation appears to depend on the type of ba riatric surgery. 
Gastric banding does not lead to an increased risk of gallstone formation because weight 
loss is more gradual, whereas laparoscopie Roux-en-Y gastric bypass and laparoscop ie 
sleeve gastrectomy are associated with increased gallstone preva lence. Patients treated 
with Roux-en-Y gastric bypass did notshow a significant difference regarding symptomatic 
gallstones compared to patients treated with laparoscopie sleeve gastrectomyH· 18 lt is 
not necessary to perfarm a prophylactic cholecystectomy in patients with asymptomatic 
cholecystolith iasis whowil I have bariat ric surgery, despite the higher incidence of gal lstone 
formation after bariatric surgery. 19 Ursodeoxycholic acid of med ian 750 (500-1 200) 
milligrams a day prevents formation of gallstones and should therefore be considered 
during the period of weight loss. 20 
Transplantation 
The incidence of asymptomatic cholecystolithiasis increases in card iac, pulmonary, rena l 
and pancreas transplantation patients the first two years after transplantation with an 
increased incidence of complications. However, prophylactic cholecystectomy does nat 
appear to be justified in these patients. 21 In symptomatic cholecystolithiasis patients who 
underwent heart or lung transplation cholecystectomy should be performed at least 
five months after transplantation, because mortality of cholecystectomy is signif icantly 
increased in the first months after transplantation 22 In contrast , risks of treatment of 
cholecystolith iasis in patients with a history of asolid organ transplantation is camparabie 
to the general population. 21 
Uncomplicated symptomatic cholecystolithiasis 
Twenty-two percent of patients with asymptomatic cholecystolithiasis will become 
symptomatic within 9 years. 23 Symptomatic cholecystolithiasis is characterized by colicky 
pain as formulated by the ROME criteria. These criteria include pain, usua lly localized 
in the epigastric region or right upper quadrant of the abdomen, lasting for at least 
30 minutes.24· 25 In addition to bi liary col icky pain (OR 2.6, 95%CI 2.4-2 .6), radiation 
to the back (OR 2.8, 95%CI 2.2-3.7) and a positive react ion to simple analgesics (OR 
2.0, 95%CI 1.6-2.5) are weakly associated with gal lstones.26 lf al l three symptoms are 
present, the positive likelihood ratio for the clin ical suspicion of symptomatic gallstones 
is 1.34 (95%CI 1.05-1 .71 )27 Blood examinatien does nat contribute to the diagnosis of 
uncomplicated symptomatic cholecystolithiasis, but can aid in exclusion of bi le duet stanes 
or pancreatitis in selected cases. Ultrasonography with a sensitivity of 0.84 (95%CI 0.76-
0.92) and a specificity of 0 .99 (0.97-1 .00) is the most appropriate diagnostic moda lity 
to detect gallstones 2 8 The diagnosis of uncompl icated symptomatic cholecystolithiasis is 
therefore based on patients' history and ultrasound confirmed gallstones. 
Forthese patients cholecystectomy is the treatment of choice3 and can be performed 
in daycare setting 29 However, the indication of performing cholecystectomy is nat 
evidence-based and we therefore recommend to use the ROME criteria. Due to this 
lack of evidence variations in practice exist. In some areas in the Netherlands more 
cholecystectomies are performed compared to other areas which cannot be explained 
by demographic differences between patients30 In addition, symptoms may persist after 
cholecystectomy.31 We therefore recommend to discuss the risk of persistent symptoms 
with patients to create realistic expectations prior to a potential cholecystectomy. 
Both laparoscopie (LC) and small-incision cholecystectomy (S IC) have shown to be 
superior to open cholecystectomy32• 33 Recently, many innovations in cholecystectomy 
techniques have been developed. The goal of these innovations is to increase the minimal 
invasive aspect of removing the gallbladder. In mini-laparoscopie cholecystectomy 
(mini-LC) smaller trocars (two of 5 mm and two of 3 mm) are used compared to 
the trocars used in conventional laparoscopie cholecystectomy (two of 10 mm and two 
5 mm). Despite smaller trocars, mini-LC has nat shown to be superior to convent ional 
laparoscopie cholecystectomy. The duration of surgery is significantly langer and 
safety of this cholecystectomy technique is yet to be determined. 34 Another recent 
cholecystectomy technique is the single-incision laparoscopie cholecystectomy (SILC) in 
which an incision is made through the umbilicus. SILC is associated with better cosmetics 
on short-term fol low-up. However, SILC is associated with incisional hernia more often .35 
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In women, the gallbladder can also be excised through the vaginal orifice. Transvaginal 
cholecystectomy (TVC) is generally performed as part of a hybrid technique w ith an 
additional transabdominal laparoscopie entrance. TVC is not superior compared to 
conventional laparoscopie cholecystectomy. The duration of TVC is significantly longer.36 
Since none of the techniques have shown to be superior, we still recommend LC or SIC 
as first choice of treatment. 
COMPLICATED SYMPTOMATIC CHOLECYSTOLITHIASIS 
Symptomatic choledocholithiasis 
Choledocholithiasis is defined as the presence of gallstones in the common bile duet. 
Although bile duet stanes may cause complications such as jaundice, cholangitis and 
pancreatitis, biliary pain alone caused by bile duet stanes may be difficult to differentiate 
from biliary pain caused by gallbladder stones. Bile duet stanes can be loca lized in 
intrahepatic as well as extrahepatic bile ducts. Common bile duet stanes are frequently 
coexistent with gallbladder stones. The prevalenee of choledocholithiasis during 
cholecystectomy varies between 3.4% and 16.3% _37-45 This variation is probably caused 
by demographic differences and variations in use of additional diagnostic moda lities. 
Transabdominal ultrasonography is the diagnostic modality of first choice with high 
specificity (1.00, 95% Cl 0 .99-1 .00) and limited sensitivity 0.38 (95% Cl 0.27-0.49) 
for choledocholithiasis. Sensitivity and specificity for diagnosing a dilated common bile 
duet are 0.42 (95% Cl 0.27-0.49) and 0.96 (95% Cl 0.94-0.98), respectively4 6 The most 
important predietors of choledocholithiasis are shown in Table 1. Basedon these predietors 
a risk assessment of choledochol ithiasis can be determined. Additiona l diagnostics are 
recommended preoperatively in case choledocholithiasis is clinical ly suspected. The aim 
is to prevent a second operative intervention. lt is not recommended to routinely screen 
for choledocholithiasis, because its prevalenee is low and screening is therefore not cost-
effective. One can determine the indication for further screening based on predictive 
indicators. No additional diagnostic rnadalities are necessary, i ft he risk of choledochol ithiasis 
is low (positive likelihood ratio< 3). lf the risk of choledocholithiasis is moderate (posit ive 
likelihood ratio 4-7) additional magnetic resonance cholangiopancreatography (MRCP) or 
endoscopie ultrasound (EUS) are recommended. MRCP has a sensitivity of 92% (95%CI 
80-99%) and specificity of 94% (95%CI 83-99%) for choledochol ithiasis47 EUS shows 
camparabie results, but may be preferabie in case of small (<5 mm) bi le duet stanes which 
are often missed by MRCP48 Direct endoscopie retrograde cholangiopancreatography 
(ERC P) is only indicated in patients with a high risk (positive likelihood ratio > 1 0) of 
choledocholithiasis (i.e. cholangitis, jaundice, ultrasonographic detection of common 
bile duet stones). ERCP has the advantage that it al lows a simultaneous therapeutic 
intervention, but may cause serious complications. lntraoperatively performed ERCP is 
associated with less ERC P related complications and a shorter hospita I stay compared to 
preoperative ERCP. Scheduling intraoperative ERCP is however cha llenging for logistic 
reasons 4 9· 50 lntraoperative cholang iography (IOCG) may be performed as alternative, 
Table 1. Predietors of common bile duet stanes 
Positive likelihood ratio Predietors 
> 10 
4-7 
<3 
Cholangitis, jaundice, ultrasound detected common bi le duet stanes 
Ultrasound detected dilatation of the common bile duet, hyperbilirubinemia 
(> 2 the upper limit of normall 
Elevated alkaline phosphatase, pancreatitis, cholecystitis, elevated amylase 
or Iipase 
if ERCP facility is unavailable. However, its role for diagnosing choledochol ithiasis 
is cantroversiaL sl. s2 
Cholecystectomy is often conducted after ERCP and extraction of common bi le duet 
stones. Compared to conservative management after ERCP, cholecystectomy results in 
lower mortality and a decreased risk of recurrent biliary pain or cholecystitis, jaund ice 
or cholangitis, and need for ERCP or other forms of cholangiography. Conservative 
management may be justif ied in patients with important comorbidity.s3 The optimal 
timing of LC after ERCP is still unclear. A randomized trial showed that LC within 72 
hours after ERCP results in decreased risk of recurrent bil iary symptoms compared to 
LC after 6-8 weeks.s4 Remaval of bath gal lbladder stones and camman bi le duet stanes 
can be performed in a single operation by open or laparoscopie cholecystectomy with 
choledochotomy. LC combined w ith laparoscopie common bi le duet exploration showed 
camparabie morbidity and morta lity as ERCP foliowed by LC. but hospita! stay is shorter 
aft er single-stage treatment. ss. s6 Si nee the experience with common bile duet exploration 
decreases, postoperative morbidity increases.s7 Therefore, ERCP remains the therapy of 
first choice. lf ERCP with stone extract ion fails, open surgical transcystic stone extraction is 
a safe second option with low morbidity and a high success rate. s6 Other options include 
radiologica I endoscopie rendez-vous procedure or percutaneous gallstone removal, but no 
trials have been performed that assessed the role of these procedures ss Transcystic stone 
extraction is also a safe option with a success rate of 75% in case choledocholithiasis 
is diagnosed intraoperatively. Postoperative ERC P is indicated if transcystic stone 
extraction fails s9· 60 
Acute cholecystitis 
Acute cholecystitis is characterized by at least one loca l abnormali ty (a positive 
'Murphy sign,' pain in right upper quadrant) and at least one systemic abnorma lity 
(fever, leukocytosis, elevated CRP). The diagnosis can be confirmed with ultrasound. 
lf any discussion exists regarding confirmation of the diagnosis of acute cholecystitis 
a CT-scan can be performed. The severity is divided into severe, moderate or mild acute 
cholecystitis . Severe acute cholecyst itis is characterized by organ dysfunction. Moderate 
acute cholecystitis is characterized by leukocytosis (> 18* 103 cel Is I mm3), a palpable, 
sensitive resistance in the right upper quadrant, duration of at least 72 hours, or evident 
0 
c 
-1 
n 
I 
C\ ç 
0 
m 
r 
z 
m 
" 0 
:::0 
0 )> 
C\ 
z 
0 
V> 
Vi 
)> 
z 
0 
-1 
:::0 
m 
~ 
:s: 
m 
z 
-1 
0 
" C\ )> 
r 
r 
V> 
-1 
0 
z 
m 
0 
Vi 
m 
)> 
V> 
m 
131 
0 
c 
--1 
(") 
I 
Cl ç 
0 
m 
r 
z 
m 
"T1 
0 
::0 
0 
~ 
Cl 
z 
0 
Vl 
Vi 
)> 
z 
0 
--1 
::0 
m 
~ 
~ 
m 
z 
--1 
0 
"T1 
Cl 
)> 
r 
r 
Vl 
--1 
0 
z 
m 
0 
Vi 
m 
)> 
Vl 
m 
132 
local inflammation (biliary peritonitis, pericholic or hepatic abscess, gangreneus or 
emphysematous cholecystitis). Mild acute cholecystitis is characterized by absence of 
criteriafora more serious grade. 61 
Treatment options of acute cholecystitis included conservative management w ith or 
without antibiotics, cholecystectomy or percutaneous cholecystostomy (gal I bladder drain). 
Antibictic treatment of acute cholecystitis patients is empirica!. In most patients w ith mild 
acute cholecystitis intraveneus antibictic treatment does not imprave early outcome.62 
Only in immune compromised patients or patients with moderate or severe cholecystitis 
antibictics may be applied. Another point of discussion is whether cholecystectomy should 
be performed in an acute setting (<1 week) or in a delayed setting (>6 weeks). Acute 
cholecystectomy results in faster recovery compared to delayed cholecystectomy.63 Small-
incision or laparoscopie technique wil I be preferred, because of faster recovery compared 
to conventional open cholecystectomy. 64-66 For patients unfit for cholecystectomy because 
of severe comorbidity, percutaneous cholecystostomy is an alternative treatment option. 
Routineuseis not recommended in these patients.67· 68 eholecystostomy can be performed 
transhepatically or transperitoneally with no evidence-based preferenee for either one of 
the techniques. The drain can be removed after two weeks when using transhepatic 
drainage or after three weeks when using intraperitoneal drainage, because bile leakage 
will not occur after this period 69 
Cholangitis 
In patients with bile duet stones, clues suggesting systemic inflammation are fever (T > 38 
oe) or cold chil ls or an inflammatory response (leukocytes <4 or > 1 0* 103 /mm3, eRP :?: 10 
mg/L). Items characterizing cholestasis are jaundice (Total Bi lirubin 34 1-Jmoi/L) or elevated 
liver biochemica! tests (Alkaline phosphatase 1.5x the upper limit of normal value, gamma-
glutamyltransferase 1.5x the upper limit of normal value, aspartate aminotransferase 
1.5x the upper limit of normal value, alanine aminotransferase 1.5x the upper lim it of 
normal value). Radiological signs that may accompany cholangitis are biliary dilatation 
or proof of the etiology (stricture, stone, stent, etc.). eholangitis is suspected in patients 
with at least one item suggesting systematic inflammation, and at least one item showing 
cholestasis or radiological signs of cholangitis. The diagnosis is confirmed if one item in 
each category is present. Simi lar to the gradation of acute cholecystit is, the severity of 
cholangitis was divided into severe, moderate or mild. Severe cholangitis is characterized 
by organ dysfunction . Moderate cholangitis is characterized by leukocytosis (> 12 or 
<4* 103 cells/mm3), a temperature ;;::: 39 oe. age :?: 75 years, hyperbil irubinemia (total 
bilirubin :?: 85 IJmoi/L), or hypoalbuminemia (< lower limit of normal value x 0.7). Mild 
acute cholangitis is characterized by absence of criteriafora more serious gradeJo 
Treatment of cholangitis consists of administration of antibictics and bile duet 
decompression. Endoscopie decompression, irrespective of proven choledocholithiasis, 
results in lower morbidity and mortality compared to surgical decompression . No 
randomized trial has been performed that compared endoscopie drainage with 
percutaneous drainage. Stent insertion is preferred for initial drainage of severe acute 
cholangitis l 1 In addition, broad spectrum ant ibictics need to be administered because of 
the polymicrobia l nature of cholangitis. 72-74 Consequently, the mortal ity rate of cholangitis 
has dropped to 2.7- 10% _75 
Acute biliary pancreatitis 
lt was beyond the scope of this guideline to discuss the compl ete management of acute 
pancreatitis. This guideline aimed to discuss the treatment of acute bi liary pancreatitis. 
Acute pancreatitis is characterized by two items of the following features: Up per abdominal 
pain, serum amylase or Iipase > 3x the upper limit of normal, or signs of pancreatitis on 
imaging. Pancreatitis is likely of biliary origin if gallstones or sludge have been detected. 
Clinical assessment and monitoring of potential complications is essential l 6 1n mi ld acute 
biliary pancreatit is without signs of cholangitis ERCP with sphincterotomy does not reduce 
the incidence of early complications, nor mortality and is not recommended.77· 78 ERCP 
does need to be conducted in patients with acute bi liary pancreatitis w ith cholangitis 
within 24 hoursl 8 For patients w ith severe acute biliary pancreatitis without cholang it is 
it remains unclear if ERCP leads to less complications and mortality.77-79 In patients with 
severe comorbidity unfit for surgery ERCP solely for the treatment of recurrent acute 
biliary pancreatitis is sufficient. 80 
In all other patients cholecystectomy is recommended to prevent recurrent symptoms. 
The optimal timing of cholecystectomy is dependent on the severi ty of the pancreatit is. 
Cholecystectomy for mild biliary pancreatitis is recommended as early as possible with 
no increase in peroperative morbid ity.8 1 Early cholecystectomy in patients with severe 
acute biliary pancreatitis may lead to an increased incidence of infected co llections. 
Cholecystectomy forthese patients should, therefore, be delayed until the peripancreatie 
collections have been dissolved or after six weeks if the collections persist.8 2 
OTHER CHAPTERS 
Bile duet injury 
Bile duet injury is defined as any t ype of injury of the bile duet system including bi le leakage 
of the intrahepatic bile duet system and cystic duet. The incidence of bile duet inju ries 
in open cholecystectomy varies between 0-0.5%, whereas the incidence in laparoscopie 
cholecystectomy is assumed to be higher varying between 0.04-1.5% 32· 33· 8 3-86 Currently, 
no cl inical evidence with a low risk of bias exists suggesting higher or lower incidence 
of bile duet injuries in new cholecystectomy techniques including SILC or TVC compared 
to conventional laparoscopie cholecystectomy. Factors that may be associated include 
learning curve, insufficient overview, anatomical variations, and not reaching the critica! 
view of safet y83 Only 42% of bile duet injuries is identified during primary operation . 
Multiple classification systems of bile duet injuries exist. In this guideline the Amsterdam 
classification (Table 2) was applied because treatment resul ts d irect ly from this 
classification 8 7 lf bi le duet injury is detected during cholecystectomy without lost t issue, 
ciosure of the duet using end-to-end anastomosis over a T-drain is a good option. An 
experienced surgeon should perfarm the operatien after conducting a cholangiogram. 
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Table 2. Amsterdam classification of bile duet injuries 
Typ A Cystic duet leakage 
Type B Bile duet leakage 
Type C Bile duet stricture 
Type D Bile duet transeetion 
An acute hepaticojejunostomy cou ld be performed, if tissue of the bile duet is lost. 
Drainage of bile ducts and subhepatic fossa and treatment of sepsis is warranted, if 
bile duet injury is suspected after surgery. Bile duet injury type A should be treated by 
lowering the pressure gradient between the common bile duet and duodenum. Stenting, 
nasobiliary drainagewithor without papillotomy can be considered. There is no evidence 
with low risk of bias that shows a preferenee of any of the options or combinations. 
Bile duet injuries type B and C should be treated preferably by endoscopie stenting (type 
B without leakage) and stenting with dilations up to 12 months (type B w ith leakage 
and type C) with recurrent replacements of the stents. lf an elective operation remains 
indicated, a delay of 6 to 8 weeks delay should be followed, especia lly w ith bile duet 
injuries type B w ith leakage. A surgical reconstruction after 6-8 weeks also appl ies for 
bile duet injuries type D83 
Gallbladder polyps, unsuspected gallbladder carcinoma and routine 
h istopathology 
Gallbladder polyps are aften found with ultrasound incidentally. Patients w ith gal lbladder 
polyps of ;;:: 10 mm should be affered cholecystectomy due toa higher risk on gal I bladder 
cancer. 88 Polyps smaller than 10 mm have a benign natural history.89 Polyps ::; 6 mm do 
not need follow-up and for polyps z 7 mm follow-up frequency is unclear90 In add ition, 
sensitivity of ultrasonography for detecting gallbladder polyps is limited leading to 
a positive predictive value of 10.5%. 91 
The incidence of unexpected gallbladder carcinoma during or after cholecystectomy 
because of cholelithiasis is 0.4% in Western Europe. Approximately two third of all 
gallbladder cancers are diagnosed this way. The postoperative management of these 
patients depends on classification of the carcinoma.92 Patients with incidenta lly diagnosed 
gallbladder cancer Tis, T1a, T3, T4 after cholecystectomy do not need additiona l surgical 
treatment. Additional lymph node dissectien is recommended in case of T1 b gal lbladder 
ca neer, with an additionalliver segment resection in case of T2 gal I bladder ca neer. In case 
of suspicion of gallbladder carcinoma with local infiltration conversion of laparoscopie to 
open cholecystectomy has no evidence-based benefit9 3 
Routine histopathological examinatien for carcinoma in cholecystectomy specimen is 
not evidence-based. Histopathological examinatien of gallbladder specimens reviewed as 
macroscopically normal during cholecystectomy doesnotchange treatment or outcome of 
patients w ith unsuspected gallbladder carcinoma. 92 Therefore, routine histopatholog ical 
examinatien seems inappropriate. 
lntraperitoneal loss of gallstones 
Occasionally during cholecystectomy, the gallbladder is perforated resu lting into loss 
of gallstones. These lost stanes cause complications in 0.5-1 .4% of cases. The most 
frequently described complications are abscesses and fistulas. Nevertheless, there is no 
need for extensive search of lost gallstones during the surgery94 
Persistent symptoms after cholecystectomy 
In some patients symptoms persist after cholecystectomy. Causes of these persistent 
symptoms are very heterogeneaus ranging from irritable bowel syndrome, functional 
dyspepsia to reflux disease. Risk of persistent symptoms strongly depends on the indication 
of cholecystectomy. lncidences of up to 33% have been described for persistent abdominal 
pain of variabie intensity3 1 We recommend to inform patients about the relatively high 
rate of persistent symptoms after cholecystectomy in order to create real istic expectations. 
Sludge 
Sludge is defined as precipitation of cholesterol crystals or calciumbilirubinate granules 
embedded in mucin in the gallbladder or bile ducts. Sludge is usually diagnosed by 
ultrasonographical findings of echogenie materia l without shadowing. lt is considered 
to be a gallstone equivalent. Sludge should, therefore, in genera l be treated identical 
to macroscopie cholelithiasis.95 Nevertheless, it should be realized that under certain 
circumstances (e.g. after pregnancy or after rapid weight loss), sludge wi lll ikely disappear 
spontaneously. 
Pregnancy and cholelithiasis 
Pregnancy is a risk factor for deve loping sludge or cholesterol gallstones. lncidences 
vary between 2-4% tor asymptomatic and 0.16-0.8% for symptomatic cholelithiasis. 
Conservative treatment carries a risk of 38-69% for recurrent symptoms or complications. 
Cholelithiasis during pregnancy should be managed similarly to non-pregnant patients 
with cholelithiasis taking into account the first trimester. The second trimester or start 
of the third trimester seem to be the most appropriate semester for potential surgical 
intervention, because organogenesis has ended and the uterus size is sti ll limited.96 
The future 
Along wi th the introduetion of mini-LC, SILC and TVC, the ongoing development of 
less invasive surgical interventions wil l continue. The challenge of better cosmetics with 
less postoperative pain will lead to new cholecystectomy techniques . In add ition, due to 
financial constraints stricter indications and t iming of cholecystectomy will be assessed 
decreasing variations in practice. Studies will focus on ways of making management of 
cholelithiasis more efficient and cost-effective. Patient-reported outcomes w ill likely play 
an important role to accomplish this aim. 
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CHAPTER 10 
DISCUSSION & FUTURE PERSPECTIVES 

DISCUSSION 
The main aim of this thesis was to assess which patients diagnosed with uncomplicated 
symptomatic cholecystol ithiasis will benefit from cholecystectomy in terms of patient-
reported outcome measures . In addition, we aimed to evaluate a strategy to reduce 
the number of non-beneficia! cholecystectomies to avoid unnecessary treatment and 
health care expenses. The possible implications of our fi ndings for diagnosis and treatment 
of cholecystolith iasis are discussed and suggest ions for future research are offered. For 
this purpose, the journey of a patient with abdominal symptoms and gal lstones from 
diagnosis to treatment is scrutinized. 
Diagnosing and treating cholecystolithiasis 
Approximately 15 to 20% of the general population experience episodes of abdominal 
pain annually.1 Some 30% of these patients will visit a general practitioner (GP) which 
camprises 2 to 4% of all visits to GPs. 1· 2 Abdominal, presumed gallstone-related, pain 
may vary from typical acute colicky upper abdominal to more nonspecif ic chronic non-
colicky pain with or without concomitant dyspeptic symptoms. 3-5 Watchful waiting, 
empirica! treatment with antacids, or transabdominal ultrasonography are some of 
the options a GP may consider6 lf ultrasound has been performed and gal lstones have 
been detected, the GP wil I have to decide whether the stanes are an incidenta l findingor 
are associated with the abdominal pain and subsequently refer the patient toa surgeon l 
Evidence for watchful waiting or empirica! treatment with antacids or transabdominal 
ult rasonography is lacking, which introduces variat ions in general practice.8 In add ition, 
criteria for appropriate referral of patients with abdominal symptoms and gallstones are 
absent. Consequently, the number of patients with abdominal symptoms and gallstones 
visiting the departments of surgery differs per hospita! and region, likely adding to 
the variation of hospita! practice.9 
For surgeons it remains a challenge to determine if the abdomina l symptoms are 
associated with the ultrasound proven gallstones. Some of the options a surgeon may 
consider are conservative treatment, esophagogastroduodenoscopy (EGD) or elective 
cholecystectomy. Conservative treatment can be applied if comorbidity enhances the risk 
of significant complications due to cholecystectomy or if the probabil ity of persistent 
symptoms is estimated to be high. However, which high-risk patient wil l benefit from 
cholecystectomy and which high-risk patient w ill benefit from watchful waiting is 
currently not known. 10 In addition, conservative treatment can also be applied to abserve 
symptoms that are transient or would lead to clues suggesting other diagnoses. However, 
this option may be challenging to propose. Although the probability of persistent 
symptoms is high in some patients, patients expect to be scheduled for surgery.11 Not 
fulfilling these expectations may put the surgeon at risk for extensive conversations 
in the limited amount of time at the outpatient clinic. 12 Many patients have upper 
abdominal pain that might warrant further investigation. A strategy that has been used 
by physicians is to perfarm EGD early in the diagnostic process. However, EGD shou ld be 
considered selectively for those who have a clear indication. Our ana lysis demonstrated 
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that endoscopy rarely avoids cholecystectomy as the endoscopie findings aften did not 
point to abdominal symptoms (Chapter 6). 13 Guidelines reported that EGO should only 
be considered in case of alarm symptoms or in Helicobacter pylori negative patients of ;::: 
50 years with persistentor recurrent symptoms despite antacid treatment. 14• 15 No studies 
reported characteristics that warrant change of these criteria tor patients with gallstones 
in order to imprave the efficiency of EGO. 
Guidelines are lacking to guide surgeons which patient to offer an elective 
cholecystectomy and which patient to treat conservatively. Therefore, the ind ication to 
perfarm a cholecystectomy lies within the surgeons' preference. This leads to variations 
in hospita! practice and aften unnecessary cholecystectom ies in terms of postoperative 
symptoms.16•18 In this thesis, we distinguished postoperative symptoms in persistent and 
de nova symptoms (Chapter 2). 19 This distinction is probably less strict in daily practice 
and should rather be seen as part of a spectrum. Symptoms may have recurred or be 
more expressed and therefore considered as new-onset while in tact being persistent.20 
The distinction of persistentand de nova symptoms may be valuable to render the group 
of patients with postoperative symptoms less heterogeneous. 
This thesis discusses absence of symptoms as most appropriate patient-reported 
outcome to measure benefit of cholecystectomy. We found that the factors that 
showed an association varied across patient-reported absence of postoperative pain, 
improved abdominal symptoms, positive surgery results, or health status impravement 
(Chapters 4, 5, 8)2 1.23 These discrepant associations call tor an explanation. First, answers 
are dependent on which patient-reported outcome measurement (PROM) questionnaire 
that was used (Chapter 3}.24 Several confounders such as co-morbidities, mood, timing 
of measurement, and expectations of the treatment influence patient' responses on 
questionnaires25 A single comprehensive PROM that is consistent across comorbid ities, 
mood, timing, and expectations may be challenging to develop. An add itional cha llenge 
is not only the episodic nature of abdominal pain associated with ga llstones in some, but 
also the heterogeneaus phenotype of abdominal symptoms in others.3·5 
The different results between PROMs also applies tor the decision model. The cost-
effectiveness of a new strategy to select patients tor cholecystectomy is dependent on 
the PROM that is used. Absence of abdominal pain was used as PROM in the decision 
model (Chapter 7). Applying other PROMs such as patient-reported improved abdominal 
symptoms or positive surgery results would certainly influence the cost-effectiveness 
of cholecystectomy. Strict selection by the treating surgeon based on the episodic 
nature of abdominal pain or having abdominal pain 1 year or less, whi lst advocating 
the merits of a watchful wa iting approach is the best way to avoid unnecessary surgery in 
uncomplicated cholecystolithiasis patients and seems cost-effective in terms of absence 
of abdominal pain. 
Limitations and strengths 
There are some limitations of this thesis that need to be addressed. First, the defin ition 
of uncomplicated symptomatic cholecystolithiasis varies substantial ly among clinicians, 5· 
26 limiting the generalizabil ity of study results . A preoperative classification homogenizing 
this heterogeneaus patient group may have been helpful. Second, we experienced that 
the response rate of cholecystolithiasis patients to complete and return the questionnaire 
set was limited (Chapters 4, 5, and 8). In retrospect, we might have increased the response 
rate by using internet-based questionnaires in addition to paper-based questionnaires27 
We would also liked to have asked patients to complete the questionnaire at 
the outpatient clinic instead of at home to prevent questionnaire set completion and 
return to be forgotten. However, the medical ethics committee emphasized that we had 
to offer patients time for reflection prior to taking part in this study. Finally, we performed 
decision analytic modell ing using a treatment arm of usual care and a treatment arm 
of restrictive care (Chapter 7). Watchful waiting was one of the treatment options in 
the decision model. Decision analytic modeling is based on assumptions which approach 
reality as closely as possible. Unfortunately, very few studies have been conducted 
adopting a watchful waiting period in patients with cholecystolithiasis and abdominal 
symptoms28 This makes it challenging to extrapolate our findings in a real world setting. 
Strengths of th is thesis included the use of the Gastrointestinal Qual ity of Life Index 
(GIQLI) as generic and the McGill questionnaire (MPQ) as disease specific questionnaire.29•32 
Other studies used the GIQLI as a disease specific questionnaire and the Short Form 36 as 
generic questionnaire33.35 By using a pain questionnaire as disease specific questionnaire 
we valued the main predietor of patient-reported success of surgery.36 The diagnosis 
of uncomplicated symptomatic cholecystolithiasis is based on abdominal pain adding 
significanee to the use of a pain questionnaire as disease specific questionnaires. 26 
The MPQ and GIQLI are standardized and validated and therefore our study resu lts can 
easily be used for comparisons with future studies. Other strengths are our attempt to 
substantiate broad-established healthcare based on evidence. In this t ime of austerity 
the effectiveness of resources should be considered. 37 Many costs could and should 
be saved by not performing unnecessary procedures with associated complications. 
lncreasing evidence of effectiveness would limit room for interpretation by clin icians 
concerning the use of a certain procedure. 
G uidelines are emi nently a tooi to reduce practice variations byoffering recommendations 
for diagnosis and treatment. The Dutch national guideline for diagnosis and management 
of gallstone disease was revised during the writing of this thesis (Chapter 9). Compared 
to the original guideline the revised gu ideline not only included higher levels of evidence 
concerning treatment of biliary pancreatitis and acute cholecystitis, but also reported 
about the effectiveness of cholecystectom ies. The right indication for cholecystectomy 
for patients with uncomplicated symptomatic cholecystolithiasis is in accordance with 
the ROME 111 criteria for symptomatic gal lstone disease combined with rad iological 
detected gallstones. Currently, the level of evidence for this condusion is rated to be 
low. However, studies included in this thesis and upcoming studies wil l certainly imprave 
the level of evidence and thereby imprave the effectiveness of cholecystectomies. 
Future perspectives 
Although we aimed to increase the patient benefit and effectiveness of cholecystectomies, 
this thesis is only one piece of a large puzzle of personalizing healthcare for patients 
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with cholecystolithiasis. There are some potential areas for future research we would 
like to discuss. First, a randomized tria l should be performed to assess if a restrictive 
care strategy with a stepwise selection for cholecystectomy is at least as effective as 
usual care for patients with features of symptomatic cholecystolith iasis. In fact, such 
a randomized controlled trial is being performed at the time of f in ishing this thesis. 38· 
39 Second, the focus of practice variations has been limited to hospitals, wh ile 
inappropriate cholecystectomies may be prevented by limiting unnecessary referrals from 
general practices to surgery departments. The extent of general practice variation and 
determinants associated with these variations should be part of future stud ies.40 Third, 
cholecystectomy and watchful waiting are treatment options mostoften applied in clinical 
practice. Remarkably, the lack of evidence supporting watchful wa iting strategy suggest 
there is much evidence to gain for this option . For example, dietary restrictions to reduce 
abdominal symptoms should be studied. Many patients report that fatty or spicy nutrition 
provoked episodes of abdominal pain in our daily clinical practice. Patients who initiated 
a strict diet eliminating these nutritional components resulted in lessen ing of complaints 
in some of these patients. In addition, watchful waiting is often applied in patients w ith 
cholecystolith iasis and comorbidity who are considered high-risk for surgery. However, 
evidence to justify this option is insufficient. 10• 41 Fourth, as mentioned in the limitations 
and strengths section, a classification of uncomplicated symptomatic cholecystolithiasis 
needs to be developed. The clinical presentation of patients w ith uncompl icated 
symptomatic cholecystolithiasis is very heterogeneous, complicating effective application 
of diagnostic and therapeutic options . Uncomplicated symptomatic cholecysto lithiasis 
may be part of a spectrum with asymptomatic cholecystolithiasis and severe acute 
cholecystitis on the ends of the spectrum. In line with the Tokio Guidelines,42· 43 criteria 
for diagnosis and severity should be determined and validated. In addition, pred ietors 
of patients with cholecystolithiasis at risk for complicated cholecystol ith iasis should be 
determined as these patients may benefit from earlier cholecystectomy. Final ly, PROMs 
should be measured routinely to assess which patient benefits from a certa in treatment. 
By using internet-based questionnaires at follow-up and tablet-based questionnaires at 
the outpatient clinic the response rate may increase, limiting potential selection bias. 
lf symptoms due to cholecystolithiasis are so difficult to disentangle and 
cholecystectomy is far less successful as we always thought, it becomes comprehensibly 
that cholecystolithiasis is not a phenomenon on itself. Maybe cholecystolithiasis is 
merely a surrogate diagnosis of a much braader diagnosis of 'metabolic syndrome.' This 
metabolic syndrome causes a great variation of symptoms related to the digestive t ract. 
With this awareness we need not to focus on diagnosing and treating a subdiagnosis 
(e.g. cholecystolithiasis), but the whole scale of related symptoms. This urges us to 
refocus on the secondary prevention and especially primary prevention of the cause of 
the metabolic syndrome, such as lifestyle, food overconsumption, and physical exercise. 
As modern healthcare becomes more and more expensive, standardized measurement of 
patient-reported outcomes combined with clinical parameters is key to increase the cost-
effectiveness and appropriateness of healthcare resources. Outcome driven and patient-
centred care should therefore be put at the heart of clinical decision-making. 
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SUMMARY IN ENGLISH 

Chapter 1 is the first part of the introduetion of this thesis and presents an overview of 
gallstone disease, the treatment options and the phenomenon called practice variations. 
Chapter 2 is the last part of the introduetion systematically reviewing the effect of 
cholecystectomy on abdominal symptoms. The aim of cholecystectomy in a large share 
of patients is to relieve abdominal symptoms that are caused by gallstones. However, 
a cholecystectomy is frequently ineffective in termsof postoperative abdominal symptoms. 
These postoperative abdomina l symptoms can be divided into persistent and de nova 
symptoms. This distinction may be useful tobetter predict which patient w ill likely benefit 
from cholecystectomy from patients that w ill not. 
Chapter 3 describes the methods to reduce variations in practice by asking patients 
routinely if they have benefited or not from a certain treatment. The volume of medical 
actions and the results strongly vary between countries, but also between regions w ithin 
one country. The quality of hea lthcare is suboptima l, patients risk complications because 
of unnecessary interventions and there are unnecessary healthcare expenses, because of 
these variations. In this chapter a perspective is described on how to reduce variations in 
practice by using patient-reported outcome measures (PROMs). lf data of differences in 
outcomes are combined with data of regional variations in practice, it will be elucidated 
in which region toa many or toa few interventions are being conducted. 
Chapter 4 describes the results of a multi-centre prospective cohort study in which pain 
characteristics are assessed that predict which patient wil I benefit of cholecystectomy and 
which patient will not using PROMs. Pat ients with a better health status with episodic 
abdominal pain lasting for a year at the most have the highest risk of being f ree of 
pain after a cholecystectomy. However, these characteristics are nat associated with 
impravement of abdominal symptoms or with the surgery results. Th is discrepancy shows 
that there are variations of patients' expectations of cholecystectomy. Selection of patients 
most likely tobenefit from cholecystectomy basedon preoperative patient characteristics, 
whilst advocating the merits of a watchful waiting approach, is, for the present, the best 
way to avoid unnecessary surgery in patients with uncomplicated cholecystolith iasis . 
In chapter 5 the results are described of a prospective cohort study of the effects of 
cholecystectomy on long-term abdominal symptoms, that are measured with PROMs. 
Abdominal pain associated with gallstones frequently appears in episodes, sametimes 
with interva ls of several years. Therefore, a cholecystectomy may seem to have cured 
abdominal pain at short-term follow-up, but symptoms may reappear at long-term 
fol low-up. Approximately 90% of patients rated their abdomina l symptoms to have 
improved compared to befare the operation and considered the surgery resu lt to be good, 
despite residual pain in a significant part of these patients. None of the characteristics 
were consistently associated with al l three outcome measures. Absence of pain at three 
months after cholecystectomy is associated with absence of pain at long term follow-up. 
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In chapter 6 the results are described of a systematic review and meta-ana lysis of 
the value of esophagogastroduodenoscopy (EGD) in patients w ith ga ll stones that have 
been referred for cholecystectomy. EGD can be a diagnostic modality to detect alternative 
causes for the abdominal symptoms. In addition, there is discussion if EGD should be 
applied selectively or routinely in patients that have been referred for cholecystectomy. 
In this study 36.3% of patients that received an EGD, had an abnormal it y in t he upper 
digestive tract. In 3.8% of the total number of patients cholecystectomy was avoided 
because treatment had cured the symptoms. Most patients in whom a cholecystectomy 
was avoided had a gastrointestinal ulcer. The value of EGD to prevent unnecessary 
cholecystectomies is lim ited and should therefore only be applied select ively. 
Chapter 7 described the results of a cost-effectiveness study of a new strategy to 
select patients that will benefit of cholecystectomy. The selection criteria for the new 
strategy are abdominal pain being presentfora maximum of one year and having pa in in 
episodes. The new strategy of using one out of two selection criteria may be an effective 
but also a cost-effective methad to reduce the proportion of patients with pain after 
cholecystectomy compared toa strategy of applying no strict criteria as in current pract ice. 
Chapter 8 shows the results of a subgroup a na lys is of the prospective mu lti-centre cohort 
study. C holecystolithiasis represents a clinical spectrum that ranges from asymptomatic 
gallstone disease to uncomplicated symptomatic gallstone disease to acute cholecystitis. 
Patients with asymptomatic gallstone disease benefit least from cholecystectomy in terms 
of impravement of health status and should receive conservative ca re. Those w ith acute 
cholecystitis benefit most and should receive surgery. The opt imal t iming t hat results 
in the highest benefit for patients with uncomplicated symptomatic cholecystol ithiasis 
remains less clear. Classically, uncomplicated symptomatic gallstone disease is 
characterized by biliary colicky pain . The frequency, maximum duration and intensity of 
these colics are variabele . This ana lysis assessed whether these characteristics of biliary 
colicky pain were associated with a clinically relevant impravement of health status after 
cholecystectomy. No association was shown, causing the timing of cholecystectomy with 
the highest benefit to be individualized. 
Chapter 9 is the last part of the results of this thesis. In an overview a summary is 
given of the Dutch guideline of 'diagnosis and treatment of cholelithiasis.' A guideline is 
eminently a tooi to reduce variations in practice by combining the best available evidence 
as an answer to clinical relevant research questions. The guideline has been updated w ith 
respect to the first version that was published in 2007. 
Chapter 10 is the discussion of th is thesis. In this part suggestions are described for 
future research to reduce variations in practice with respect to the t reatment of variations 
in practice. 


SUMMARY IN DUTCH 
(SAMENVATTING IN HET NEDERLANDS) 

Hoofdstuk 1 vormt het eerste deel van de inleiding van dit proefschrift en geeft een 
overzicht van het ziektebeeld galsteenlijden, de behandelingsmogelijkheden en het 
fenomeen dat praktijkvariatie heet. 
Hoofdstuk 2 is het laatste deel van de inleiding waarin het effect van cholecystectomie 
op buikklachten systematisch wordt beschreven. Het doel van een cholecystectomie bij 
een groot deel van de patiënten is het verlichten van buikklachten, die door galstenen 
zouden worden veroorzaakt. Echter, een cholecystectomie is vaak ineffectief in termen 
van postoperatieve buikklachten . Daarbij kan een onderscheid worden gemaakt tussen 
persisterende symptomen en nieuwe symptomen . Deze onderverdeling kan mogelijk van 
nut zijn om beter te voorspellen welk type patiënt baat zal hebben van een operatie en 
welke niet. 
Hoofdstuk 3 beschrijft de methode om variaties in praktijk terug te dringen door 
routinematig patiënten zelf te vragen of ze wel of geen baat hebben gehad bij een 
behandeling . De hoeveelheid aan medische handelingen en het resultaat ervan variëren 
sterk tussen landen, maar ook tussen regio's binnen één land. Door deze var iatie is 
de kwaliteit van zorg suboptimaal, lopen patiënten onnodige risico's op compl icaties door 
onnodige ingrepen en zijn er onnodige kosten. In dit hoofdstuk wordt een perspectief 
beschreven hoe praktijkvariatie te verminderen door gebruik te maken van patiënt 
gerapporteerde uitkomstmaten ofwel PROMs (Patient-reported outcome measures). 
Als men gegevens over verschi llen in resultaat combineert met gegevens over reg iona le 
praktijkvariaties, wordt duidelijk waar teveel en waar te weinig wordt behandeld. 
Hoofdstuk 4 beschrijft de resultaten van een prospectief cohort onderzoek met meerdere 
centra waarin, gebruikmakend van PROMs, pijn karakteristieken worden bepaald die 
voorspellen welke patiënt baat heeft bij een cholecystectomie en welke niet. Patiënten 
met een betere gezondheidstoestand met episodische klachten die maximaal een jaar 
duren hebben de hoogste kans om pijnvrij te worden na een cholecystectomie. Echter, 
deze karakteristieken zijn niet geassocieerd met verbetering van buikklachten of met 
het chirurgie resultaat. Deze discrepantie toont aan dat er verschil is in verwachtingen 
die patiënten kunnen hebben van een cholecystectomie. Om patiënten te selecteren die 
waarschijn lijk baat hebben van een cholecystectomie, kan vooralsnog het best gekeken 
worden naar preoperatieve patiëntfactoren, terw ijl ook de voor- en nadelen voor een 
afwachtend beleid moeten worden meegewogen. 
In hoofstuk 5 worden de resultaten beschreven van een prospectief cohort onderzoek naar 
de effecten van cholecystectomie op buikklachten op de lange term ijn, die zij n gemeten 
met PROMs. Buikpijn die geassocieerd wordt met galstenen komt vaak in episodes, soms 
met intervallen van enkele jaren. Daardoor kan het lijken alsof een cholecystectomie 
de buikpijn heeft genezen op de korte termijn, maar klachten kunnen dan toch weer 
verschijnen op de lange termijn. Ongeveer 90% van de patiënten oordeelde dat hun 
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buikklachten beter waren ten opzichte van voor de operatie en het chirurg ie resu ltaat 
als positief, terwijl een groot deel van deze patiënten niet vrij van pijn was . Geen van 
de karakteristieken was voorspellend voor al deze drie uitkomstmaten. Als patiënten 
geen bu ikpijn meer hebben na 3 maanden is dit voorspellend voor afwezigheid van pijn 
op de lange termijn. 
In hoofdstuk 6 worden de resultaten beschreven van het systematisch literatuuronderzoek 
en de meta-analyse van de waarde van een oesophagogastroduodenoscopie (EGD) bij 
patiënten met galstenen die verwezen zijn voor een cholecystectomie. EGO kan een 
diagnosticum zijn om alternatieve oorzaken voor de buikklachten op te sporen. Ook is 
er discussie over het feit of dat EGD selectief of routinematig moet worden toegepast 
bij patiënten, die voor een cholecystectomie worden verwezen. In deze studie komt 
naar voren dat 36,3% van de patiënten, die een EGO ondergingen, een afwijking heeft 
in de bovenste tractus digestivus. Bij 3,8% van het totale aanta l patiënten werd een 
cholecystectomie voorkomen. De meeste van de patiënten waarbij een cholecystectomie 
voorkomen werd hadden een gastra- intestinaal ulcus. De waarde van EGD ter voorkom ing 
van onnodige cholecystectomieën is beperkt en zal daarom alleen selectief moeten 
worden toegepast. 
Hoofdstuk 7 beschrijft de resultaten van een kosteneffectiviteitsonderzoek van een nieuwe 
strategie om patiënten te selecteren die baat zullen hebben van een cholecystectomie. 
De selectie criteria voor de nieuwe strategie zijn buikpijn die maximaal een jaar aanwezig 
is en het hebben van episodische pijn. De nieuwe strategie gebruikmakend van 1 van 
de 2 criteria lijkt niet alleen een effectieve, maar ook kosteneffectieve methode om het 
aantal patiënten met pijn na een cholecystectomie te verm inderen ten opzichte van een 
strategie waarbij geen strikte criteria worden gehanteerd zoals in de huidige praktijk. 
Hoofdstuk 8 toont de resultaten van een subgroep analyse van het prospectieve 
cohort onderzoek met meerdere centra. Galsteenlijden kan worden gezien als een 
klinisch spectrum dat varieert van asymptomatisch galsteenlijden naar ongecompliceerd 
symptomatisch ga lsteenlijden naar een acute galblaasontsteking. Patiënten 
met asymptomatisch galsteenlijden hebben in het algemeen geen baat van een 
cholecystectomie en worden doorgaans conservatief behandeld. Patiënten met een 
acute galblaasontsteking hebben juist veel baat hebben van een cholecystectomie en 
worden doorgaans geopereerd. Wanneer patiënten met ongecompliceerd symptomatisch 
galsteenlijden het meeste baat hebben van een galblaasoperatie is minder du idelijk. In het 
klassieke geval wordt ongecompliceerd symptomatisch galsteenlijden gekarakteriseerd 
door kolieken. Deze kolieken variëren in frequentie, maximale duur en intensiteit. In deze 
analyse werd onderzocht of deze karakteristieken van kolieken geassocieerd waren met 
een klinisch relevante verbetering van de gezondheidstoestand na een cholecystectomie. 
Er werd geen associatie aangetoond, waardoor het tijdstip van de cholecystectomie 
waarbij de meeste gezondheidswinst kan worden behaald per ind ividu moet 
worden afgewogen. 
Hoofdstuk 9 vormt het laatste deel van de resultaten van dit proefschrift. In een 
overzicht wordt een samenvatting gegeven van de Nederlandse richtli jn 'onderzoek en 
behandeling van galsteen lijden.' Een richtlijn is bij uitstek een middel om praktijkvariatie 
te doen beperken door het best besch ikbare bewijs te bundelen als antwoord op klin isch 
relevante onderzoeksvragen. De richtlijn is geactualiseerd ten opzichte van de eerste 
versie verschenen in 2007. 
Hoofdstuk 10 vormt de discussie van dit proefschrift. In dit deel worden suggest ies voor 
toekomstig onderzoek beschreven om praktijkvariatie ten aanzien van de behandel ing 
van galsteen patiënten te verminderen. 
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